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ABSTRACT 
 
Animal studies show that periconceptional maternal supplementation with 
nutrients involved in the provision of methyl-groups can alter DNA methylation patterns 
in the offspring. This thesis examines possible associations between maternal nutrition 
and offspring DNA methylation patterns in humans in the context of seasonal influences.  
Two complementary studies were conducted in rural Gambia. The ‘indicator’ 
group enrolled 30 non-pregnant women and followed them monthly for one year, to 
measure dietary intakes and blood biomarker levels of choline, betaine, folate, methionine 
and vitamins B2, B6 and B12, as well as plasma homocysteine, S-adenosyl-methionine 
(SAM), S-adenosyl-homocysteine (SAH), cysteine and dimethylglycine (DMG). The ‘main’ 
group enrolled 136 mother-infant pairs, with infants conceived at the peak of the rainy 
(July to September) or dry (February to April) season. The same panel of blood 
biomarkers were measured on maternal samples collected early in pregnancy. In the 
infants, DNA methylation at seven metastable epialleles (MEs) was assessed.  
Significant seasonal variation was observed within the indicator group for dietary 
intakes of choline, betaine, folate and B2 and all metabolic biomarkers. A possible change 
in dependence between the betaine and folate pathways between seasons was identified. 
Within the main group, a seasonal variation was observed in both maternal biomarker 
levels and infant DNA methylation. The rainy season was associated with a higher 
maternal SAM:SAH ratio, higher concentrations of most methyl-donors (folate, betaine and 
methionine) and cofactors (B2 and B6) and higher infant DNA methylation. DNA 
methylation at the MEs studied was associated with B2, cysteine and the SAM:SAH and 
DMG:betaine ratios, but not with the other biomarkers.  
 7 
These data suggest that Gambian seasonality influences maternal methyl-group 
supply, which may be linked to DNA methylation patterns in offspring. Future work is 
required to confirm this observation, and understand precise mechanisms, so optimal 
nutrition at critical phases can be determined. 
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PART I:  
INTRODUCTION 
 
 
 “…epigenetic changes, at least in part, explain the link between a poor start to life 
and later disease risk. It strengthens the case for all women of reproductive age having 
greater access to nutritional, education and lifestyle support to improve the health of the 
next generation, and to reduce the risk of the conditions such as diabetes and heart disease 
which often follow obesity" (University of Southampton’s press release, 18th April 2011; 
Mark Hanson British Heart Foundation Professor and Director of the University of 
Southampton's Human Development and Health Unit) 
 
 
CHAPTER 1. BACKGROUND TO THIS THESIS 
In this PhD thesis the background, design and findings of the study conducted by 
myself in rural Gambia from June 2009 through July 2011 are presented. The thesis also 
includes a final discussion where potential future developments are illustrated and some 
conclusions for further research are provided.  
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1.1. THESIS STRUCTURE 
This PhD thesis follows a ‘mixed style’, where research papers are incorporated 
into broader thesis Chapters. Four stand-alone documents have been included, all written 
by myself as first author: a book Chapter on epigenetics which is waiting for editor’s 
revision for publication, has been included as part of the introductory literature review. 
The three other stand-alone documents are scientific papers: the first (literature review 
on one-carbon metabolism, in Chapter 2, Section 2.2.) is published; the second (results of 
one of the PhD studies, in Chapter 4, Section 4.1.) has been submitted and comments from 
reviewers are currently being addressed; and the third (results of the other PhD study, in 
Chapter 5, Section 5.1.) is shortly going to be submitted, in peer-reviewed journals. The 
different manuscripts are focused on the same research topic but are submitted as 
independent research contributions. Inevitably, this has led to some repetition of concepts 
and methods. In addition, where critical information was not covered in the research 
papers but was considered relevant to this thesis, additional details are described 
separately. Each manuscript is prefaced by the required cover sheet.  
Part I contains three introductory Chapters: Chapter 1 is an introduction to the 
thesis, Chapter 2 an introduction to the research topic (including the review paper 
published and a book Chapter on epigenetics) and Chapter 3 an introduction to the PhD 
research studies. Part II contains two Chapters, each detailing one of the two study groups 
investigated as part of this PhD project. Chapters 4 and 5 comprise one research paper 
each, as well as additional information and results. Part III contains a final discussion and 
conclusions for both studies in combination (Chapter 6). It also describes directions for 
future research, as well as outlining future publications to be written, not included in this 
thesis. 
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1.2. CANDIDATE’S INVOLVEMENT 
I defined the topic of this thesis and the main hypothesis in close collaboration 
with my two supervisors, Dr Branwen Hennig and Dr Sophie Moore, as well as Prof 
Andrew Prentice, Dr Sharon Cox and Dr Tony Fulford. The research forms the 
continuation of a pilot project that I conducted as MSc student in ‘Public Health Nutrition' 
at the London School of Hygiene and Tropical Medicine (LSHTM) in 2007, on intake of 
methyl-donors in The Gambia. My contribution involved all stages of the Wellcome Trust 
(WT) grant proposal preparation and study design including definition of methods, liaison 
with our collaborators and elaboration of the budget. 
Once the grant proposal was approved, I started working at the Medical Research 
Council (MRC) International Nutrition Group (ING) and became the MDEG (Methyl-Donors 
and Epigenetics) project principal investigator (PI), based primarily at the MRC Keneba 
field station in The Gambia. There, I took responsibility for the development of all the 
preparatory documents (field manual, protocols and ethical applications) and for setting 
up, implementing and monitoring the project data collection. I was based full-time in The 
Gambia for two years in order to organise, conduct and supervise the field data collection. 
Prior to the start of the fieldwork, I was in charge of planning the logistics, designing the 
database and training the study team (field assistants, lab technicians, nurses and data 
clerks). During the study, I also organised the field visits and lab work, participating in 
them when possible and then supervising and monitoring the sample collection by the lab 
and field teams when I was not available to lead. I organised the shipment of samples to 
collaborators and monitored data entry. Particularly, a great deal of the dietary data entry 
was done by myself to pilot the new version of the dietary software, and I also contributed 
with Darren Cole, its designer and programmer, to the software development. The data 
cleaning was carried out by myself.   
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All statistical analyses presented in this thesis fell under my responsibility, 
receiving expert statistical guidance from Dr Tony Fulford. This thesis was entirely written 
by me and I am first author on all research papers presented as part of it. The papers I 
wrote were commented on by the relevant co-authors, whose inputs were incorporated 
prior to submission for publication.  
 
1.3. COLLABORATING INSTITUTIONS 
Very specific laboratory work was needed for each of the areas of this project, for 
which MRC ING did not have the equipment or the expertise. Therefore, at the point of the 
initial grant application, appropriate collaborators, who were well-known experts in their 
field were identified. At the stage of the sample analysis, I visited all the laboratory 
facilities and I was shown or participated in the techniques used, hands-on. These 
collaborators and their institutions were the following:  
- Prof Steven H. Zeisel (Department of Nutrition, Gillings School of Global Public Health 
and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North 
Carolina, USA). His team analysed the food sample content for choline and betaine. 
- Prof Sheila Innis (Department of Pediatrics, University of British Columbia, 
Vancouver, British Columbia, Canada). Her team analysed the maternal plasma 
biomarkers. 
- Prof Rob Waterland (Departments of Pediatrics and Molecular & Human Genetics, 
Baylor College of Medicine, USDA/ARS Children's Nutrition Research Center, Houston, 
Texas, US). His team analysed the infant DNA methylation. 
- Christine Clewes and Lorna Cox (MRC Human Nutrition Research (HNR), Elsie 
Widdowson Laboratory, Cambridge, UK). They organised the B2 status assays. 
Additionally, Darren Cole, Dr Gail Goldberg and Dr Celia H Prynne (MRC-HNR) 
provided the computer tools for the dietary assessment.  
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1.4. FUNDING 
A grant to support this research was awarded by the Wellcome Trust (WT ref. 
086369MA) to Dr Branwen Hennig, with Dr Sophie Moore and Prof Andrew Prentice as 
co-PIs and myself as named researcher. This research grant covered most costs of the 
project, including my salary and laboratory analysis of substances under study by 
collaborators and commercial laboratories. MRC core funding to the International 
Nutrition Group (MC-A760-5QX00) covered additional fieldwork costs in The Gambia.  
 
1.5. STUDY TIMELINE 
The chronology of the fieldwork activities and subsequent analysis is shown in 
Appendix I. 
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CHAPTER 2: STUDY BACKGROUND 
 
2.1. INTRODUCTION 
Evidence for the intra-uterine environment’s influence, in early development, on 
susceptibility to chronic diseases such as cardiovascular disease (CVD) or diabetes during 
adulthood (1) is now compelling. Maternal undernutrition is one such influence (2), which 
may be of particular relevance in low- and middle-income countries (LMICs) . As an 
example, between five and 20% of African women have a low BMI as a result of chronic 
undernutrition (3). Additionally, it was estimated that more than 20 million infants 
worldwide (15.5% of all births) are born with low birth weight, and 95.6% of these in 
LMICs (4). Around 15% of the infants born in sub-Saharan Africa weigh less than 2,500 g 
(4). In parallel to this, in LMICs undergoing social, nutritional and economic transition, 
chronic diseases are becoming critical in mortality rates (5): 41 million people are 
estimated to die of chronic non-communicable diseases (NCDs) in 2015, out of a total of 64 
million deaths, and four out of five of these deaths will be in LMICs (6). In addition to 
mortality rates, chronic diseases remain amongst the top causes of disability-adjusted life-
years (DALYs) lost globally. NCDs have a huge negative impact, particularly in LMICs 
economies, since NCDs usually affect people still economically productive (7). For 
example, the global health burden of stroke alone is of 44 million DALY’s lost (8) and 
estimated losses to gross domestic product as the result of coronary disease, 
cerebrovascular disease, and diabetes in 2005 were $20 million dollars in a country such 
as Ethiopia (8).  
The concept of ‘mismatch’ relates to the metabolic response to fetal nutritional 
deficits, designed to cope with environments where nutrition is marginal (and potentially 
providing short-term advantages), but which may then be detrimental when followed by a 
transition environment with energy excess and lack of exercise (9). This can manifest with 
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disease and thus can become a key cause of increasing prevalence chronic diseases in 
LMICs (10). Adaptations to environmental insults during critical windows of development 
may permanently alter physiological function, through changes in tissue and organ 
structure, metabolism or gene expression (11). The mechanisms triggering these 
permanent changes are known as “metabolic programming” or also, given that nutrient 
supply variations are thought to be one of the stronger environmental stimulus for these 
adaptive processes, “nutritional programming” (12). The molecular basis for these 
mechanisms is still unclear. Several candidate mechanisms have been identified, such as: 
1) permanent structural changes in an organ due to suboptimal concentrations of key 
factors during development (e.g. reduction in ß cells in the endocrine pancreas); 2) 
persistent epigenetic modifications altering gene expression (e.g. DNA methylation); and 
3) permanent effects on regulation of the cellular aging (e.g. increases in oxidative stress) 
(13), which might interact to a different extent. Disentangling and understanding such 
mechanisms is paramount to design appropriate prevention interventions.  
This PhD is aiming at contributing to this broad goal, by focusing on metabolic 
programming, specifically DNA methylation, an epigenetic mechanism which has attracted 
a lot of attention in the recent past due to its role in cancer and other chronic conditions as 
well as early development (14). DNA methylation consists of the addition of methyl-
groups to the DNA chain, a process that interferes with transcription. Methyl-groups 
utilised in DNA methylation (described in detail in Section 2.2.2.) come ultimately from the 
diet. This thesis investigates whether the links observed between maternal dietary 
methyl-donor supply and epigenetic outcomes in the offspring in animal models also 
operate in man, thus aiming to increase our knowledge of epigenetic processes occurring 
during early human development. 
This Chapter contains a literature review of my research topic (Section 2.2.), with 
sections from a book Chapter which introduces the different epigenetic mechanisms 
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(Section 2.2.1) and a published review paper that provides further detail on DNA 
methylation, the links with nutrition and the existent evidence of DNA methylation in fetal 
programming (Section 2.2.2.). Section 2.3 includes the background information about the 
study setting (West Kiang, The Gambia), and Sections 2.4 and 2.5. introduce my PhD 
research studies.  
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2.2. LITERATURE REVIEW 
2.2.1. BOOK CHAPTER – ‘Epigenetics’  
Article cover sheet:  
1. For a ‘research paper’ prepared for publication but not yet published 
1.1. Where is the work intended to be published?  
This manuscript is a book Chapter on Epigenetics written for publication in a 
textbook on “Basic principles of genetic epidemiology in human and infectious 
diseases”. The purpose of this Chapter is to give an introductory overview to 
different epigenetic mechanisms and their importance in human developmental 
physiology and disease. As there is substantial overlap with other sections 
included in this thesis, two full sections have been eliminated from the book 
Chapter, namely those sections which describe the dependence of methylation on 
dietary substrates (one-carbon metabolism) and the role of epigenetics in fetal 
programming, areas thoroughly discussed in the review paper I in Section 2.2.2. 
Other sections in this Chapter go beyond the scope of this thesis, as they describe 
in broad detail the epigenetic diseases and therapy, and therefore, I have also 
excluded them from this thesis.  For the easy flowing of the text, the rest of the 
book Chapter sections have remained untouched, even if some repetition still 
exists. 
1.2. List the paper’s authors in the intended authorship order 
Dominguez-Salas P and Moore G 
1.3. Stage of publication – Not yet submitted/Submitted/Undergoing revision from 
editor’s comments/In press 
It was submitted on 01/10/2010.  
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2. For multi-authored work, give full details of your role in the research included in the 
paper and in the preparation of the paper. (Attach a further sheet if necessary) 
I was approached by the editors to write this book Chapter. I led the writing phase 
and it was then reviewed by Prof Gudrun Moore (Institute of Child Health, 
University College of London, UK). The Chapter is currently awaiting feedback 
from the editors. It reviews epigenetic mechanisms in a broader sense, with 
special attention to DNA methylation, and their health and disease consequences.  
 
 
Candidate’s signature ________________________ 
Supervisor or senior author’s signature to confirm role as stated in (2) ______________________  
 30 
EPIGENETICS 
Paula Dominguez-Salas1, Gudrun Moore2 
1 MRC International Nutrition Group, London School of Hygiene & Tropical Medicine, London, UK 
2 Institute of Child Health, UCL, London, UK 
 
 
 
The ‘Human Genome project’ (HGP) was launched in 1990 (15) to sequence the 
genome and to map the approximately 19,600 genes contained within it (16). By 2003 the 
sequence of 3 million base pairs had been obtained. Now the actual biological functions of 
these genes need to be elucidated. After this wonderful breakthrough in 2003, scientists 
launched the next stage in gene regulation discovery, the delineation of the epigenome. 
This is the study and mapping of the layer of information or chemical modifications on top 
of the DNA bases, found to be key in both regulation and function of the genes beneath. 
In 1950 Waddington (17) defined the term ‘epigenetics’ as “any mechanism by 
which multicellular organisms with identical genotype in all cells could develop diverse 
expression patterns or phenotype”. The modern definition describes epigenetics as “the 
study of stable and heritable alterations in gene expression potential, which is not 
mediated by DNA sequence alteration” (18, 19). Epigenetic marks can even be inherited 
through generations (transmitted from parent to offspring via the gamete) and this has 
been shown in both plants and mice (20). However, apart from the well characterised 
imprinted genes (discussed in Section 2.2.1.) the transgenerational epigenetic inheritance 
has not been shown in humans (21). 
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2.2.1.1. Molecular Mechanisms in Epigenetics 
The basis of epigenetics is complex, bringing together different additive molecular 
layers collectively referred to as epigenome. There are many different molecular 
modification or mechanisms that fall under the term ‘epigenetics’ with common 
agreement in the inclusion of DNA methylation, histone modifications, antisense RNAs and 
small interfering RNAs. All these different epigenetic mechanisms physically regulate DNA 
transcription of specific genes for expression or silencing, without altering the primary 
DNA sequence. Depending on the gene, epigenetic disturbance may lead to different 
phenotypic outcomes, some physiologically beneficial (i.e. oncogene suppression) and 
others detrimental (i.e. developmental syndromes).  
 
DNA methylation 
DNA methylation is the best-characterised epigenetic mechanism to date, due to 
its chemical stability and the development of sophisticated analytical methods to study it 
in vitro. In mammals, DNA methylation occurs mainly at C5 of the pyrimidine ring of 
cytosine bases within CpG dinucleotides, converting it to 5-methylcytosine with the 
addition of a methyl-group (-CH3). This covalent modification inhibits the affinity of 
methylation-sensitive DNA binding proteins, affects chromatin structure and ultimately 
correlates with transcriptional silencing (22). 
In normal mammalian cells most of the genomic CpG sites (90-98%) are 
methylated, and this includes exons, intergenic DNA and transposons (23). Transposons 
are mobile genetic elements that can ‘move’ to different locations in the genome. Although 
the reason is unclear, it is thought that it could be a protective mechanism against 
expression of unwanted genes (24). Conversely, CpG-islands have a high density of CpG 
and are found in 50-60% of gene promoter regions (25). CpG-islands are typically 
unmethylated and act as a regulation switch. A gene can be hypermethylated overall but 
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have a hypomethylated promoter region which will control its expression (23). One of the 
‘Human Epigenome project’ (HEP) aims is to analyse the patterns of DNA methylation in 
the regulatory regions of all known genes (19). This is a major undertaking, as an 
individual’s epigenotype is unique. Although some methylation sites are likely to be 
common for every cell (i.e. those encoding “housekeeping” proteins), distinct tissue-
specific methylation patterns exist for many genes with specialised functions in each 
individual (26).  
 
Figure 2.1: One-carbon metabolism 
 
DMG, dimethylglycine; Gly, glycine; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; 
Ser, serine; THF, tetrahydrofolate. 
 
The methyl-groups for DNA methylation are supplied by S-adenosyl-methionine 
(SAM) (see Figure 2.1), and are catalysed by various types of DNA methyltransferases 
(DNMTs). De novo methylation patterns during gametogenesis, embryogenesis and tissue 
differentiation are established mainly by DNMT3A and DNMT3B, activity of which is 
down-regulated upon differentiation of embryonic stem cells and remains low during 
adult life. Maintenance of these patterns in somatic cells is dependent on different DNMT1 
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variants, which also have some de novo activity (27). The way these modifications remain 
stable in cells relies upon the 10-fold higher enzymatic avidity of DNMT1 for 
‘hemimethylated’ cytosine (from DNA where only one of the two strands are methylated). 
Therefore, when DNMT1 reaches a hemimethylated portion of DNA, with a methyl-group 
in one of the two strands, it loads the methylation mark onto the newly synthesised 
strand, as found in the parental strand (27). The accuracy to copy DNA methylation 
patterns is estimated at 96% (28). Recent studies have suggested that DNMTs can have a 
dual role both in methylation and demethylation (29, 30). Studies interfering with the 
activity of these essential DNMTs during embryonic development have led to abnormal 
development in humans (31), and genome-wide hypomethylation and embryo death in 
mice (32, 33). 
 
Histone-based epigenetic marks 
Nuclear DNA is organised in the form of chromatin, a highly compact 
nucleoprotein complex whose basic unit is the nucleosome, which can adopt different 
three-dimensional conformations (34). The nucleosome consists of a 146 bp stretch of 
DNA wrapped around a histone octamer (2 pairs of H2A, H2B, H3 and H4 histone 
proteins). Each histone has a N-terminal tail rich in basic amino acids, which is key to the 
folding of nucleosomes and inter-nucleosomal interactions (34). Thus, chromatin can 
appear in two states depending on the necessity for accessibility by transcription binding 
proteins: euchromatin, more open and transcriptionally competent, and heterochromatin, 
condensed and transcriptionally silent.  
Some genomic regions are made up entirely of heterochromatin, but other regions 
can undergo transition between the open and the compact conformation (22). Post-
transcriptional covalent modifications such as methylation of lysines and arginines, 
phosphorylation of serines and threonines, ubiquitination and sumoylation of lysines, 
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acetylation or ADP-ribosylation, mainly at the N-terminal tail of aminoacids and catalysed 
by specific enzymes (e.g. HAT-histone acetyltransferases-, HMT-histone 
methyltransfersases-, etc.), can affect transcription by modifying the configuration of the 
chromatin towards one or the other state. Additionally, histone modifications can affect 
the activity of non-histone proteins. The effect depends on the type of modification, their 
number (i.e. diacetylation, trimethylation, etc.) and location (34) within the histone. For 
example, lysine acetylation is generally associated with increased transcriptional activity 
(35, 36). Lysine methylation can lead to activation or repression of transcriptional activity, 
depending on the residue position and the degree of methylation (37). These 
modifications also play a role in DNA repair and can be reversed by specific enzymes. The 
existence of these permutations and the way they influence each other and DNA 
methylation in dictating locus specific transcriptional competence of each cellular type 
suggests the idea of a “histone code” (22). However, this code has not yet been deciphered 
fully, as novel modifications are continually being characterised (34). Additionally, as 
histones completely detach from the DNA during replication, it remains unclear how these 
patterns are maintained through cellular division. Nevertheless, there is strong evidence 
of the heritability of histone modifications, and is thought to rely mainly on the (H3-H4)2 
tetramer (38).  
 
RNA-based regulation marks; non-coding RNAs and antisense RNAs 
Non-coding short RNAs like micro-RNAs (miRNAs) may also trigger post-
transcriptional silencing of target genes (39), by specific base pairing with complementary 
mRNA sequences in the 3’ untranslated regions resulting in either inhibition or 
degradation of mRNA (40). About 60% of human mRNA are targeted by miRNAs and they 
are involved in cell differentiation, proliferation and apoptosis (41). They can be altered 
by miss-expression or mutation (22). MiRNAs also have tissue specific expression 
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contributing to cell identity (42). Antisense RNA was the first non-coding RNA found to 
have post-transcriptional regulation function. 
 
Non-histone protein-based regulation marks 
Although not directly participating in chromatin modifications, three types of 
proteins are critical for epigenetic regulation: chromatin remodelling complexes, effector 
binding-proteins and insulator proteins (25). Specific CpG-binding proteins such as MeCP2 
interpret DNA methylation by recruiting transcribing or repressing complexes that 
decipher the histone/DNA methylation marks. Polycomb-group proteins can remodel 
chromatin and target human gene promoters, throughout development (43). Other factors 
are involved in chromatin structure and gene regulation, such as nucleosome positioning, 
whose presence or loss at the transcription start site results in inactivation or activation 
respectively, maybe by affecting the access for binding of transcription factors (44).  
 
Relations between epigenetic mechanisms 
The different mechanisms seem to ‘crosstalk’ in an orchestrated manner, creating 
an ‘epigenetic landscape’ (37) that reinforces the desired signal and establishes a 
transcriptionally favourable/unfavourable chromatin conformation (19). For example, 
some specific histone modifications can promote DNA methylation and vice versa (45, 46). 
Methyl-CpG-binding protein MeCP2, when attached to methylated cytosines, appears to 
attract other proteins with enzymatic activity that promote nearby histone deacetylation 
(31). MiRNAs and small interfering RNAs (siRNAs) have also been shown to crosstalk with 
other epigenetic processes, by regulating the involved enzymes in DNA methylation and 
histone modification (47, 48). It has been suggested that CpG-islands not associated with 
annotated promoters could mark the transcription start site of non-coding RNAs (35). 
 36 
The rules governing the establishment and maintenance of epigenetic marks are 
still poorly understood, but it is believed that genetic variation in the underlying DNA 
sequence itself, as well as in the sequence of unlinked modifier loci do play a role (49). A 3-
generation study of 48 families observed considerable interindividual variation at 
methylation of specific genes (i.e. IGF2/H19 and IGF2R) but also familial clustering, 
suggesting a genetic component to the epigenetic variation (50). However, as discussed in 
the next sections, environmental factors and stochastical processes are also known to be 
involved.  
 
2.2.1.2. Epigenetics in development 
Epigenetic regulation has been found to operate very actively in normal mammal 
cell functioning, from conception to aging and death (35). A well-known example of 
physiological epigenetic activity is genomic imprinting, mono-allelically expressed genes 
for which only maternal or paternal allele are expressed. Approximately 70 imprinted 
genes are known in man and over 100 in mice (45). A good example is the insulin-like 
growth factor-2 gene (IGF2) on chromosome 11p15.5, encoding a developmental growth 
factor.  It is maternally suppressed and paternally activated (maternally imprinted). Many 
imprinted genes are involved in growth and metabolism. This mechanism is thought to 
respond to conflicting interests of the parental genomes in the offspring growth and 
development (paternal imprinting would favour the production of larger offspring, and 
maternal imprinting favours smaller offspring) (51). Another classic example is X 
chromosome inactivation in women, where one of the two copies of the X chromosome 
randomly selected within each cell (52) is silenced by promoter methylation, resulting 
also in mono-allelic gene expression (53). 
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Prenatal development  
Reprogramming of DNA methylation of the totipotent zygote takes place in 
primordial germ cells and during pre-implantation (25). Mammal sperm and egg genomes 
are highly methylated when compared with somatic cells. However, a few hours after 
fertilisation, rapid demethylation of the paternal DNA takes place by active but yet 
undefined mechanisms, in addition to histone modification acquisition (54). The maternal 
DNA follows a slower and more passive process than sperm, with demethylation by simple 
dilution of DNA methylation during replication, preventing DNMT activity at the 
replication fork (55). Despite genome-wide hypomethylation, some imprinted regions 
maintain their methylation status at this point, guided by histone modifications (54). Up to 
the morula stage, DNA methylation remains reduced and cells are pluripotential with all 
genes potentially active (45). Simultaneously, primordial germ cells undergo changes in 
histones and reorganization of chromatin. After implantation genome-wide resetting of 
epigenetic marks occurs for most of the genome in a lineage-specific manner, and 
continues to a lesser extent over the rest of the fetal development. Re-methylation at this 
stage varies upon the part of the embryonic tissue concerned and whereas ectoderm and 
mesoderm become hypermethylated, primary endoderm and trophoblast remain 
hypomethylated. There seems to be a sequence of re-methylation dictating the structure 
and function of each somatic tissue (56).  
Inherited paternal/maternal imprinting is erased during gametogenesis to 
establish new imprints according to the sex of the parent-to-be in the embryonic gametes 
(57). As the embryo develops into one of the sexes, gene imprinting is placed accordingly 
(e.g. paternal imprinting during sperm production) (25). DNA methylation is not the only 
epigenetic mechanism involved in imprinting but seems to be the most important.  
Early embryogenesis is critical in the establishment of epigenetic patterns but the 
timing of events remains unclear in humans. In mice, primordial germ cells appear at day 
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7.5 of gestation (58), and their epigenetic patterns are completely removed by day 15.5. 
Methylation patterns are then re-established, with a sex-specific timing. In the male, de 
novo methylation begins at day 15.5-18.5 of gestation and continues post-natally (59).  
Total methylation is thought to change over time (60, 61), whereas methylation at 
specific loci, such as imprinted genes, seems to be more stable. Thus, most studies so far 
have concentrated on the more than 70 imprinted genes identified to date in human (57) 
(web catalogue at http://igc.otago.ac.nz/home.html). Failure to adequately propagate 
epigenetic marks onto newly synthesised chromatin during cell replication may lead to 
severe mitotic defects and apoptosis (62, 63). 
 
Cell differentiation 
Differentiated cells in a multi-cellular organism are genetically identical, with the 
exception of B and T lymphocytes. These cells can differ structurally and functionally, 
expressing only the genes that are necessary for their own activity (54). Epigenetic 
mechanisms contribute to loss of pluripotency and confer individual cell characteristics, 
combining genotype, developmental history and environmental influences (54). Tissue-
specific CpG-islands methylation of genes essential for development has been found, 
suggesting programming of DNA methylation patterns (64). Thanks to the activity of 
enzymes such as DNMT1, tissue patterns are maintained during mitosis (65). Epigenetic 
marks can be kept through life, until maintenance mechanism start to deteriorate due to 
oxidative stress or ageing. However, changes can occur also as a response to 
environmental, behaviour, physiological or pathological signals (18). 
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Role of environmental signals 
A molecular response to environmental changes is an interesting feature of 
epigenetics. It is considered as a possible interface between genes and the environment in 
determining phenotype (21). External factors leading to epigenetic dysregulation include 
dietary excess or deficiency of key nutrients (e.g. folate deficiency), chemical carcinogens 
such as tobacco smoke or dietary contaminants (e.g. aflatoxin B1), environmental agents 
(e.g. arsenic), ionising or UV radiation, lifestyle (e.g. stress) or infectious agents (e.g. 
Helicobacter pylori, human hepatitis virus).(66).  
 
Figure 2.2: Maternal diet-induced hypermethylation at agouti viable yellow (Avy) allele 
 
Effects of maternal dietary methyl supplementation during pregnancy on the epigenome of viable 
yellow agouti (Avy) mice, leading to variation in coat-color phenotype of Avy/a offspring in isogenic 
Avy/a animals. The Avy alleles of yellow mice are hypomethylated, allowing maximal ectopic agouti 
expression. Avy hypermethylation silences ectopic agouti expression recapitulating the agouti 
phenotype (Waterland et al., Mol Cell Biol, 2003) 
 
In mouse models some genes, namely metastable epialleles sensitive to 
environment influences, have shown to undergo epigenetic changes and exhibit variable 
expression in an isogenic context. The most classic example of metastable epialleles is the 
agouti viable yellow (Avy) allele. The Avy allele is a dominant mutation of the murine 
agouti (A) locus, caused by the insertion of a retrotransposon which acts as an alternative 
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promoter for this gene which, when active, leads to expression of a yellow coat colour. 
When the promoter is silenced by methylation, a pseudoagouti coat colour is produced 
(darker) (see Figure 2.2). It has been shown experimentally that maternal 
supplementation with methyl-donors alters the proportions of the litter coat colour 
towards pseudoagouti and that this is also associated with higher level of methylation (67-
69). Another interesting study showed that the dam’s behaviour during lactation (licking 
and grooming) could also alter DNA methylation of a glucocorticoid receptor gene 
promoter in the hippocampus in their litter and lead to modified responses to stress (70). 
 
2.2.1.3. The role of epigenetics in disease 
The well studied example of the Avy yellow mouse also shows the interesting 
phenotypical traits of obesity and insulin resistance due to epigenetic silencing, whereas 
pseudoagouti mice remain lean throughout their lifetime (21). In humans, one of the most 
useful models for the study of epigenetics and disease is the one provided by pairs of 
monozygotic twins, of identical genotype, whilst not being phenotypical identical, and 
exhibiting discordant susceptibility to complex diseases (diabetes mellitus, schizophrenia, 
cancer, etc.). It has been reported that monozygotic twins have similar DNA methylation 
patterns at early age, these patterns diverging over the lifetime on overall content and 
distribution of methylated cytosines and histone acetylation. Many of the discrepancies 
seemed to refer to Alu sequences (short retrotransposon elements that have the ability to 
cause epigenetic dysregulation of neighbouring genes, and thus with potential effect in 
human disease) (60). 
Aberrant epigenetic marks have shown to be involved in a whole array of diseases, 
including diseases evident at birth or in infancy and chronic diseases becoming 
symptomatic later in life. Although epigenetic marks are deposited early in development, 
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adaptations occurring through life can lead to major epigenetic reprogramming and thus 
to disease. 
 
2.2.1.4. Epigenetic technologies 
Highly specialised animal models and combination of novel analysis technologies 
have helped rapidly expanding knowledge in epigenetics, and particularly DNA 
methylation. Sodium bisulfite treatment of DNA converts unmethylated cytosine residues 
into uracil, whilst methylated cytosine residues remain unchanged, thus used to identify 
methylated cytosines and assess DNA methylation level (71). Other techniques exist to 
identify methylation sites such as methylation-sensitive restriction enzymes, Aza-
labelling, immunoprecipitation, etc. Sequencing allows the DNA methylation state to be 
determined.  
Genome-wide profiling with restriction landmark genomic scanning has been 
successful in identifying differentially methylated sequences, but is labour intensive and 
associated with bioinformatics problems (72). Oligonucleotide tiling microarrays offer a 
more affordable alternative though they are being challenged already by next-generation 
sequencing platforms.  
Modern ‘Methylation chips’ – akin to genotyping chips - allow for a comprehensive 
genome-wide profiling of DNA-methylation using ‘BeadChip’ technology, that includes 
bisulfite treatment, whole-genome DNA amplification, hybridization and single-base 
extension, fluorescence staining and scanning of chip. The number of CpGs sites that can 
be interrogated simultaneously, keeps expanding with each new generation of 
methylation chips and allows for a high-throughput of samples at ever decreasing costs 
with advancements in technology. 
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2.2.1.5. Outlook 
Many of the difficulties and challenges faced at present by epigenetics have already 
been highlighted. Ultimately our aim is to fully understand the role of epigenetics in 
complex diseases for molecular diagnostic and therapeutic applications in medicine. This 
includes regulation and crosstalk of the epigenetic pathways, the stability and rewriting 
over time, the extent of external exposure required or the timing of events, particularly 
whether responsiveness to diet and other factors during development is restricted to 
more vulnerable and sensitive periods or expanded during the life-course. 
To achieve this, it is necessary to develop data resources analogous to those 
currently existing in genetics, to establish epigenomic maps describing patterns of inter-
individual variation. In this sense, the HEP is orders of magnitude larger than the 
analogous HGP. DNA methylation might be the easiest candidate for epidemiological 
studies due to the covalent nature of the bond, not being lost during routine DNA 
extraction, as opposed to the more complex histone modifications. Methylation analysis 
will also allow for the exploitation of existing DNA biobanks for epigenome mapping 
purposes (73). This approach must keep in mind that biobanks mostly contain DNA from 
blood, which will not be a reflection of activity in other tissues and the data should be 
viewed with caution. Research on epigenetics is challenging but the potential for discovery 
and for progress in health and disease makes it an exciting field to work in! 
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2.2.2. RESEARCH PAPER I –‘ Maternal nutritional status, one-carbon 
metabolism and offspring DNA methylation: a review of current 
evidence in human subjects’.  
Article cover sheet:  
1. Research paper already published 
1.1. Where was the work published?  Proceedings of the Nutrition Society 
1.2. When was the work published?  February 2012 
1.2.1. If the work was published prior to registration for your research degree, give 
a brief rationale for its inclusion        N/A 
1.2.2. Was the work subject to academic peer review?  Yes  
1.2.3. Have you retained the copyright for the work? Yes 
If yes, attach evidence of retention  See Appendix II 
 
2. For multi-authored work, give full details of your role in the research included in the 
paper and in the preparation of the paper. 
I was selected in a postgraduate competition to present preliminary results from 
my PhD at the Postgraduate Symposium of the Nutrition Society Summer Meeting 
2011 and to have a review paper on my research topic published in the 
Proceedings of the Nutrition Society journal. I wrote the manuscript and my co-
authors provided comments which were incorporated prior to submission. The 
paper was also revised based on the peer reviewer’s comments.  
 
 
Candidate’s signature ________________________ 
Supervisor or senior author’s signature to confirm role as stated in (2) ______________________ 
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2.2.3. Additional discussion on human studies 
The Dutch Hunger Winter cohort produced the first evidence of DNA methylation 
response to ‘in utero’ nutritional influences (74, 75). Heijmans, Tobi et al. focused initially 
on IGF2 DNA methylation, showing an association of prenatal famine exposure with 
persistent hypomethylation in the offspring, compared to non-exposed. They identified for 
the first time a critical window in early pregnancy, consistent with the hypothesis of 
sensitivity during the resetting of the methylation patterns after erasure. However, the 
changes in IGF2 methylation could not be related to gene expression and, although they 
hypothesised the DNA methylation changes might be related to a deficiency in methyl-
donors such as methionine, they could not conclude it, nor could rule out other factors 
such as stress (74). They then expanded this research to a larger number of imprinted and 
non-imprinted genes within pathways important for growth and metabolic disease. They 
investigated whether the effect of prenatal famine observed was extended to DNA 
methylation of other genes and if it mirrored the sex and time specific associations 
observed through epidemiological studies of prediction of phenotypes in this cohort. The 
second study concluded that exposure to famine could result in higher or lower DNA 
methylation in different genes, which suggested a more ‘intelligent adaptive response’ 
rather than a ‘deficiency response’. An interaction of DNA methylation at certain genes 
with sex and an effect of maternal malnutrition exposures later in gestation were found to 
be significant in this study (75). Important limitations of these studies were that: i) they 
were retrospective and could not link the DNA methylation to the individual intake (even 
if the ration distribution had been the same, there could be important differences in the 
actual intakes); and ii) they had not been related to any phenotypic outcome and thus it 
remained unknown what the real effects of that magnitude of DNA methylation change 
were. The results of both studies can neither be easily explained by deficiency in methyl-
donors nor explain differences in susceptibility to disease at later ages observed in that 
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population. The authors also tried to link DNA methylation at four of the studied genes 
with being born small for gestational age, without any association identified (76). 
However, a later study provided for the first time evidence in humans that increase in 
infant IGF2 DNA methylation was associated with maternal use of folic acid and with 
maternal SAM level as well as with a decrease in birth weight (77). Another study looking 
at determinants of variation in DNA methylation patterns in newborn infants also 
highlighted the association of DNA methylation with maternal B12 but not with folate 
(78). These studies strengthen the case for DNA methylation as a mechanism for fetal 
programming and for plasticity being dependant on methyl donor supply. However, they 
do not take account of the complexity of the one-carbon metabolism and the involvement 
of other components of the diet and substrates of one-carbon metabolism, which might 
result in non-linear associations. This complexity and the small to modest sample sizes 
might lead to inconsistencies found between studies in the associations with biomarkers. 
Also, said studies have the problem of inter-tissue variability of DNA methylation within 
an individual, which might affect the interpretation. Furthermore, the studies do not (as 
yet) provide information of phenotypes in the long-term. The Gambian study (79) was 
new in that it looked at MEs (with no inter-tissue DNA methylation variation by 
definition), and surprisingly showed a robust consistency in the response to season of 
conception (hypothesised to be mediated by methyl-donors deficiency) of different genes 
and a greater effect size than the previous studies in humans had shown. The relevance of 
methylation patterns at MEs in terms of health outcomes is yet to be elucidated, although 
animal models show that MEs have the potential to be involved in disease (69).  
All in all, the evidence available in humans for maternal methyl-donor deficiency 
effects on offspring DNA methylation at the design of this study was scarce, but of great 
interest to warrant further investigation.  
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2.3. STUDY CONTEXT: WEST KIANG, THE GAMBIA 
2.3.1. The Gambia 
The research presented in this thesis was conducted in the rural West Kiang 
region of The Gambia. With 11,295 km2 distributed over a narrow strip of about 15 km on 
each side of the river Gambia, the Republic of The Gambia is the smallest country on 
mainland Africa (see Figure 2.3, left side). It is located on the West coast, 13º 28’ North of 
the Equator, and bordered to the North, East and South by Senegal. The Gambia gained its 
independence from the UK in 1965. 
 The Gambian population, of five main ethnic groups (42% Mandinka, 18% Fula, 
16% Wolof, 10% Jola and 9% Serahuli) (80) and predominantly Muslims, was estimated at 
1,73 million in 2010 (81). The Gambian 2010 Human Development Index was 0.390, 
placing it in the 151th position out 169, with a Gross National Income per capita of $1,358, 
a 34.3% of the population in severe poverty (below poverty line) and a life expectancy at 
birth of 56.6 years (82). According to the 2011 UNICEF report on The State of the World’s 
Children, the prevalence of HIV in 2009 was 2.0%, the under-five mortality rate was 103 
per 1000 and the proportion of infants with low birth weight was 20% (83). The rural 
population included 63% of the total inhabitants and the adult literacy rate was 45% (83).  
The Gambian population, as happens in other sub-Saharan countries, is in the early 
stages of shifting towards urbanisation and undergoing a nutrition transition (84). Both 
these demographic and nutrition transitions are likely to lead to changes in lifestyle and a 
‘double-burden of disease’, where malnutrition and infectious diseases coexist with an 
increasing prevalence of non-communicable diseases (NCDs), including obesity, 
cardiovascular disease or type -2 diabetes (5). Hypertension is prevalent in urban Gambia 
and not rare in some rural areas of the country (85). Obesity among Gambian women 35 
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years or older was found to be between 32.6% in urban areas, down to the 4% in the rural 
area around Farafenni (86). 
Figure 2.3: Map of The Gambia, West Africa 
Reproduced from The Gambian Experience (regional map) and The Lonely Planet (Gambian map) 
 
2.3.2. West Kiang 
West Kiang is a district in the Lower River Region (see Figure 2.3, right side) with 
13,800 inhabitants registered in 2009 (West Kiang Demographic Surveillance System, WK 
DSS) in 34 villages, in approximately 750 km2 with limited road access. Of these, 2,480 
were estimated to be women of reproductive age. The population is predominantly 
Mandinka (see Figure 2.4). Villages in West Kiang are divided into compounds, where 
extended families live together, with an average size of 16 people per compound (WK 
DSS). Roles for men and women are distinctive and well defined. Women are the main 
workforce: cooking, growing and harvesting the staple foods (87). Men are also involved 
in agriculture, but mainly in groundnut cultivation (traditionally the main cash crop). 
Rural subsistence farming is the main livelihood. Thus, income and eating patterns 
fluctuate strongly according to the annual farming calendar, heavily influenced by the 
monomodal annual rainy season (88).   
West	Kiang	
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Figure 2.4: Village population size by ethnicity in West Kiang 
 
Source: West Kiang Demographic Surveillance System, data from 2010 (provided by T.Fulford and 
B.Hennig) 
 
2.3.3. Seasonality and seasonal findings 
Agricultural calendar 
The tropical climate in The Gambia has two very distinct seasons, a hot rainy 
season from June through November, and a cooler dry season, covering the remaining 
months. The total annual rainfall monthly recorded in Keneba between 2009 and 2010 is 
detailed in Figure 2.5. This seasonality strongly shapes the daily life in West-Kiang. The 
cereal crops are harvested between September and December. Thus, food supplies are 
particularly plentiful in November and December, while in the rainy season, particularly in 
July and August, food shortages often occur, as food stores from previous year’s harvest 
and cash are lower (88). At this time, there is also a high agricultural workload, 
undertaken predominantly by women. This can lead to a negative energy balance (89), 
and for this reason this season has traditionally be known as ‘hungry’ season. November 
to May is conversely termed ‘harvest’ season.  
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Figure 2.5: Daily rainfall (mm) monthly average in Keneba from June 2009 to September 
2010 
 
Data obtained from the Water Resources Department of the Gambian Government 
 
Dietary patterns 
The effect of seasonality in the eating patterns and intake is both quantitative and 
qualitative. In addition, the agricultural work also limits available time for cooking, which 
further affects the types of food that can be prepared during the farming (rainy) season 
(90).  
Between January and June all the cereals and groundnuts (Arachis hypogaea) are 
available, whilst the rainy season is characterised by low stocks of both. The main cereal 
crops produced are rice (Oryza sativa), millet (Pennisetum typhoideum and Pennisetum 
gambiense), maize (Zea mays) and sorghum (Sorghum margaritiferum). Rice is the staple 
of choice and is eaten with main meals or in porridge. Porridge is very popular as 
breakfast and there is a different range of types, from a thinner type (‘mono’) to the 
thickest one (`sato´). Boiled rice is eaten with different types of sauces. The other staples 
are often consumed steamed (‘futo’) (88). Sauces normally include a combination of oil, 
groundnuts, green leaves (‘jambo’), vegetables and dry or fresh fish. Cooking is always 
done by women, either in small kitchens build of mud bricks with little to no ventilation or 
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outside the house, using wood as fuel. Meals are usually shared by several family members 
and are eaten from the same bowl.  
Groundnuts are used as ‘cash crops’ and also eaten as a good source of protein 
(including methionine). Groundnuts sauces are highly appreciated but, during the rainy 
season shortage other less preferred foods can be consumed as a replacement. In this 
period, bush foods such as green leaves and fruits, are plentiful. This can potentially lead 
to more dietary diversity. During the dry season the availability of wild foods and leaf 
vegetable decreases, but usually home-grown vegetables (e.g. tomato, okra, etc.) are 
available from home gardens by April/May (91). Some leaves such as cassava leaves are 
still available, but leaf sauces are not frequently eaten during this period, because other 
preferred foods are plentiful. Shortages begin to be felt in June (91). 
During the dry season, there is higher availability of cash for buying items such as 
oil, meat or fish (88). Meat consumption is generally low, and mainly restricted to special 
occasions and celebrations. Fish, however, is easily available and frequent in the rural 
West Kiang diet all over the year. In the river Gambia, several types of fish may be caught 
(i.e. bonga –oily fish, catfish, barracuda, tongue-sole and shrimps).  
It is believed that some changes in dietary patterns have occurred over the last 
decades, particularly increased palm/vegetal oil usage in cooking (90). Traditionally, red 
palm oil was only purchased by the more wealthy families (92). According to a focus group 
study conducted recently in West Kiang, the food choices are dependent not only on 
individual preferences but also on cash availability and access (90). Nowadays, the food 
availability might have been modified, at least in part, by the increasing cash in the region 
from national or international ‘remittance economy’, where family members who have 
migrated to urban areas or abroad send money back to rural areas (93). Improved 
transport in the region might also play a role. At present, increased influence from the 
coast and ‘imported’ products (e.g. tinned milk, sardines, candies, biscuits or mayonnaise) 
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exist in the area and this might have contributed to changes in the dietary practices. Yet, 
the population as a whole still has a limited consumption of this type of foods and remains 
largely dependent on the locally grown crops (personal observation).  
 
Nutrition 
Seasonal variations in availability of leaves, cereals and groundnuts, result in 
nutrient intake variation. The population of several villages in West Kiang (core villages) 
has been well characterised in this respect: dietary studies have been conducted for the 
last 40 years, particularly in pregnant and lactating women. Such studies specifically 
focused on energy intake (94) and also in macro- and micronutrients intake and 
nutritional status, including calcium, phosphorus, folate, vitamin C and vitamin A (91, 95). 
These studies have clearly shown seasonal variation in different nutrients, with specific 
patterns for each nutrient. For instance, the rainy season was associated with increased 
calcium intakes (by 16%) whilst decreased phosphorus consumption (by 15%) (91). Few 
of the one-carbon metabolism methyl-donors and cofactors have been investigated. Most 
information available (B2 and folate) dates back to 1978-80 (95). A specific Gambian food 
database was produced for the dietary studies (96) but this did not contain information 
related to methyl-donors and cofactors composition. In 1997, plasma homocysteine, folate 
and B12 concentrations were studied in women during the dry season. The mean plasma 
homocysteine concentration (geometric mean 8.92 µmol/l) in Gambian non-pregnant 
women was similar to that of UK women (97).  
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Health and reproductive outcomes 
Seasonality has also a number of effects in population health that have been 
thoroughly studied. During the rains an increase on disease transmission has been 
observed, including falciparum malaria, pneumonia and gastroenteritis, and therefore a 
peak of prevalence of childhood-prone diseases and malnutrition in September and 
October (98). Moreover, the risk of infection-related mortality is 10-fold higher in adults 
born during the nutritionally poorer rainy season, suggesting that immune function could 
be compromised during early-life development (99). Several signs of immunological 
deficit such as reduced thymic size and T-cell output have been identified. Thus, the 
implications of DOHaD are thought to extend beyond NCD of affluence, to those involving 
susceptibility to infectious diseases (100). 
Effects of Gambian seasonality at conception and birth have also been observed on 
reproductive outcomes, namely prematurity and small for gestational age births (SGA) 
(101). As observed in Figure 2.6 prematurity and SGA showed divergent seasonal 
patterns. SGA was highest at the end of the rainy season, peaking in November at 30.6%, 
with the nadir of 12.9% in June, inversely to maternal weight changes (101). Peaks in 
prematurity, in July (17.2%) and October (13.9%) closely paralleled increases in 
agricultural labour and malaria infections respectively (101). Nutritional supplementation 
with high-energy groundnut biscuits (4.3 MJ/day) during pregnancy has confirmed the 
key role of nutrition in this seasonal differences. Prenatal dietary supplementation 
reduced retardation in intrauterine growth, with a highly significant effect on the average 
birth weight (102, 103). This effect was considerably greater during the rainy season 
(increase of 201 g versus 94 g), where mothers are most ‘at-risk’ (103). Also, a substantial 
reduction in the prevalence of stillbirths and perinatal mortality was observed. 
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Figure 2.6: Month-by month percentage of SGA and premature infants 
 
Fitted seasonality models for preterm and small-for-gestational-age (SGA) infants. The dashed 
green and yellow lines represent the proportion of SGA and preterm infants per calendar month 
respectively. The solid green and yellow lines represent the Fourier fit for SGA and preterm infants. 
(Modified from Rayco-Solon et al., Am J Clin Nutr 2005 (101)) 
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2.3.4. Epigenetics 
Over the last years, preliminary epigenetic studies have also been conducted in 
West Kiang. Based on the hypothesis that periconceptional maternal micronutrient 
supplementation affects fetal DNA methylation, two studies looked at how the epigenome 
was affected in offspring of women receiving a United Nations International Multiple 
Micronutrient Preparation (UNIMMAP) supplement during pregnancy. DNA methylation 
genome-wide within gene promoters (104) and at imprinted genes (105) was explored, in 
cord blood and postnatal DNA samples of their offspring. The data, although based on 
small numbers, suggest that periconceptional maternal nutrition in humans can alter 
offspring methylation at imprinted loci and is an important determinant of newborn 
whole genome methylation patterns (104) (105). Sex-specific effects of micronutrient 
supplementation on imprinted genes were also observed (105).  
Epigenetics have also been investigated with respect to seasonality in West Kiang, 
as discussed in Section 2.2.2. DNA methylation in two groups of children conceived either 
during the dry or the rainy season was compared. DNA methylation at metastable 
epialleles (i.e. alleles that are variably expressed due to epigenetic modifications, MEs) 
was higher in children conceived during the rainy season (August-September) than during 
the dry season (March-May), as shown in Figure 2.7 (79). This suggested the possibility 
that methyl-donor intake might be higher during the rainy season and raised the need for 
further investigation.  
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Figure 2.7: DNA methylation at putative MEs is influenced by season of conception in The 
Gambia 
 
MEs: metastable epialleles 
Percent methylation at five MEs in DNA of Gambian children, by season of conception. Each 
diamond represents one individual, and the black lines group means (n = 25/group). At all genomic 
regions, DNA methylation is higher in individuals conceived in the rainy season (BOLA3 P = 0.03, 
EXD3 P = 0.03, PAX8 P = 0.02, SLITRK1 P = 0.006, ZFYVE28 P = 0.002; overall P = 0.0001) 
(Waterland et al., PLoS 2010 (79)). 
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2.4. STUDY RATIONALE 
As presented above, the marked pattern of seasonality in this rural Gambian 
setting provides an excellent research opportunity to investigate effects of maternal 
nutrition on offspring outcomes. This experiment of ‘natural’ variation in dietary and 
other lifestyle pattern enables the testing of hypotheses related to nutritional deprivation, 
that might be unethical to answer through a traditional intervention in humans. Such 
questions include a deeper understanding on the mechanisms mediating fetal 
programming. As previously outlined in the literature review, and based on previous 
findings from epigenetic studies in West Kiang, DNA methylation is a candidate 
mechanism worthwhile to pursue due to its key role in in early fetal development, its 
sensitivity to environmental factors and dependence on dietary factors. The hypothesis of 
the role of maternal nutrition in epigenetics, tested in animals, has obtained promising 
results. This thesis expands these observations to study early development factors 
affecting DNA methylation in humans. 
  
 69 
2.5. HYPOTHESIS AND OBJECTIVES 
The current study set out to explore the hypotheses that, in rural Gambia, seasonality in 
food availability leads to differences in biomarkers status for methyl-groups supply and 
such changes, when occurring around conception can lead to detectable differences in 
DNA methylation patterns of women’s offspring. 
 
The specific objectives are summarised in Figure 2.8: 
 
Figure 2.8: Conceptual framework of the study 
 
Note: the encircled numbers correspond to the 5 objectives below 
 
1) To establish the annual patterns in the intake of methyl-donors and cofactors in 
women of reproductive-age, by assessing the daily intake and analysing the 
nutritional content in local foods. 
2) To assess the annual patterns in the nutritional status for a comprehensive set of 
methyl-related intermediary metabolites. 
3) To replicate the effect of seasonality in the DNA methylation of infants born to women 
who conceived at the peaks of the rainy/dry seasons. 
4) To assess whether seasonal differences in offspring DNA methylation can be mediated 
by maternal methyl-donor status, by exploring their relationship . 
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5) Finally, to assess the relationship between diet and nutritional status and thus 
(indirectly) the relationship between maternal diet and DNA methylation outcomes in 
their infants.  
 
To achieve these aims and objectives, the research projects described hereafter 
were designed. These objectives were addressed through two separate but integrated 
studies running in parallel, as described in detail in the next Chapters. The nature of 
seasonality in The Gambia lent itself for an ‘experiment of nature’, as defined by the recent 
MRC guidance for the use of natural experiments to evaluate population health 
interventions 2012 (106, 107). These guidelines were produced after the present study 
was designed and conducted, but the potential limitations highlighted by the document 
are acknowledged. Even if this approach needs special care in the interpretation of 
findings (i.e. bias and confounding issues) and limits the possibility of establishing causal 
inferences, the design proposed will allow for exploratory work of exposures that would 
be unethical to manipulate without further knowledge and may provide hints on potential 
causation (106). 
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CHAPTER 3: OVERALL STUDY DESIGN AND METHODS 
 
3.1. FIELD SITE 
The MRC has been involved with work in West Kiang, district of The Gambia, since 
the late 1940s. Since 1974, the MRC has run a permanent field-station in Keneba (MRC 
Keneba, Appendix III (A)), which is the largest village, in the centre of West Kiang. MRC 
Keneba has a well-established infrastructure and receives logistical support from MRC 
Fajara, the main operational MRC Unit, The Gambia, approximately 160 km away from 
Keneba on the Atlantic coast. In addition to its international research agenda, in 
conjunction with the regional health team, the MRC provides medical care to the whole 
region, focusing primarily on maternal and child health. Furthermore, the MRC is the 
biggest employer in the region, and the second largest employer in the country. All this has 
helped develop strong links with the local community, who are very supportive of the 
MRC’s research programmes. The WK DSS was set up in 2004; it covers the whole region 
and facilitates the characterisation and the tracking of its population. Compound heads are 
visited four times a year to record births, deaths, in- and out-migration, and other vital 
events such as marriages. The facilities at MRC Keneba include clinical services, a 
laboratory for clinical and research analyses, several research rooms with specific 
equipment, a data office, and a fleet of vehicles to conduct the fieldwork. This provides a 
good platform for research studies, where accurate information can be collected, samples 
can be immediately processed and stored, and participants can be followed as part of long-
term studies.  
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3.2. STUDY POPULATION: MAIN GROUP AND INDICATOR GROUP 
The study presented in this thesis is an observational prospective proof-of-
principle research, conducted across West-Kiang. The primary exposure was season. 
Maternal dietary intakes were used both as outcome of season and secondary exposure. 
Biomarkers of methyl-donor status were looked at as proximal endpoints, cross-
sectionally to season and dietary intake (see Figure 2.8). Maternal biomarkers were also 
examined as exposure for the offspring DNA methylation, which was looked at as a distal 
outcome prospectively of all other variables. Under the term biomarkers, this thesis refers 
to all the laboratory analysis done in maternal blood (plasma and red blood cells (RBC)) to 
determine their nutritional status in respect to one-carbon metabolism.  
The study was composed of two complementary studies, termed from this point 
onwards as the ‘indicator group’ study and ‘main group’ study. The fieldwork for both 
studies started in July 2009 and concluded in June 2010 (indicator group) and June 2011 
(main group). 
The joint Gambian Government/MRC Ethics Committee (SCC/EC 1151) and the 
LSHTM Ethics Committee (EC 5525) granted ethical approval for all aspects of this work. 
The standardised information sheets and consent forms are given in Appendix IV and V. 
 
3.2.1. Study 1: Indicator Group 
Thirty healthy non-pregnant women of reproductive age were followed up 
monthly during one year. This indicator group was set up to meet objectives 1 and 2, i.e. 
provide data on annual variation in the intake of a comprehensive set of methyl-donors 
and cofactors and a corresponding set of blood biomarkers of one-carbon metabolism. 
This group also provided information of dietary intake to help estimate seasonal 
differences in intakes of the women in the main study within the first weeks of pregnancy 
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and achieve indirectly objective 5 (establish relationship between early pregnancy 
maternal diet and infant DNA methylation outcomes).  
In the indicator group, a detailed 2-day dietary assessment was performed 
monthly (Appendix III (B)). Following the dietary assessment, blood was collected to 
assess selected biomarkers and determine associations with diet cross-sectionally (see 
Figure 3.1). The dietary assessment consisted of direct observation of the meal 
preparation and weighing all ingredients for the cooking to determine the recipe 
nutritional composition. The participant’s intake was then weighed throughout the day. 
All data were recorded by field assistants, resident in each of the three villages, and 
recorded. The information from two forms (Recipe form, Appendix VI, and Dietary intake 
form, Appendix VII) was used to establish a list of Gambian common foods and 
ingredients, for which samples were collected for composition analysis of vitamins B2, B6, 
B12, folate, choline, betaine and methionine. Further details are given in Chapter 4, 
sections 4.1 and 4.2. 
Only non-pregnant women of reproductive age were recruited. This was done for 
two main reasons: (i) our research hypothesis was that extensive demethylation and 
remethylation of fetal DNA takes place around conception and early development (i.e. 
when it may not be known yet that they are pregnant). Therefore this group was deemed a 
good proxy of periconceptional status; and (ii) plasma choline levels, and other 
components within one-carbon metabolism, may be modified during pregnancy or 
menopause, as they are up-regulated via oestrogens. Women who became pregnant or 
self-withdrew from the study were replaced by another eligible woman from the same 
village (see Section 4.1). 
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Figure 3.1: Flow diagram of the indicator group set-up and recruitment 
 
DSS: Demographic surveillance system; LMP: Last menstrual period 
 
3.2.2. Study 2: Main group 
A cohort of approximately 1600 women of reproductive age, from all 36 villages in 
West Kiang, was followed-up monthly for pregnancy detection. The objective was to 
identify women conceiving at the peak of the rainy (July-September) and the dry 
(February-April) season and to follow-up their infants (see Figure 3.2). The decision on 
the peaks of the two seasons was mainly based on the local rain patterns. As shown in 
Figure 2.5, July, August and September are the wettest months of the year. The driest 
months include February to May, but some years rains can start as early as May. The final 
number of women-infant pairs fully enrolled into the study was limited by the number of 
full term pregnancies conceived during the two season time windows. The ability for early 
detection of pregnancy was limited in part by willingness of women to disclose their 
pregnancy status, thus the cut-off for ‘early’ blood sample collection was set within the 
first 16 weeks.  
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The main group contributed to objectives 2, 3, 4 and 5 (see Table 3.1), by 
determining maternal nutritional blood biomarkers status close to conception and 
following up their offspring to establish association with DNA methylation patterns.  
In order to protect the right of women to keep their pregnancy confidential, this 
study was designed in such way that blood samples were collected prior to pregnancy 
detection, based on the lack of a menstrual period (as determined by a last menstrual 
period (LMP) questionnaire, Appendix VIII). To avoid unnecessary blood collection of 
women unlikely to be pregnant, a decision tree was included in the training of field 
workers (see Figure 3.3 to assess the need for or the exemption from blood collection). 
Further details about the fieldwork are given in Chapter 5, sections 5.1 and 5.2. 
The women of the indicator group were excluded from the main group 
recruitment but were given the opportunity of joining it should they become pregnant. 
Recruitment into the main group study was done jointly with a trial of Early Nutrition and 
Immune Development (the ENID Trial) (ISRCTN49285450) examining the effect of pre-
natal and infancy daily nutritional supplementation (micronutrients and/or energy) on 
infant immune development. ENID is a large and long-term project, within the same target 
population (all women of reproductive age in West Kiang), and this study (Methyl-Donors 
and EpiGenetics, MDEG) was partially nested within this trial. 
This helped maximise the local resources, whilst minimising the burden on the 
participants, and provided this study with the opportunity of accurate gestational age 
assessment by obstetric ultrasound. At approximately 12 weeks of pregnancy ±2 weeks, 
pregnant women were randomly assigned to one of four pre-natal nutrition 
(micronutrient and/or energy or placebo) supplements. All participants, included those 
who were not in ENID, were given 60 mg iron and 400 g folate (FeFol), either as a part of 
the ENID nutritional supplement, or alone. This is in line with the current national 
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guidelines in The Gambia, which recommend this daily supplement to all pregnant women 
until the end of pregnancy. 
 
Figure 3.2: Flow diagram of the main study set-up and recruitment 
 
DSS: Demographic surveillance system; LMP: Last menstrual period  
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Figure 3.3: Decision tree for field blood collection from participants following the report 
of a missed menses 
 
Assessment done as a part of the monthly LMP questionnaire; LMP: Last menstrual period 
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3.3. DATA ANALYSIS 
3.3.1. Data entry 
Specific identification numbers (study IDs) were given to participants of both 
studies at the time of recruitment, including a check letter. Data entry of the monthly visits 
for both the indicator and the main group was done real-time in a specifically designed 
Access database. More details on the entry of dietary intake data is given in Sections 4.1. 
and 4.2. 
 
3.3.2. Data manipulation 
Due to the quality control measurements put in place for the data entry (i.e. 
automatic range of maximum/minimum ‘acceptable’ values to prevent entry of erroneous 
values and double data entry), the need for data cleaning at the end of the study was 
limited. Once laboratory analyses were complete, checks were done to identify values out 
of range (where normal data ranges were available) or erroneous (e.g. repeated samples). 
Data were then plotted (box-plots) in order to check for outliers and any other noticeable 
errors. Data errors that could not be rectified and clear outliers were dropped from the 
dataset. Dietary intake data were single-entered and therefore, intensive data cleaning 
was performed to identify mistakes, as detailed in Section 4.2.2. 
Continuous outcome variables and covariates were assessed for normality, 
graphically by drawing histograms and numerically by applying the Shapiro-Wilk test. 
Almost all continuous covariates of dietary intake, blood markers and DNA methylation 
were skewed. Therefore, they were transformed to logarithms (intake and biomarkers) or 
logits (DNA methylation percentages) to normalise the distributions. Summary statistics 
of dietary intake and biomarkers were reported as geometric means. 
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3.3.3. Statistical analysis  
All statistical analyses were conducted using Stata 11 (Stata Corporation, College 
Station, Texas, USA). The analysis was different by study group/objective, as detailed in 
the following sections. The common link in both study groups was the women’s biomarker 
concentrations in blood. The specific statistical analyses for each study group are 
described in the respective relevant Chapters (Chapters 4 and 5). 
 
3.3.3.1. Summary of data analysis by objective 
The specific details of the statistic analysis for each of the studies are given in 
Chapters 4 and 5. In summary:  
 
Objectives 1 and 2: assessing the annual patterns in the dietary intakes and blood 
biomarkers of one-carbon metabolism related substances in West Kiang 
The indicator group study was set up to describe and establish annual seasonal 
trends in methyl-donor and cofactors dietary intake and one-carbon metabolism blood 
biomarkers. Thus, the analysis of this study group was mainly descriptive. The overall 
level of dietary intakes and blood biomarkers were assessed and compared with 
international recommendations/cut-offs of normal range. The data represented repeat 
observations for each participant on consecutive months, and were thus not independent. 
This correlation was accounted for using random effect models with Generalised Least 
Squares (GLS) regressions. Seasonality patterns were modelled using the truncated 
Fourier series approach. This mathematic model is good to define seasonality, as the 
Fourier series are smooth linear functions whose terms are approximately orthogonal to 
one another and inherently cyclic (108). They offer flexibility in the dimensionality of the 
fitted seasonal effect: truncating the higher-order terms of the series removes higher-
frequency noise (108). Generally, fitting the first two pairs of Fourier terms (F2 model: sin, 
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cos, sin2, cos2) were significant in these data and deemed sufficient. Further details of this 
analysis are described in Chapter 4. In the main group, biomarkers were compared (one-
way analysis of variance, ANOVA) in dry versus rainy season measurements. Biomarkers 
status differences between seasons were also assessed in the main group with one-way 
ANOVA. More details are given in section 5.1. 
 
Objective 3: assessing seasonal DNA methylation differences 
 One-way ANOVA was used also to compare mean DNA methylation percentage at 
each CpG site, by testing differences in DNA methylation of infants conceived during the 
rainy and the dry season. Multivariate analysis of variance (MANOVA) was used to assess 
methylation at each gene, considering all its CpG sites simultaneously. Effect of non-
nutritional determinants on DNA methylation was also assessed (e.g. infant sex) by 
multivariate regression analysis. Further details are given in Section 5.1. 
 
Objective 4: assessing the association of maternal biomarkers with infant DNA 
methylation 
The initial analysis was centred on plasma SAM and the SAM:SAH ratio as ‘bottle 
neck’ factors. In order to establish the blood biomarker concentration at conception, back-
extrapolation employing data from the indicator group (objective 2) was used, after 
comparison of seasonal patterns between both groups for reliability and stability. Multiple 
regression was used to explore the prediction capacity of the different biomarkers of DNA 
methylation, examining the independent influence of each biomarker on DNA methylation. 
Their interactions were also examined. Principal component analysis was used to 
investigate all biomarkers jointly, and multilevel analysis to pool the different loci 
together. All analysis were adjusted by infant sex, as sex differences in DNA methylation 
have been repeatedly reported (75, 104, 105). Similarly, maternal age and BMI were 
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included in the models, as it can affect both infant DNA methylation and maternal 
biomarker blood concentrations. Further details are given in Section 5.1. 
 
Objective 5: assessing the association of maternal dietary intake with infant DNA 
methylation 
After having established the annual trend for dietary intake and biomarkers in 
objectives 1 and 2, and having used these to estimate the biomarker blood concentration 
at conception by back-extrapolation in objective 4, the same approach was planned for the 
dietary intake information to estimate the maternal intake around conception. The 
prediction capacity of biomarkers from the dietary intake was assessed to establish the 
viability of such approach. Details are given in Chapter 4.  
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Table 3.1: Overview of objectives and methods 
Objective Study group 
(Paper/Chapter) 
Methods 
 
1. To assess the annual patterns 
in the intake of methyl-donors 
and cofactors 
Indicator group 
(Paper II/Chapter 4) 
Monthly 48-weighed-records throughout a 
year (2 days x 12 months x 30 women) 
Food samples for analysis of vitamins B2, 
B6, B12, folate, choline, betaine, methionine 
content) 
2. To assess the annual patterns 
in blood biomarkers of a 
comprehensive set of one-carbon 
metabolism related metabolites 
in women of reproductive age, 
monthly or as close as possible to 
time of conception 
Indicator 
(Paper II/Chapter 4) 
& Main group  
(paper III/Chapter 5) 
Monthly blood sample throughout a year 
(1 sample x 12 months x 30 women) 
LMP questionnaires monthly 
One-off blood collection in early pregnancy 
-at first lost menses (decision tree) 
Pregnancy test at second lost menses 
Determination of gestational age by 
ultrasound 
3. To replicate the effect of 
seasonality at time of conception 
on the DNA methylation of infants 
Main group 
(Paper III/Chapter 5) 
Determination of gestational age with 
ultrasound scan (confirmation that date of 
conception fits within pre-defined season 
window) 
Back-extrapolation of nutritional status of 
mother to time of conception using 
indicator group data 
DNA methylation analysis of candidate loci 
by pyrosequencing in offspring by season of 
conception 
4. To test for relationship of these 
seasonal differences in offspring 
DNA methylation with the 
methyl-donor status of their 
mothers 
Main group 
(Paper III/Chapter 5) 
Combining data from objectives 2 and 3 
5. To assess (indirectly) the 
relationship between maternal 
diet during early development 
and DNA methylation outcomes 
in their infants 
Main + Indicator 
group 
(Chapters 4 and 6) 
Combining data from objectives 1-4 
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3.3.3.2. Sample size calculations and power 
Indicator group 
Precise sample size/power calculations were not possible due to the scarce 
information existing on variation in the dietary intake and blood levels of the substances 
under study. Instead, this study must be regarded as an exploratory study to provide such 
data. It was judged that sampling 30 women to allow for losses to follow-up, withdrawals 
and pregnancies, together with a replacement system, at 12 time points evenly spaced 
across the year, should provide a good estimate of the seasonality with resolution at the 
level of one month. 
 
Main study 
The sample size for the main study group was subject to the number of 
pregnancies occurring during the study period and willingness of women to participate. 
Based on numbers from previous studies undertaken in this population, it was considered 
feasible to recruit a maximum of 100 mother-infants pairs per 3-month season. For the 
testing of the hypothesis of differences in DNA methylation between infants born in the 
rainy and dry season, it was established that 100 infants per season would have enabled 
the detection of 0.46 standard deviations in methylation level with power 90% and at 5% 
significance. 
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Part II:  
RESEARCH PAPERS WITH RESULTS 
 
 
CHAPTER 4: INDICATOR GROUP 
This Chapter describes in detail and discusses the methods and results of the 
statistical analysis performed in the indicator group study, investigating the annual 
variation in dietary intake of methyl-donors and cofactors and blood concentrations of 
one-carbon metabolites in women of reproductive age. The main methods and findings 
have already been submitted as a peer-reviewed paper, which is presented as Section 4.1. 
In addition, this Chapter provides further unpublished information on methods and 
results and explores and discusses the data in greater detail. 
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4.1. RESEARCH PAPER II: ‘DNA methylation potential: dietary intake 
and blood concentrations of one-carbon metabolites and co-factors 
in rural African women’ 
Article cover sheet:  
1. For a ‘research paper’ prepared for publication but not yet published 
1.1. Where is the work intended to be published?  
This paper presents the main findings of indicator group study and was submitted 
to the American Journal of Clinical Nutrition, the accepted modified final version 
is included as Appendix IX. 
1.2. List the paper’s authors in the intended authorship order 
Dominguez-Salas P, Moore SE, Cole D, da Costa KA, Cox SE, Dyer RA, Fulford AJC, 
Innis SM, Waterland RA, Zeisel SH, Prentice AM and Hennig BJ. 
1.3. Stage of publication – Not yet submitted/Submitted/Undergoing revision from 
peer reviewers’ comments/In press 
Submission on 30/07/2012 
 
2. For multi-authored work, give full details of your role in the research included in the 
paper and in the preparation of the paper. (Attach a further sheet if necessary) 
I conceived and designed the study, conducted the research and analysed the data, 
in collaboration with some of the authors (Moore, Cox, Fulford, Prentice, Hennig). I 
wrote the manuscript and my co-authors provided comments, which were 
incorporated prior to submission. 
 
Candidate’s signature ________________________ 
Supervisor or senior author’s signature to confirm role as stated in (2) ______________________ 
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ABSTRACT 
Background: Animal models show that periconceptional supplementation with folic acid, 
vitamin B12, choline and betaine can induce epigenetic differences in offspring phenotype 
mediated by changes in DNA methylation. In humans, altered DNA methylation patterns 
have been observed in offspring whose mothers were exposed to famine or who were 
conceived in the Gambian rainy season. 
Objective: To understand seasonality of methylation patterns in rural Gambian women 
we studied natural variations in dietary intake of nutrients involved in methyl-donor 
pathways and their impact on the respective metabolic biomarkers. 
Design: In 30 women of reproductive age (18-45 y), we monitored diets monthly for one  
year using 48h-weighed records to measure intake of choline, betaine, folate, methionine 
and vitamins B2, B6 and B12. Blood concentrations of these nutrients, as well as S-
adenosylhomocysteine (SAM), S-adenosylmethionine (SAH), homocysteine and 
dimethylglycine (DMG) were also assessed monthly. Seasonality was modelled using 
truncated Fourier series. 
Results: Dietary intake of vitamin B2, folate, choline and betaine varied significantly by 
season; with the most dramatic variation seen for betaine. All metabolic biomarkers 
showed significant seasonality, with the highest fluctuations in B6 and folate. Correlations 
between dietary intakes and blood biomarkers were found for B2, B6, active B12 
(holotranscobalamin) and betaine. We observed a seasonal switch between the betaine 
and folate pathways and a limiting role of B2 in these processes.  
Conclusions: Our data suggest that environmental influences impacting on maternal diet 
are measurable more reliably by plasma biomarker status than diet. This is likely to affect 
methyl-donor supply during pregnancy. 
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4.1.1. INTRODUCTION  
The ‘Developmental Origins of Health and Disease’ hypothesis (DOHaD) is built on 
a substantial body of evidence that early life environment (especially nutritional) has 
lifelong effects on human health (109). The current challenge is to identify the underlying 
molecular mechanisms; epigenetic regulation is a strong candidate. Epigenetic 
modifications of DNA convey stable alterations in gene expression potential, that are not 
mediated by changes in DNA sequence. DNA methylation, involving the addition of methyl-
groups (-CH3) to cytosines within cytosine-phosphate-guanine (CpG) dinucleotides, 
appears to be the most stable epigenetic modification (110). Hence, DNA methylation 
patterns established during early ontogeny can persist for life (19). 
One-carbon metabolic pathways supply methyl-groups for all biological 
methylation reactions (Figure 4.1). Methylated folate (5,10, methylene tetrathydrofolate) 
and betaine, a metabolite of choline, are the immediate substrates providing methyl-
groups to re-methylate homocysteine and form methionine (111). Methionine is 
adenylated to S-adenosyl-methionine (SAM), which donates methyl-groups for DNA 
methylation, converting to S-adenosyl- homocysteine (SAH) in the process. SAH is then 
metabolized to homocysteine which can be re-methylated to methionine or enter the 
trans-sulfuration pathway leading to cysteine. Dietary supply of folate and choline, as well 
as of vitamins B2, B6 and B12, acting as enzyme cofactors are key to these processes.  
Animal studies have demonstrated that periconceptional supplementation of the 
maternal diet with betaine, choline, folic acid and vitamin B12 can affect the establishment 
of DNA methylation patterns, altering phenotype and gene expression of the offspring 
(112). In humans such a causal association has not been described, however, 
periconceptional undernutrition during the ‘Dutch Hunger Winter’ was associated with 
decreased DNA methylation of the insulin-like growth factor (IGF2) gene in the offspring 
in adulthood (74). In The Gambia, a periconceptional micronutrient supplementation trial 
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showed association between periconceptional maternal nutrition and offspring DNA 
methylation, genome-wide and at imprinted loci (104, 105). Also, Gambian children 
conceived during the rainy season (August-September) had significantly greater 
methylation at five metastable epialleles (MEs) than those conceived in the dry season 
(79). MEs are genomic loci whose epigenotype is established stochastically in the early 
embryo and maintained thereafter across all tissues. 
 
 
Figure 4.1: One-carbon metabolism 
 
Figure modified from Dominguez-Salas et al. 2012 (111). 
BHMT, betaine-homocysteine methyltransferase; CBS, Cystathionine-β-synthase; CHDH, choline 
dehydrogenase; CTGL, Cystathionine- -lyase; DMG, dimethylglycine; DNMT, DNA 
methyltransferases; GNMT, glycine N methyltransferase; MAT, methionine adenosyltrasferase; 
MTHFR, Methylenetetrahydrofolate reductase; MS, methionine synthase; SAH, S-
adenosylhomocysteine; SAHH, SAH hydrolase; SAM, S-adenosylmethionine. 
Methyl-groups released from conversion of SAM to SAH are also used for other methylation 
reactions (e.lg. proteins). 
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Seasonal variations in food supply and metabolic demand in rural Gambia provide 
a natural experiment to study effects of maternal dietary intake on epigenetic 
programming in humans. Here, we investigate the effects of seasonality on dietary intake 
and blood concentrations of methyl-donors, cofactors and related metabolites in rural 
Gambian women. We aimed to evaluate whether seasonal variation can explain the 
differences in DNA methylation status previously reported (79).  
 
4.1.2. SUBJECTS AND METHODS  
4.1.2.1. Study population 
This observational study was conducted between July 2009 and June 2010. Non-
pregnant women of reproductive age (18-45 years) from three villages in the rural area of 
West Kiang (Jiffarong, Janneh Kunda and Keneba), The Gambia, were invited to 
participate. The West Kiang Demographic Surveillance System, run through the MRC 
Keneba field station, was used as the sampling framework and the population sample (10 
per village) was obtained by random selection, proportional to five age groups (18-45 
years) to ensure all age groups were represented. Exclusion criteria included confirmed 
pregnancy, severe anaemia (<70 g/l), menopause, contraceptive use or planning to move 
away from the village during the course of the study. All blood samples were tested for 
haemoglobin concentration to determine anaemic status and malaria parasites, and 
participants were treated at MRC Keneba, when necessary. Any woman excluded during 
the course of the study, e.g. who became pregnant or chose to withdraw, was replaced by a 
new participant from the same age-group and village. Thirty women were visited each 
month throughout a single calendar year. Each visit involved two days of dietary 
assessment and collection of a fasted blood sample on the third day. 
The Scientific Coordinating Committee of MRC Unit, The Gambia, granted scientific 
approval and the joint Gambian Government/MRC Ethics Committee (SCC/EC 1151) and 
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the London School of Hygiene and Tropical Medicine Ethics Committee (EC 5525) granted 
ethical permission for this study. Following community approval, informed written 
consent was obtained from each woman prior to participation.  
 
4.1.2.2. Dietary intake measurement 
 
Dietary records 
The foods eaten in West Kiang are mostly grown locally. The diet typically consists 
of a staple (refined white rice, millet or maize) with a sauce made from a limited number 
of ingredients, such as vegetable/palm oil, groundnuts, green leaves, fish or vegetables 
(91). Full details of the local diet have been described elsewhere (88). Two main meals are 
eaten daily, one in the early afternoon and the second in the evening. Breakfast, often 
cereal porridge, left-overs from the previous day, or tea and bread in a more Westernised 
style, is eaten by some, but not all women. Food intake of each participant was determined 
by direct 24-h weighed dietary record on two consecutive days each month, using 
standardised procedures. On each day of assessment, women were visited in their 
household early in the morning by a trained fieldworker who then stayed with the subject 
throughout the day to weigh and record a description of all foods eaten, including meals 
and ‘inter-meal’ snacks. Since, families in this community eat from a common shared bowl, 
participants were supplied with a standard plastic container to separate and weigh their 
individual portion (scale Salter 1020 with Aquatronic Feature 5kg, 1 g accuracy). After 
taring the container, staples, sauces and any other foods were added one-by-one, with the 
container weighed after each addition, then weighed again to record the individual 
components of any left-over food at the end of the meal. Total food intake was thus 
calculated. Quantitative information on all recipes was obtained by weighing all individual 
ingredients, including water, as well as the cooked weight of the food (scale Salter 
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Brecknell WS 15 kg, 5 g accuracy). The food records and recipes also identified all of the 
different foods, including sauces, spices and condiments consumed.  
 
Food composition 
Contemporaneously, samples of 98 of the most commonly eaten foods in West 
Kiang were collected at different times of the year from the local markets (Appendix X 
(A,B)). Up to eight samples of each food were combined in a single composite sample. Food 
samples were prepared as consumed (raw or cooked), blended and freeze-dried (Edwards 
Modulyo EF4, USA) to constant weight before preparing composite samples for analysis of 
the target nutrients. Total choline (coefficient of inter-assay variation (CVi) = 4.7%) and 
betaine (CVi = 3.5%) were determined by liquid chromatography/electrospray ionization-
isotope dilution mass spectrometry (LC/ESI-IDMS) (113), including the following choline 
compounds: free choline, glycerophosphocholine, phosphocholine, phosphatidylcholine 
and sphingomyelin, at UNC-CH Nutrition Obesity Research Center, University of North 
Carolina, USA. Vitamin B2 (CVi = 4.4%), B6 (CVi = 6.3%) and methionine (CVi = 4.3%) 
were determined by gradient high performance liquid chromatography with fluorescence 
detection against calibration standard solutions of known concentration (in-house 
methods), whilst folate (CVi = 7.6%) and vitamin B12 (CVi = 7.8%) were analysed by a 
surface plasmon resonance inhibition assay (Biacore Q assay) in a commercial laboratory 
(Eclipse Scientific Group Ltd., Cambridgeshire, UK). 
 
Dietary intake calculation 
The two sets of dietary data (dietary records and food composition) were entered 
into DINO (‘Diet In Nutrients Out’). DINO is a dietary assessment software application 
specifically designed by MRC Human Nutrition Research (HNR), Cambridge, UK, to 
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calculate dietary intakes of Gambian foods. Intakes of energy, folate, B2, B6, B12, choline, 
betaine and methionine among the women in this study were thus calculated.  
 
4.1.2.3. Blood biomarker measurement 
Blood biomarker status measurements included folate, B2, B6, B12, active B12 
(holotranscobalamin), choline, betaine and methionine, as well as total plasma 
homocysteine (tHcy), SAM, SAH and DMG. A fasted blood sample was taken in the morning 
of the day following the two-day dietary assessment. The samples were transported on ice 
to the MRC Keneba laboratory within an hour and immediately centrifuged, aliquoted and 
frozen at -70 C. Red blood cells (RBC) were washed three times with physiological saline 
solution (0.9% w/v NaCl), and stored at -40 C. Plasma tHcy (CVi= 1.7%), methionine (CVi 
= 1.1%), cysteine (CVi = 1.4%) (114), choline (CVi = 5.41%), betaine (CVi= 2.66%), DMG 
(CVi = 4.30%) (115), SAM (CVi = 1.0%) and SAH (CVi = 3.0%) were measured by liquid 
chromatography-tandem mass spectrometry (LC-MS-MS) in the Nutrition and Metabolism 
Laboratories of the Child and Family Research Institute at the University of British 
Columbia (CFRI/UBC), Canada, as previously reported (114, 115). Plasma vitamin B6 (CVi 
pyridoxal = 10.0%, CVi pyridoxal phosphate = 8.0%, CVi pyridoxic acid = 13.0%) was also 
measured by LC-MS-MS at CFRI/UBC based on the method of Midttum et al. (116), and 
plasma B12 (CVi = 3.3%), active B12 (CVi = 4.5%) and folate (CVi = 7.4%) were 
determined using a microparticle enzyme intrinsic factor assay and ion capture assay, 
respectively, with an AxSyM analyser (Abbot Laboratories, Chicago, IL), also at the 
CFRI/UBC laboratory. B2 status in RBC was assessed by the erythrocyte glutathione 
reductase activation coefficient assay (EGRAC), which measures the ratio of glutathione 
reductase activity in the presence and absence of added flavin adenine dinucleotide (CVi = 
3.1%). EGRAC was performed on a microplate at MRC HNR (117). Higher EGRAC values 
denote greater B2 deficiency. 
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4.1.2.4. Statistical Analysis  
Statistical analyses were performed using Stata 11.0 (StataCorp, College Station, 
TX). All dietary intake variables and blood biomarkers showed evidence of a positively 
skewed distribution and were therefore logarithmically transformed and are reported as 
geometric means. Biomarkers of nutrient status were considered as falling into two main 
groups for analysis: i) those that were consumed in the diet and also analysed in blood (i.e. 
folate, B2, B6, B12, choline, betaine and methionine, and ii) those which are here 
considered as ‘functional biomarkers’ of one-carbon metabolism, namely SAM, SAH, tHcy 
and DMG. Two additional variables were created, the SAM/SAH and the DMG/betaine 
ratio, to summarise the methylation activity and the betaine-pathway activity, 
respectively. The cut-off for statistical significance was considered at P<0.05. 
To assess the reliability and stability of each dietary and biochemical (blood 
biomarker) variable, autocorrelations were calculated from multiple measurements of 
each woman one to five months apart. These were performed on ‘detrended’ values (i.e. 
adjusted for seasonality so that the observed difference between the measurements 
represented the sum of real variations in intake and/or biomarkers over time, as well as 
errors in measurement, and was not reflecting an underlying seasonality).  
Trends along the year were calculated for diet and biomarkers separately. These 
were established using random effects multi-level models through Generalised Least 
Squares (GLS) regression to account for the repeat observations for each woman. The 
Fourier series approach was used to model patterns of seasonality (108). Two pairs of 
terms were judged to be sufficient for all variables, except for choline and betaine dietary 
intake and plasma B12, each of which required four pairs of terms. The EGRAC values 
reflect B2 status and are expressed as 1/x for seasonal trend graphic representation. To 
express the effect size of the seasonality, a coefficient of cyclic variation (CCV) was 
calculated, by square root of half the sum of the squared coefficients of the Fourier terms. 
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The differences in dietary intake and biomarker concentrations were also calculated 
comparing the peak of the rainy/hungry (Jul-Sept) and dry/harvest (Feb-Apr) season.  
Finally, dietary predictors of biomarker concentrations were investigated cross-
sectionally across all months, by pairwise matching dietary intake with the specific blood 
biomarker status by simple regression analysis. Multiple linear regression was then used 
to assess the relationship between dietary intake and the ‘functional’ biomarkers (which 
had no direct equivalent measured in the diet). 
 
4.1.3. RESULTS 
4.1.3.1. Study population  
A total of 86 women were approached, of whom 62 consented and took part in the 
study. The mean age of the study participants was 31 years (range 18-45 years). Results 
for the dietary assessments of women who became pregnant during the course of the 
study were retained, but all biochemical analysis of blood samples taken after conception 
were removed from the data set as pregnancy can alter one-carbon metabolism (118). 
Therefore, there were complete dietary intake assessments for 28-30 women for each of 
the 12 months and fasted blood samples for 20 to 29 women per month. The average 
duration of participation in the study was 6 months.  
 
4.1.3.2. Dietary intake  
Dietary data were collected for a total of 706 days, which included 1143 different 
recipes. The mean daily weight of food consumed (excluding water intake) was 1553 g 
(95% CI 1489-1619 g/d), with no significant variation over the year (p=0.78). The overall 
mean of energy intake was 1830 kcal/d (95% CI 1712-1816), with no significant variation 
over the year (p= 0.60).  
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 The results of the autocorrelations to establish the reliability (precision of a single 
measurement or extrapolation back to zero lag) and stability (variation with time not 
related to seasonality) of the dietary intakes are shown in Figure 4.2. Additionally, 
repeatability of measurements on two consecutive days ranged between 40.1% and 60.1% 
(CCVs are shown in Table 4.1). The dietary intakes of folate, B2, B6 and choline were 
significantly below the current international recommendations (see Table 4.1), expressed 
as Estimated Average Requirement (EAR). The EAR is the daily dietary intake level of a 
nutrient expected to satisfy the needs of 50% of a population group. The dietary intakes 
surpassing these recommendations are also in Table 4.1, and were below 30% for all 
except for B12 (100%) and methionine (98.9%). 
The monthly variation in dietary intakes, expressed as percentage deviation from 
the overall geometric mean, are illustrated in Figure 4.3, panels A, B, C and D. The annual 
variation in the intakes of folate (p=0.0038), B2 (p=0.016), choline and betaine (both 
p<0.0001) was statistically significant. The results show that the intakes of B2 and folate 
decreased over the rainy season until September, followed by an increase, to reach their 
highest intake towards the end of the dry season peak (May). Choline and betaine intake 
was highest in September, with second peaks in December and April respectively. 
Methionine, B6 and B12 intake, conversely, did not vary significantly throughout the year 
(p>0.05). Among those nutrient intakes which showed significant variation over the year, 
substantial differences between both seasons were also shown for betaine, folate and B2 
(Table 4.1) but not for total choline. B2 and folate were higher during the peak of the dry 
season (February-April, 12.1% and 14.9% respectively) and betaine was higher during the 
peak of the rainy season (July-September, 32.4%). 
Figure 4.2: Reliability and stability of dietary intakes and blood biomarker concentrations for substances under study 
  
Autocorrelation (internal correlation) of each variable measurement with measurements for the same woman one to five months apart (lag 1-5), adjusted by 
seasonality 
n dietary intake measurements = average of 29 women x 12 months x 2 days; n biomarker measurements= 316 (293 for B2) 
DMG, dimethylglycine; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine. 
Table 4.1: Dietary intakes of one-carbon metabolites of Gambian women of reproductive age and international intake recommendations for women 
n= average of 29 women x 12 months x 2 days; GM = Geometric mean; 95% range = GM  2SD; *p-value <0.05  
EAR: Estimated Average Requirement (119, 120): the daily dietary intake level of a nutrient expected to satisfy the needs of 50% of a population group; Repeatability = 
measurement of the reliability calculated on how similar the intakes between two consecutive 24-h weighed record measurements were in each subject; CCV= 
Coefficient of cyclic variation, calculated as the square root of half the sum of the squared coefficients of the Fourier terms; Rainy season ‘Hungry’= July-September; 
Dry season ‘Harvest’= February-April 
152.6% Fcho, 15.6%Gpcho, 3.3% Pcho, 37.6%Ptcho, 0.8%Sm (Percentage contribution to total choline from free choline, glycerophosphocholine, Phosphocholine, 
Phosphatidylcholine, Sphingomyelin). 2 Adequate Intake (AI): dietary intake believed to be adequate for everyone in the demographic group to maintain health, 
established where no sufficient data to establish EAR are available, only an AI has been set for choline (21) 3 Recommendations are for Methionine + Cysteine are 19 
mg/kg/d, calculated for an average weight of 55 kg 
Nutrient 
Units  
12 month GM 
(95% range) 
EAR 
(prevalence 
of adequacy) 
GM  
Rainy season  
(95% CI) 
GM  
Dry season  
(95% CI) 
Difference 
between 
seasons (%) 
Repeatability of 
measurement on two 
consecutive days (%) 
CCV (%) 
(CI 95%) 
Folate 
µg/d  
131.7 
(69.2-251.5) 
320 
(1.2%) 
120.5 
(112.3-129.2) 
138.4 
(129.0-148.6) 
-14.9* 52.1 6.6 
(3.3-9.9) 
B2  
mg/d  
0.30 
(0.08-1.18) 
0.9 
(6.2%) 
0.27 
(0.23- 0.31) 
0.30 
(0.26-0.35) 
-12.1 60.1 12.3 
(5.4-19.2) 
B12 
µg/d  
2.7 
(0.4-21.0) 
2 
(100%) 
2.8 
(2.2-3.5) 
2.6 
(2.1-3.3) 
5.8 44.9 14.7 
(4.7-24.7) 
Total choline 
mg/d  
155.21 
(60.6-396.7) 
4252 
(2.8%) 
158.4 
(142.0-176.7) 
158.4 
(141.9-176.7) 
0.1 52.9 15.1 
(10.4-19.8) 
Betaine  
mg/d  
33.5 
(6.9-163.3) 
N/A 42.3 
(35.3-50.6) 
28.6 
(23.9-34.2) 
32.4* 48.8 31.8 
(24.2-39.4) 
B6  
mg/d  
0.92 
(0.49-1.75) 
1.1 
(28.7%) 
0.88 
(0.81-0.95) 
0.93 
(0.86-1.01) 
-6.4 40.1 4.3 
(1.0-7.6) 
Methionine 
g/d  
2.03 
(1.23-3.38) 
0.83 
(98.9%) 
2.06 
(1.94-2.18) 
2.11 
(1.99-2.24) 
-2.7 44.7 2.4 
(0.1-4.8) 
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Figure 4.3: Seasonal trends of methyl-donors and cofactors as per dietary intake and blood  
DIETARY INTAKE BLOOD BIOMARKERS 
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DIETARY INTAKE BLOOD BIOMARKERS 
  
biomarker concentrations, expressed as percentage of geometric mean of all measurements 
(between July 2009 and June 2010) 
n dietary intake measurements = average of 29 women x 12 months x 2 days; n biomarker 
measurements= 316 (293 for B2); 95% CI 
B2 status is shown as the inverse of EGRAC assay results; DMG, dimethylglycine; Hcy, homocysteine; 
SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine. 
P-value for intake of folate = 0.0038; B2 = 0.016 , betaine and choline <0.0001; B6, B12 and methionine 
>0.05 
P-value for biomarkers: B12= 0.03; all others p<0.001). 
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4.1.3.3. Blood biomarkers 
During the 12 months of study, 316 plasma samples were obtained for analyses. 
Fewer RBC samples (a total of 293) were prepared for analysis of B2, as it was not always 
possible to obtain the second heparinised blood sample required. The autocorrelation 
calculations for biomarkers showed that, with the exception of SAH and DMG, all were 
stable (i.e. they correlate almost as well at 5 months as at 1 month lag) (Figure 4.2). 
Different degrees of reliability were apparent: the measurements of B12 and active B12 
were highly reliable, whilst others, particularly SAH, showed poorer reliability (i.e. 
correlation was weak even at 1 month lag). 
The geometric means and CCVs of biomarker concentrations for this group of 
Gambian women over the one-year study period are shown in Table 4.2. The annual 
variation in blood biomarker concentrations as a percentage variation from the geometric 
mean are illustrated in Figure 4.3, panels E, F, G and H. All blood biomarkers exhibited 
large, significant annual variation (B12 had a p-value =0.03 and all the other biomarkers 
p<0.001). However, the actual seasonal pattern of variation differed in timing and 
amplitude (magnitude of variation from the geometric mean, as indicated by the CCV), 
between the various biomarkers measured, with highest seasonal variation for plasma 
folate, B6 and the DMG:betaine ratio. Plasma folate and B6 status were highest in May-
June, at the end of the dry season and lowest from September to March (Figure 4.3, panel E 
and H). B2 status declined progressively from the beginning of the rainy season peak 
(July), until January, then improved again. Betaine reached its peak later in the rainy 
season (September) (Figure 4.3, panel E). Plasma choline showed higher concentrations in 
November while B12 and methionine, in contrast to the other nutrients, remained 
relatively stable over the year (Figure 4.3 F, E and G, respectively). Regarding the 
functional biomarkers, the SAM:SAH ratio was highest in July, and lowest in March, with 
the seasonal fluctuation in the ratio explained largely by the seasonal change in SAH. 
Plasma tHcy showed an opposite change, with the lowest and highest plasma tHcy 
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concentrations found in July and April respectively. Plasma DMG concentration was 
highest between November and March, month at which DMG:betaine ratio reached the 
highest peak too. 
As for dietary intake, Table 4.2 also shows the concentration differences between 
the peak of the rainy and dry season for each biomarker. Comparison of the biomarker 
concentrations according to these showed that the plasma SAM, betaine and folate 
concentration, and SAM:SAH ratio were higher , while the plasma SAH, tHcy, DMG, 
DMG:betaine ratio, B12 and B6 were lower in the rainy than in the dry season (Table 4.2). 
A lower EGRAC value during the rainy season denotes a less deficient status and thus 
higher B2 level. Cysteine, choline and methionine exhibited some variation between 
seasons but this represented less than a 1.5% difference between seasons. Effect of village 
was significant for intakes of B12 (p-value= 0.0023) and betaine (p-value= 0.0024), as well 
as for plasma concentrations of choline (p-value= 0.0039), folate (p-value= 0.0131), 
methionine (p-value= 0.0022) and SAM:SAH ratio (p-value= 0.0038). However the effect of 
village did not confound other effects.  
 
4.1.3.4. Dietary intake and blood biomarkers 
Next, the relationships between the dietary intakes of the nutrients under study 
and their blood concentration were regressed cross-sectionally to determine the 
predictive ability of dietary intake on blood biomarkers. Additional comparisons were 
made between selected nutrients to investigate interactions in specific pathways. 
Positive associations between dietary intakes and respective plasma biomarkers 
were not observed for folate, choline (with total choline or any of its components) or 
methionine (data not shown). Significant positive associations were found between the 
dietary intake and blood biomarkers for B6 ( : 0.166, 95% CI: 0.017-0.316), betaine ( : 
0.037, 95% CI: 0.006-0.069) and B2 ( : -0.038, 95% CI: -0.064- -0.0112, where a higher 
EGRAC indicates greater deficiency thus explaining the negative coefficient). Dietary B12 
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showed no significant association with the plasma total B12, but was positively associated 
with plasma active B12 ( : 0.043, 95% CI: 0.015-0.071). Plasma concentrations of folate 
were negatively associated with the combined intake of choline and betaine ( : -0.214, 
95% CI: -0.297- -0.131). Plasma concentrations of choline and betaine were not, however, 
associated with folate intake, but were inversely associated with the intake of B2 ( : -
0.065, 95% CI:  -0.103- -0.028 and : -0.058, 95% CI: -0.096–0.021). 
To explore the potential impact of the dietary intake of the selected nutrients on 
one-carbon metabolism more generally, we also determined the strength of the 
associations between dietary intake and functional blood biomarker status. No statistically 
significant associations were found between the plasma SAM:SAH ratio or plasma SAM 
concentration and the intake of any of the nutrients under study. Plasma SAH showed 
association with B12 intake ( =0.039, 95% CI: 0.006- 0.072). Plasma tHcy and DMG 
concentrations were correlated with the combined intake of choline and betaine ( = 
0.121, 95% CI: 0.060- 0.182 and = 0.088, 95% CI: 0.004-0.172, respectively. As found for 
plasma choline and betaine, the plasma DMG was also inversely associated with the 
dietary intake of B2 ( =-0.086, 95% CI:  -0.152- -0.020).   
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Table 4.2: Mean concentrations of blood biomarkers throughout the year and by season 
n= 316 (293 for B2); * p-value <0.05 
GM = Geometric mean; 95% range = GM  2SD 
Rainy season ‘Hungry’= July-September; Dry season ‘Harvest’= February-April 
CCV= Coefficient of cyclic variation, calculated as the square root of half the sum of the squared 
coefficients of the Fourier terms 
1 For the B2 assay, higher values of EGRAC reflect higher B2 deficiency 
(-) is indicated where no suitable cut-off could be identified 
  
Biomarker 
Units  
12 month 
GM 
(95% range) 
Cut off for 
Adequacy 
(prevalence 
adequacy) 
GM 
Rainy 
season 
‘Hungry’ 
(95% CI) 
GM 
Dry season 
‘Harvest’ 
(95% CI) 
Difference 
between 
seasons 
(%) 
CCV (%) 
(CI 95%) 
Folate  
nmol/l  
14.9 
(6.6-33.4) 
>10 (121) 
(82.3%) 
13.4 
(12.2-14.9) 
12.5 
(11.4-13.9) 
6.7 
23.8 
(20.5-26.5) 
B21 
EGRAC 
coefficient  
2.4 
(1.5-3.7) 
<1.3 (122) 
(0.7%) 
2.3 
(2.1-2.4) 
2.6 
(2.5-2.7) 
-14.11* 
9.0 
(7.6-10.4) 
B12 
pmol/l  
342.3 
(139.1-842.2) 
>220 (123) 
(80.7%) 
333.7 
(285.9-389.6) 
353.1 
(302.5-412.1) 
-5.8* 
3.5 
(1.9-5.1) 
Active B12 
pmol/l  
70.9 
(20.0-251.5) 
>37 (124) 
(85.8%) 
67.2 
(55.9-80.8) 
76.3 
(63.5-91.7) 
-13.5* 
6.2 
(3.7-8.8) 
Choline 
mol/l  
8.2 
(4.7-14.0) 
>10 (120) 
(20.9%) 
8.2 
(7.6-8.8) 
8.3 
(7.7-8.9) 
-1.3 
11.1 
(8.9-13.4) 
Betaine  
mol/l  
40.4 
(20.9- 78.4) 
- 
45.7 
(41.7-50.1) 
36.5 
(33.3-39.9) 
20.1* 
9.8 
(7.6-12.0) 
DMG 
mol/l  
3.3 
(1.1-9.3) 
- 
2.9 
(2.5-3.4) 
3.4 
(2.9-4.0) 
-18.4* 
16.3 
(13.4-19.3) 
DMG:betaine 0.08 
(0.03-0.26) 
 
- 
0.06 
(0.05-0.07) 
0.09 
(0.08-0.11) 
-49.0* 
23.3 
(20.6-25.9) 
Methionine 
mol/l  
29.1 
(19.6-43.3) 
- 
28.9 
(27.3-30.7) 
29.4 
(27.7-31.1) 
-1.5 
3.9 
(2.0-5.8) 
SAM 
nmol/l  
90.3 
(59.1-137.8) 
- 
90.3 
(85.3-95.5) 
86.3 
(81.6-91.2) 
4.4* 
4.6 
(3.0-6.1) 
SAH 
nmol/l  
12.2 
(6.8-21.9) 
- 
11.1 
(10.5-11.9) 
12.9 
(12.1-13.7) 
-15.9* 
7.8  
(4.7-10.9) 
SAM:SAH 7.42 
(3.8-14.5) 
- 
8.1 
(7.6-8.7) 
6.7 
(6.2-7.2) 
17.6* 
9.4 
(5.8-12.9) 
Homocysteine 
mol/l  
8.03 
(4.2-15.3) 
<15 (125) 
(98.8%) 
7.9 
(7.2-8.7) 
8.1 
(7.4-9.0) 
-2.9 
10.2 
(7.9-12.5) 
B6  
nmol/l  
39.7 
(14.3-110.6) 
>20 (120) 
(91.1%) 
33.8 
(29.8-38.2) 
36.0 
(31.8-40.7) 
-6.6 
26.2 
(22.4-30.0) 
Cysteine 
mol/l  
224.9 
(170.8-296.1) 
- 
217.1 
(207.9-226.7) 
219.0 
(209.9-228.6) 
-0.9 
4.1 
(3.0-5.2) 
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4.1.4. DISCUSSION 
To our knowledge, this is the first study to comprehensively address dietary 
intakes and blood biomarkers relevant to one-carbon metabolism in an African 
population. Our results reveal that, as hypothesised, in this group of rural subsistence-
farming non-pregnant Gambian women, dietary intakes and blood biomarker status of 
one-carbon-related nutrients and metabolites vary widely across the year. These seasonal 
fluctuations may provide the biological underpinnings of the seasonally-dependent 
changes in DNA methylation of metastable epialleles recently reported by us in this same 
population (79).  
 
4.1.4.1. Dietary intake  
Contrary to studies conducted several decades ago where energy intake was 
shown to be considerably lower during the rainy/hungry season (126), total food weight 
and energy intake in this study remained stable throughout the year. Several factors may 
contribute to this, including now-common financial remittances from family members 
living abroad that permit purchase of staple foods in the rainy/hungry season. High levels 
of energy expenditure in the farming season still perpetuate the historical rainy/hungry 
versus dry/harvest season divide, but it seems less severe nowadays.  
Unlike overall energy intake, the qualitative composition of the diet varied over 
the year, resulting in significant monthly variation in micronutrient intakes. The dietary 
intakes of B2, folate, choline and betaine show clear seasonality, whilst methionine, B6 and 
B12 intakes remain stable over the year (Figure 4.3). A possible explanation is that the 
major dietary source of protein (fish), which was also a major source of dietary 
methionine and B12, remained relatively constant month by month, while more 
perishable crops varied more throughout the year. B6 is nearly ubiquitous in foods. An 
additional factor may be the month of Ramadan, which fell between August 20th and 
September 20th 2009 during our study period. This may have contributed to the peaks in 
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dietary intake of betaine and choline with foods such as bread, potatoes and eggs, which 
are consumed more frequently when breaking the fast (20). The dietary intakes of folate, 
B2, and choline were less than a half, and intake of B6 was more than three quarters of the 
current EARs. 
Published data on seasonal variation in the intake of these nutrients in this 
population are available only for B2 and folate from 1979 to 1981(95). The deficient 
intake of B2 in both studies is consistent with the scarcity of milk and meat in the diet 
(88). B2 intake in the present study is lowest during the rainy season, which is consistent 
with dietary patterns found three decades ago (95). The seasonal variability in folate 
intake, however, is less consistent with the seasonality previously reported, perhaps 
explained by potential secular changes in the agriculture patterns (e.g. cultivation and 
consumption of green leaves in home gardens throughout the year). Oranges, which were 
identified as a source of folate in the past, particularly in the rainy season, were not 
consumed by any of the women in the study sample. However, these differences between 
the seasonal trends in both studies must be interpreted with caution. There might have 
been real differences due to genuine changes in the seasonal behavioural/dietary patterns 
but these might also just be methodological differences. In this respect, studies (and 
therefore food composition lab analysis assays) were 30 years apart, which could lead to 
technical differences in the measurements. Also this study was based on food analysis 
specific to the region under study (prone to a different types of error, as discussed in 
Section 4.4.4.), as opposed to using generally accepted food composition tables. These 
factors might lead to differences on either direction. Limited data are available on the 
dietary intake of these nutrients among women of reproductive age elsewhere in West 
Africa. Studies in urban Mali (127) and Burkina Faso (128) have reported similar low 
folate intakes, but higher intakes of B2 and B6, and lower B12 intakes, than in our 
population, possibly explained by differences in geographic location (e.g. river access and 
thus fish consumption), and proportion of purchased foods. The Adequate Intake (AI) level 
for choline in women is 425 mg/day (120); betaine recommendations are not yet fully 
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established. The intake values in this study were less than 40% of published AI. Whereas 
choline intake is known to be low in low-income countries (129), the 2005 NHANES 
survey found that adequate choline intake is often not achieved in the US either (130). 
Little is known about dietary betaine intakes, which in the present study had a geometric 
mean of 33.5 mg/d (95% range of 6.9 -163 mg/d). For reference, studies in the US have 
reported a range of betaine intake of 113-315 mg/d for adult women (131). 
The repeatability of dietary intake between two consecutive days was good, 
suggesting that the women tended to eat similar foods in terms of dietary intake from one 
day to another, potentially from the same stocks. However, the stability from one month to 
another changed very quickly after adjustment for seasonality (Figure 4.2), indicating a 
low reliability in the measure of habitual intake. This could possibly be due to differences 
in cash availability at different times, leading to variations in food availability variation 
independent of season. Whatever the explanation, it is clear that the dietary intake trends 
should be interpreted with caution. This strongly favours the assessment of plasma 
biomarker concentrations over dietary intake. 
 
4.1.4.2. Blood biomarkers 
All plasma biomarkers measured showed significant seasonal trends throughout 
the year (Figure 4.3). The periods of peaks and troughs for the different biomarkers do not 
generally coincide. Experimental studies have shown a reciprocal interplay between the 
folate-dependent remethylation and betaine-dependent remethylation of homocysteine to 
methionine, such that deficiency of either folate or choline (and hence betaine) leads to 
increased utilization of the alternate pathway. (132). Notably, there were increases in 
DMG at a time when folate and B2 decreased – and vice versa – (Figure 4.4), suggesting 
reciprocal switching from the folate-dependent to the betaine-dependent homocysteine 
remethylation pathway. High DMG may indicate remethylation of tHcy via betaine –
homocysteine methyltransferase (BHMT) (Figure 4.1). Betaine is both a metabolite of 
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choline and also present in the diet, converting into DMG. The inverse relation between 
betaine and DMG gives good evidence of utilisation of betaine for remethylation and the 
DMG:betaine ratio also supports this (Figure 4.3, panel F). The status for B2 is highly 
deficient in this population. The seasonal nadirs in B2 status may therefore impair the 
folate pathway, leading to an activation of the betaine pathway. The effect B2 appears to 
play could be due to its role as cofactor for methylenetetrahydrofolate (MTHFR), which 
catalyses the formation of 5-methyltetrahydrofolate needed for homocysteine 
remethylation (Figure 4.1) (133). Whereas B12 could have a similar effect as cofactor for 
methionine synthase (Figure 4.1), in the folate pathway, blood concentrations of B12 do 
not seem to be limiting in this population. Furthermore, plasma tHcy decreases when B6 
rises, suggesting a higher activity of the transsulfuration pathway. This pathway leads to 
cysteine, an important sulphur amino acid, and precursor of glutathione, via the vitamin 
B6 dependent enzyme cystathionase β-synthase (Figure 4.1).  
Higher availability of methyl-groups and cofactors, as seen in increased levels of 
folate, betaine and B2, over the rainy season may explain why SAM is also higher at this 
time, leading to a higher SAM:SAH ratio, often viewed as a ‘methylation index’. SAM 
converts into SAH by cleavage of methyl-groups during biological methylation reactions. 
The substantially higher methylation index (17.6%) would support a higher methylation 
capacity during the rainy season, consistent with previously reported DNA methylation at 
specific loci in Gambian children conceived during this season (79).  
Bates et al. (95) described the widespread B2 deficiency in pregnant and lactating 
women in The Gambia 30 years ago as well as very similar annual trends. The poor status 
of B2 detected reflects the poor intakes observed, but the present study shows a much 
more marked deficiency than that reported in the previous studies, which were conducted 
between the 1970s and 1980s. The early EGRAC analyses were done using the original 
Glatzle method at the Dunn Nutrition Unit in Cambridge (no reference available) with 
some ‘mid-stream’ modifications based on later existing literature (134, 135). This 
method was later modified to avoid values of EGRAC<1, which appeared when samples 
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were saturated or nearly saturated (leading to reaction inhibition), by modifying the pre-
incubation conditions, but also shifted the EGRAC towards higher values. There is 
evidence that changes in cofactor-induced reactivation conditions during the move to an 
automated laboratory method yields higher EGRAC values that consequently tend to 
overestimate the prevalence of B2 deficiency (122, 133).  
 
Figure 4.4: Seasonal trends of folate, B2 and DMG blood concentration, expressed as 
percentage of geometric mean of all measurements (between July 2009 and June 2010) 
 
Interdependence of folate-dependent and betaine-dependent pathways 
n biomarker measurements= 316 (293 for B2); 95% CI 
B2 status is shown as the inverse of EGRAC assay results; DMG, dimethylglycine 
P-value blood B2, folate and DMG <0.0001 
 
The stability and reliability of our measurement of biomarkers are generally better 
than those for the dietary intakes measurements. The comparatively reduced reliability of 
SAH and DMG measures could be due to either strong biological intra-individual 
fluctuations or to sample processing issues. SAM may convert to SAH during sample 
processing, and this conversion could be more strongly noticed in SAH than in SAM due to 
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the difference in total concentrations. However, every effort was made to avoid any delays 
in processing, thus we regard this to exert minimal effects on our measurements. 
 
4.1.4.3. Dietary intake and blood biomarkers 
 The overall goals of this study were to examine: 1) whether dietary intakes predict 
nutritional blood biomarker status and contribute to the concentration of functional 
biomarkers, and; 2) how the seasonality observed in blood biomarkers reflected the 
seasonality observed in dietary intakes. Dietary intake was only directly associated with 
the blood biomarkers betaine, B2, B6, and active B12. The weakness of the associations 
between the monthly trends in biomarker concentrations and dietary intake may be 
explained by blood concentrations being subject to physiological utilisation (interactions 
between supply and demand) and complex regulation, or possibly by the inherent error 
associated with dietary assessment. As discussed above, biomarker concentrations can 
also be affected by compensatory mechanisms linking the folate- and betaine-dependent 
pathways, both methionine and homocysteine (which remethylates into methionine) 
playing pivotal roles. For example, blood concentrations of betaine are sustained by 
dietary intake and choline oxidation, which can in turn be obtained by diet or formed 
endogenously. Premenopausal women have the capacity to synthesise 
phosphatidylcholine via oestrogen-mediated induction of the phosphatidylethanolamine-
N-methyltransferase (PEMT) gene (136). Conversely, use of betaine to provide methyl-
groups takes place simultaneously and is related to the use of the folate-dependent 
methionine resynthesis cycle (137). As is apparent from the choline and betaine example, 
the metabolism of the different nutrients is highly interrelated, with deficiency or 
abundance of one substance affecting the metabolism of the others, probably to ensure 
maintenance of a constant supply of valuable methyl-groups. Furthermore, methyl-
tetrahydro-folate requires its methyl-group being transferred for example from serine or 
glycine. Finally, homocysteine can be removed from the system by conversion to cysteine 
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via the transsulfuration pathway. SAM, the ultimate methyl-donor providing methyl-
groups for DNA methylation, is also a positive allosteric regulator of cystathinine B 
synthase involved in transsulfuration. 
 
4.1.4.4. Strengths of this study 
 This is the first comprehensive study of one-carbon metabolites in an African 
setting. Very detailed information was collected for close to 30 women every month for 
one year. In this population, the profound seasonal changes in diet quality combined with 
seasonal variations in metabolic demand due to very high levels of physical activity in the 
rainy/farming season create a special opportunity to examine the inter-relationships 
between dietary supply and circulating methylation-pathway metabolites in a manner that 
could not readily be achieved through experimental dietary manipulations. High levels of 
deficiency of several key micronutrients (vitamins B2, B6, folate and choline) also 
permitted us to study a situation in which the methyl-donor pathway may well be 
substrate-limited. Interestingly our data appear to show profound differences from 
studies of rural vegetarian women in India who are highly B12 deficient and relatively 
folate replete (138). Closer comparisons of these populations may provide additional 
insights into nutritional influences on DNA methylation. 
 
4.1.4.5. Limitations of the study 
 As with most studies that attempt to assess human nutrient intakes in free-living 
conditions, there are several limitations. Although the weighed record method is viewed 
as the gold standard for quantitative dietary assessment (118), it is by no means perfect 
and behavioural changes from the daily practice could have taken place (139). Food 
composition data can also introduce error, due to limited number of samples and the high 
number of steps required in the processing. The random error inherent to any dietary 
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assessment method could have attenuated correlations (140), as clearly suggested by the 
reliability curves shown in Figure 4.2. 
 
4.1.4.6. Conclusions 
 This study demonstrates that natural climate-dependent seasonality in food 
availability and dietary choices, especially in a micronutrient deplete population, creates 
an excellent ‘experiment of nature’ in which to examine linkages between diet, the 
metabolome and possible reproductive influences on DNA methylation in humans. This 
has allowed us to reach the following conclusions: 1) that, due to the biases (possible 
under-reporting) and imprecision inherent in estimating dietary intake, and due to the 
complex relationships between intake and nutrient availability for metabolic pathways, it 
is far preferable to assess plasma biomarker concentrations, as these provide a more 
accurate and more proximal indication of methyl-donor status; 2) that the previously 
described (137) reciprocal compensation between the folate-dependent and betaine-
dependent re-methylation pathways may be driven by a moderate-to-severe vitamin B2 
deficiency that is paradoxically worst in the dry/harvest season; 3) that, contrary to our 
initial assumption that the rainy/hungry season would put women at greatest risk of a 
deficient methyl-donor supply, the reverse was clearly apparent with lower homocysteine 
and higher methylation indices (SAM:SAH ratio); and 4) that these findings are consistent 
with our previously reported findings of elevated DNA methylation at metastable 
epialleles in individuals conceived during the rainy season (79). 
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4.2. ADDITIONAL METHODS 
4.2.1. Study population 
The selection of the three villages from which participants were selected 
(Jiffarong, Keneba and Janneh Kunda) was based on several criteria. The aim was to 
capture as much variation as possible within the district. These villages are located at 
Eastern, Central and Western points within the region, as shown in Figure 4.5.  The three 
villages selected differed according to location to main access routes (South Bank road), 
proximity to river and proximity to primary healthcare centres, although all villages are 
predominantly Mandinka. 
 
Figure 4.5: Map of geographical location of the indicator group villages within West Kiang 
 
Indicator group villages  
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Meetings were held with the authority (‘alkalo’) of each of the three villages to 
seek permission for conducting this study. The burden of the study group was high for the 
participants and for their families (i.e. two full-days of fieldworker presence at their 
compound, in addition to blood sample being collected monthly). Therefore, details of 
study and the protocol were carefully explained to the women and also to their families. 
Additionally, sessions of sensitisation were conducted to respond to the concerns raised 
regarding the frequency of the bleeding and the amount of blood. 
A short LMP questionnaire, similar to that for the main group, was conducted. 
Women who did not see their menses for two consecutive visits had a urine sample 
collected for pregnancy testing (Quickvue One-step hCG Combo © dipstick test, 
BioMérieux SA, Marcy l’Étoile, France). If the result was positive, they were invited to MRC 
Keneba for an antenatal care visit and excluded from the indicator group if the pregnancy 
was confirmed. The gestational age was determined by ultrasound scan, to determine 
whether samples should be used. Participants from the indicator group were excluded 
from the main group recruitment, but if they became pregnant and fulfilled the eligibility 
criteria of conception timeframes, they were invited to enrol into the main group. 
 
4.2.2. Dietary intake 
24-hour weighed records 
Field assistants were trained to conduct a very detailed assessment of dietary 
intake (two day 24-hour weighed intake records recipe collection), as described in Section 
4.1.2.2 (Appendix III (B)). Each day, the field assistant would arrive at the participant’s 
compound prior to the cooking/breakfast time and remain there throughout the day, or 
followed women to the field. For the recipe preparation (e.g. porridges, sauces or full 
meals such as “nyankatango” – rice normally cooked with pounded groundnuts and flaked 
fish), each ingredient was weighed separately (after washing, peeling and eliminating 
inedible parts), including added water, and all ingredients were recorded in the ‘recipe 
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form’ (Appendix VI), with information on the food sources (i.e. home garden, bush, shop, 
rural market, coast or other). The form included details on the potential for cooking smoke 
exposure (i.e. type of kitchen –ventilation). 
At the beginning of the study, subjects were supplied with a standard plastic 
container that they kept for the length of the study, and used for the separation of their 
individual portion for measurement and so that their individual intake could be estimated 
accurately (as opposed to their normal practice of family shared bowls) (139). 
Components of the meal were added one-by-one progressively (generally staples were 
added first, followed by sauces, and then any other extra foods (pieces of vegetables, fish 
or meat)) and recorded separately in the dietary intake form (Appendix VII). Thus, each 
new measure included all the previously added foods, in addition to the container weight 
and the newly added food. Values for each individual food could then be calculated by 
difference with the previous measurement (taring method). If the portion was not 
finished, the inverse procedure was followed for the left-over weighing. Meat or fish bones 
were weighed first and subtracted from the initial amount of fish/meat. All other 
individual ingredients left-over were then measured and lastly the staple was weighed, 
indicating if it was still mixed with sauce or alone. If the woman expressed her will to 
continue eating her food afterwards, left-overs were again measured at that stage 
(recorded as “second attempt” in the dietary intake form – Appendix VII). Any snack or 
drink consumed during the day (other than water) was also weighed.  
 
Food composition analysis 
In parallel to the dietary fieldwork, a list with all ingredients used by the 
participants was compiled, with details of the most frequent source also recorded. The list 
was updated every month throughout the year. On average five samples (range 2-8) for 
each ingredient were collected (subject to availability), by the field assistants or by myself, 
for content analysis of methyl-donors and cofactors. Samples came mainly from the three 
villages of study, regional rural markets were also visited and some foods were obtained 
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from the coastal urban area. Particular attention was given to potential seasonal 
differences: two sets of samples, one during the rainy season and one during the dry 
season, were collected for those foods deemed to potentially experience composition 
changes across seasons, such as meat or rice. The decision was made depending mainly on 
whether the sources varied along the year (e.g. local vs. imported rice) or if they were 
literature reports of potentially important changes of composition (e.g. meat 
composition). The details on the collection and origin of each sample were compiled in the 
food collection form (Appendix XI, Form G02A).  
The information on the processing was recorded on the laboratory processing 
form (Appendix XI, Form G02B). A flow diagram of the procedure for food preparation 
prior to analysis of methyl-donor and cofactor content is shown in Figure 4.6. Final 
‘composite’ samples (n=98) were created to analyse and obtain an average composition 
value, by mixing together individual freeze-dried samples of the same ingredient but with 
different origins. The composite sample mix was prepared by combining equal amounts of 
the original foods (i.e. prior to freeze-drying). The amount of water needed to rehydrate 
the composite samples was calculated and sent to the analysing laboratories. At the 
University of North Carolina the powdered sample were analysed (analysis of choline 
compounds and betaine), whilst Eclipse Scientific Group rehydratated the samples prior to 
analysis (analysis of B2, B6, B12, folate and methionine). The main details on those 
analyses are given in Section 4.1.2.2. Total choline analysis included five different 
compounds: free choline (Cho), glycerophosphocholine (GPC), phosphocholine (Pcho), 
phosphatidylcholine (PTC), and sphingomyelin (SM). Betaine is also a choline metabolite 
but values are not included in the calculation of total choline since the conversion of 
choline to betaine is irreversible (141). The lower detection limits for quantification of 
substances under study were as follows: folate 0.021 µg/g, B2 0.5 mg/kg, B6 0.1mg/kg, 
B12 0.002 µg/g and methionine 0.02g/100g. Detection limits for choline compounds 
ranged between 1 and 40, with betaine detection being the most sensitive and GPCho 
detection being the least sensitive (113). 
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Figure 4.6: Food processing 
 
Flow diagram of the processing steps prior to analysis of foods (ingredients) 
 
Dietary intake calculation 
Data collected in the recipe and dietary intake forms were entered into the DINO 
programme (version 2.1). This programme is an Access-based application, with several 
sections. The section of ‘Food tables’ includes food composition tables, namely those that 
already exist for some nutrients and the expansion based on the information from this 
project for methyl-donors and cofactors. It also contains the ‘Nutrient Profile Calculator’ 
for recipe calculation, based on the system used for the UK National Diet and Nutrition 
Survey. The section on ‘Dietary Coding’ allows for data entry using the taring system (for 
the meals) or portion sizes (for the snacks). Finally the ‘Data Analysis’ section provides 
result tables in Excel, including daily intakes, average portion weights and main 
contributors. Examples of data entry screens in DINO are shown in Appendix XII. 
From the beginning of the dietary data collection (July 2009), the forms were 
entered and a list of all the food items coded was drawn up, for the collection of foods to 
be analysed. This list was extended as new records were entered. Recipe and dietary 
intake data were cleaned on data entry, as DINO does not allow for any missing value, or 
mismatching value (for example weight of rice + sauce being below the weight of rice 
only), or unusually high portion sizes. This ‘check system’ helped early detection of 
problems in the data collection that could be addressed by conferring with the field 
assistants conducting the work. This was the first time that DINO was used in real time for 
a project. While piloting the software, some issues were raised in order to improve its use, 
and also to better respond to the specific needs of the current study. These were 
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addressed through changes in the programme, to make it easier to use by data clerks and 
better reflect the intakes on an individual basis. For example, the ‘Nutrient Profile 
Calculator’ application was designed specifically for this study. 
 
4.2.3. Blood biomarkers 
Details of blood collection and sample analysis are given in section 4.1.2.3. The 
10ml blood sample was collected into a 7.5 ml EDTA Sarstedt Monovette© and a 2.4 ml 
LithHep Sarstedt Monovette©.  
Samples of whole blood were used to prepare malaria slides and haemoglobin 
concentration was measured with a Delphi portable haemoglobin meter (Delphi 
Industries, Auckland, New Zealand). Then, samples were spun at 2750 g and 4°C in a 
Hettich EBA 21 centrifuge for 10 minutes to separate plasma for aliquoting and later 
biomarker analysis. RBCs were washed 3 times in the LithHep tube with physiological 
saline solution (0.9% w/v NaCl), and then spun at 2750g for 15 minutes, prior to storage 
at -40°C. All sample collection processing methods followed protocols, as agreed with 
collaborating institutes and in line with local procedures at MRC Keneba. 
B2 status was the measured as EGRAC on microplates. This method developed in –
house at the MRC HNT is equivalent to the method on the Cobas FARA centrifugal analyser 
previously used at HNR, and based on the initial procedure of Vuilleumier et al. (117) for a 
Cobas-Bio centrifugal analyser. Measured EGRAC results were verified by internal cross-
comparisons with the FARA method, but the microplate assay has better precision 
(unpublished data). The reagents and preincubation conditions used for both methods 
(microplate and Cobas-FARA) are the same, with the exception of the addition of a low 
concentration of detergent (Triton X-100) in the current method, which is needed to 
equalise the light-path in the microplate wells. For both methods, the activity of 
erythrocyte glutathione reductase is measured before and after stimulation by in vitro 
saturation with flavin adenine dinucleotide (FAD). The main difference between methods 
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is the absorbance reader and in this case, the reduction in absorbance at 340 nm was read 
with an iEMS temperature-controlled microplate spectrophotometer. 
 
4.2.4. Data analysis 
Dietary intake 
During the data entry into DINO, a number of problems were encountered. For 
example, it is not unusual that the remaining rice and sauce from evening meals are mixed 
overnight and stored for breakfast the following morning. In such cases, the real 
proportions could not be calculated but a rice-sauce average proportion, from other data 
available of rice with a similar sauce for the same participant and at similar time of the 
year, was used instead. 
Once the nutritional composition results from the freeze-dried food samples were 
available, these were entered into DINO (as composition per 100g of food) and data 
cleaning / quality control checks performed. On occasions, possibly due to an under-
recording of the added water during the recipe observation (the water was usually added 
at various stages), an ‘overconcentration’ of the recipe (i.e. more water evaporated than 
actually added) was observed. To check the adequacy of the recipes concentration, the 
energy content of each recipe was plotted against the energy content information of the 
same ‘standard’ recipe available in DINO. For the energy calculation of the newly collected 
recipes, data available from The Gambia (96) and Mali (142) were mainly used, and from 
British foods otherwise (143). Outliers affected by overconcentration were replaced by 
the same recipe for the same woman at similar time of the year. When that was not 
possible, the recipes of other participant in the same village for the same month were 
considered. The software calculated automatically the daily intake of the substances under 
study. 
In addition to the analysis included in the ‘Dietary intake’ section of the research 
paper II (Section 4.1.3.2), the correlations between pairs of the different dietary intakes of 
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methyl-donors and cofactors were calculated, after standardisation for total energy intake. 
Additionally, the principal contributors to the total population intake were calculated, by 
grouping the main intakes by ingredient or by type of recipe (e.g. different types of fish, 
rice preparations or green leave sauces). 
 
Blood biomarkers 
Full details of the analysis of blood biomarkers are given in the Methods section of 
the research paper II (Section 4.1.3.3).  
 
Dietary intake and blood biomarkers 
Full details of the analysis of dietary intake and blood biomarkers are given in the 
Methods section of the research paper II (Section 4.1.3.4) 
 
4.3. ADDITIONAL RESULTS 
4.3.1. Study population  
To help ensure a constant sample size of 30 women per month, a replacement 
strategy was put in place, where women who withdrew or who were excluded were 
replaced by a new recruit from the same village and age group. The reasons for 
replacement were:  
a) Pregnancy (n=14): pregnant women were removed from the study after 
confirmation of status by ultrasound. There are no known preferential dietary 
customs or major taboos (i.e. foods prohibited) specific to pregnancy in this 
population that could alter dietary intake qualitatively (126). A recent study in a 
comparable rural community in Burkina Faso has also shown no significant 
difference in the dietary intake between pregnant and non-pregnant women (144). 
Although it is acknowledged that intake could be reduced during early pregnancy in 
some women feeling sick, the dietary intake data of pregnant women were included 
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in the analysis until the moment where they were replaced. However, one-carbon 
metabolism is known to be substantially affected by pregnancy (145), due to 
hormonal and physiological changes and enhanced requirements, and therefore 
blood samples collected during the first months of pregnancy were excluded from 
the analysis. Thus, blood samples collected during pregnancy, as confirmed 
retrospectively using gestational age (due to the time delay of pregnancy detection), 
were excluded from the analysis.  
b) Self-withdrawal (n=11): a higher withdrawal rate was observed than expected, 
seemingly as a consequence of the monthly bleeding (quantity and frequency). Out 
of the 11 women who withdrew, more than half (n=6) were from Janneh Kunda, 
whilst 3 were from Jiffarong and 2 from Keneba. 
c) Moved away or long term travel (n=6): participants who could not be visited for 
more than one consecutive month were excluded from the study and replaced. 
d) Menopause (n=5): these cases were identified during the first visit, which explains 
the smaller sample size for the first month. After this, special care was given to early 
menopause (or underestimation of date of birth, in a population traditionally 
without birth registry) and to ensure the participants were still seeing their menses 
when joining the study. As was the case for pregnant women (and for contraceptive 
users, see below), the information collected on dietary intake information was 
included, but blood biomarker data was disregarded in the analysis. 
e) Known contraceptive users (n=1). 
 
A small number of participants (n=4) refused to have their blood collected after 
their dietary intake on a few occasions. Together with the samples withdrawals, this led to 
a reduced sample numbers available for the biomarker analysis compared to dietary 
intake assessments. The details on follow-up with respect to both dietary intake and 
biomarker data points for each participant by month and village are shown in Figure 4.7.  
 123 
Figure 4.7: Duration of follow-up of participants in the indicator group and sample size of 
dietary and biomarker data  
 
 
Ji: Jiffarong; JK: Janneh Kunda; Ke: Keneba 
Total dietary/biomarkers: number of months of data analysed 
  
Participants
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Total	
dietary
Total	
biomarkers
1 2 2
2 9 9
3 12 12
4 4 0
5 10 10
6 1 0
7 2 0
8 12 12
9 2 2
10 12 12
11 3 0
12 5 0
13 5 5
14 6 6
15 6 4
16 9 9
17 5 4
18 3 3
19 3 3
20 1 0
21 2 2
22 2 2
23 1 1
24 2 2
Total	per	
month	(Ji) 10 7 10 7 9 6 10 7 10 9 10 9 10 9 10 9 10 9 10 9 10 9 10 10 119 100
Participants	
JANNEH	
KUNDA
25 2 2
26 3 3
27 2 0
28 1 0
29 3 2
30 11 11
31 12 11
32 1 0
33 11 11
34 7 6
35 11 11
36 3 2
37 6 6
38 7 5
39 9 9
40 5 4
41 9 9
42 2 1
43 4 4
44 4 4
45 3 3
46 2 2
47 1 1
Total	per	
month	(JK) 10 7 10 9 10 8 10 9 10 10 10 10 9 9 9 7 10 9 10 9 10 10 10 10 118 107
Participants	
KENEBA
48 10 8
49 8 8
50 2 1
51 3 3
52 12 12
53 1 0
54 11 11
55 12 12
56 12 12
57 10 9
58 11 11
59 10 8
60 8 8
61 4 4
62 2 2
Total	per	
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4.3.2. Dietary intake  
The effect of village of residence and participant age (in years) was assessed as 
covariates with respect to the dietary intake of each individual nutrient by multiple 
regression (GLS). An effect of village was seen for the intakes of B12 (Keneba = 4.08 µg/d, 
Jiffarong = 2.55 µg/d, and Janneh Kunda=2.08 µg/d; p-value = 0.0023) and betaine 
(Keneba = 40.27 mg/d, Janneh Kunda = 33.83 mg/d and Jiffarong = 28.48 mg/d, p-value = 
0.0024), with intakes for both highest in Keneba. Age had no effect in any of the individual 
dietary intakes. 
The monthly variation in dietary intakes, expressed as percentage deviation of the 
geometric mean is presented in the research paper II in Section 4.1.3.3. In addition, Figure 
4.8 shows the seasonal variation for the different choline compounds measured. These all 
contribute to the calculation of total choline but they were also looked at individually for a 
better understanding of their individual contribution to total choline intakes. All five 
compounds had significant annual variation. The graph shows that the choline peak in 
September is likely to be mainly driven by phosphatidylcholine and phosphocholine, 
whilst the peak in December seems to be driven by sphingomyelin and free choline, and 
the later smaller peaks, by free choline and phosphatidylcholine. The best sources of free 
choline were foods of vegetable origin (green leaves, potatoes and groundnuts), whilst for 
glycerophosphocholine, phosphocholine, phosphatidylcholine and sphingomyelin, main 
sources were of animal origin (egg, shrimp, milk or meat). The specific information on 
food composition is shown in Appendix X (B). 
As discussed in research paper 1 (Section 2.2) the supply of methyl-groups for 
remethylation of homocysteine in one-carbon metabolism has two complementary 
pathways. Some of the different dietary methyl-donors and cofactors are needed in 
combination (i.e. folate, B2 and B12). Therefore, independently of seasonality and repeat 
measurements, the correlations between different intakes within the Gambian diet were 
assessed. The correlation coefficients, adjusted for energy intake, are shown in Table 4.3. 
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B12 is not correlated with any other nutrient whilst the other B-vitamins, B2, B6 and 
folate, seem to be significantly correlated, with coefficients ranging between 41.0% and 
62.8%. The highest correlation was observed between choline and betaine. These 
correlations can be explained to a large extent by common sources of each nutrient 
contributing to the total intake. Major contributors (grouped by food type) to the dietary 
intake are summarised in Table 4.4. 
 
Table 4.3: Correlation coefficients between methyl-donors and cofactors in the diet of 
rural Gambian women 
Nutrient B2 B6 Folate B12 Choline Betaine 
B2 1      
B6 0.5132* 1     
Folate 0.4100* 0.6275* 1    
B12 0.0764 0.0145 -0.0142 1   
Choline 0.2471* 0.2961* 0.2832* 0.0989 1  
Betaine 0.1678* 0.1010 0.1504* 0.0054 0.3682* 1 
Methionine 0.0903 0.2331* 0.2185* 0.0092 -0.0774 -0.0130 
* p-value <0.05 
 
 
  
 126 
 
Figure 4.8: Seasonal trends for dietary intake of choline compounds, expressed as 
percentage deviation of the median (July 2009 to June 2010) 
 
Thick line: percentage of the geometric mean; Thin lines: 95% CI 
Choline compounds: Free choline (Cho), glycerophosphocholine (GPC), phosphocholine (PCho), 
phosphatidylcholine (Ptdcho), and sphingomyelin (SM). 
P-value intake Cho = 0.043; GPC <0.0001; Pcho = 0.005; Ptdcho <0.0001; SM = 0.036 
 
Table 4.4: Main contributors to the methyl-donor and cofactor intakes in the diet of rural 
Gambian women 
 
Nutrient B2 B6 Folate B12 Methionine Choline Betaine 
1st 
contributor* 
Rice Rice Rice Fish Rice Rice Leaf 
sauces 
2nd 
contributor* 
Milk Millet Millet Meat Fish Groundnut Bread 
3rd 
contributor* 
Millet Leaf 
sauces 
Mangoes Milk Millet Beans Fish 
Ingredients were grouped by type of food (e.g. green leaf sauce includes all the sauces made out of 
leaves such as morango, kucha, jambo or others) 
* 1st, 2nd and 3rd contributors to population intakes were calculated quantitatively 
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Wood was used as cooking fuel by all women observed. They generally used the 
same type of kitchen throughout the year, independent of the season: 80.5% of women 
cooked in closed kitchen of mud brick, which were poorly ventilated with just one door 
and without any window; 3.7% cooked in kitchens with some windows; and 7.9% cooked 
outside in the courtyard. The remaining 7.9% of women showed a variation in cooking 
place across the year (i.e. closed kitchen used more often during the rainy season and 
open air cooking done more often during the dry season).  
 
4.3.3. Blood biomarkers 
The effect of village of residence and participant age (in years) was also assessed 
as covariates with regards to the blood biomarker levels. An effect of village was found for 
folate which was highest in Janneh Kunda (Janneh Kunda = 15.80 nmol/l, Keneba = 15.14 
nmol/l and Jiffarong = 12.49 nmol/l; p-value = 0.032), and for SAM:SAH ratio, which was 
higher in Keneba than the other two villages (Keneba = 7.89, Janneh Kunda = 7.39, 
Jiffarong = 6.88, p-value< 0.0001) and lowest in Jiffarong in both cases. Choline (ß= 0.009 
mol/ per year, p-value= 0.001), betaine (ß= 0.010 mol/l per year, p-value= 0.03), 
SAM:SAH ratio (ß= 0.007 per year, p-value= 0.001) and SAM (ß= 0.006 nmol/l per year, p-
value= 0.029) levels seemed to increase with age, whilst methionine (ß= -0.005 mol/ per 
year, p-value= 0.038) decreased. However, village and age were not included in the final 
analysis models because the effects observed made little difference to the overall results 
(details not presented).  
As described in Section 4.1.2.3, participants were asked to fast overnight prior to 
blood sample collection. On 24 occasions (out of 316; 7.6%), women reported to have 
eaten. However, without the information on what was eaten, how much or when, it was 
decided not to take into account the fasted / non-fasted status in the overall analysis 
models.  
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Seven different vitamers exist for B6 (116). Three of those vitamers have been 
analysed for this study, namely pyridoxal (PL), pyridoxal-5’-phosphate (PLP) and 4-
pyridoxic acid (PA). Figure 4.9 shows the seasonal variation for the different B6 vitamers 
measured. There is a strong similarity in their variation throughout the year, although 
with different concentrations. The geometric mean concentrations were 3.76 nmol/l (95% 
CI 3.54-4.01 nmol/l) for PL, 27.68 for PLP (95% CI 25.04-30.59 nmol/l) and 7.77 (95% CI 
7.07-8.53 nmol/l) for PA. 
 
Figure 4.9: Seasonal trends for B6 vitamers in blood expressed as percentage deviation of 
the median (July 2009 to June 2010) 
 
PL: Pyridoxal; PLP: Pyridoxal-5’-phosphate; PA: 4-Pyridoxic acid; all p-values <0.0001 
 
The association of the different individual methyl-donors and cofactors with the 
main functional biomarkers was assessed in Table 4.5. SAM is a positive allosteric 
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modulator of cystathionine  synthase (CBS) (146), which means that SAM regulates the 
flux through the transsulfuration pathway which coverts homocysteine into cysteine. 
Hence cysteine was considered as an ‘outcome’ blood biomarker in this study, even if we 
did not investigate the dietary intakes. Table 4.5 shows that plasma B6 did not seem to 
predict any of the selected functional biomarkers (p-value>0.05), other than cysteine. 
Homocysteine was associated with all methyl-donors and cofactors, but the folate-
pathway and betaine were associated with decreased tHcy, whilst choline and methionine 
were associated with an increase of tHcy, SAM:SAH ratio showed a similar pattern, 
although neither folate nor active B12, seemed to play a role. The DMG concentration was 
positively associated with choline and betaine concentrations, but also negatively with 
folate and B2. 
 
Table 4.5: Regression coefficient of the individual blood methyl-donor and cofactors with 
the main functional biomarkers in plasma. 
Methyl-donor/cofactor Functional 
biomarker 
 
 coefficient P-value 
Folate nmol/l  SAM:SAH ratio 0.100 0.060 
 SAM 0.077 0.015* 
 SAH -0.027 0.628 
 Homocysteine -0.182 <0.0001* 
 DMG -0.119 0.019* 
 Cysteine 0.051 0.019* 
B2 1/EGRAC  SAM:SAH ratio 0.254 0.011* 
 SAM 0.087 0.187 
 SAH -0.114 0.251 
 Homocysteine -0.219 0.018* 
 DMG -0.532 <0.0001* 
 Cysteine 0.028 0.532 
Active B12 pmol/l  SAM:SAH ratio 0.046 0.216 
 SAM -0.003 0.924 
 SAH 0.2867 0.001* 
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Methyl-donor/cofactor Functional 
biomarker 
 
 coefficient P-value 
 Homocysteine -0.198 <0.0001* 
 DMG 0.020 0.715 
 Cysteine 0.016 0.413 
Choline mol/l  SAM:SAH ratio -0.331 <0.0001* 
 SAM 0.051 0.301 
 SAH 0.287 0.001* 
 Homocysteine 0.213 0.002* 
 DMG 0.257 0.001* 
 Cysteine 0.088 0.008* 
Betaine mol/l  SAM:SAH ratio 0.164 0.015* 
 SAM 0.027 0.559 
 SAH -0.139 0.042* 
 Homocysteine -0.293 <0.0001* 
 DMG 0.430 <0.0001* 
 Cysteine -0.075 0.014* 
Methionine mol/l  SAM:SAH ratio -0.2123 0.034* 
 SAM -0.039 0.445 
 SAH 0.101 0.281 
 Homocysteine 0.266 <0.0001* 
 DMG 0.013 0.873 
 Cysteine 0.112 0.001* 
B6 nmol/l  SAM:SAH ratio 0.016 0.720 
 SAM 0.021 0.398 
 SAH -0.007 0.871 
 Homocysteine 0.060 0.079 
 DMG 0.065 0.091 
 Cysteine 0.048 0.004* 
* p-value <0.05;  Generalised Least Squares regression between log-biomarkers, adjusted by 
seasonality (sin1-cos2) 
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4.3.4. Dietary intake and blood biomarkers 
Details of the results of relationships between dietary intakes and blood 
biomarkers are covered in the Results section of the research paper II (Section 4.1.3.4). 
 
 
4.4. ADDITIONAL DISCUSSION 
In this section, additional issues beyond the scope of the research paper II (Section 
4.1.4) are discussed.  
 
4.4.1. Study population  
As discussed in Section 4.3.1, it was not possible to follow a stable population 
across the full 12-month period of study. This could have introduced random bias, 
potentially confounding the individual effect with the season effect, in those individuals 
who only participated for a specific month or season. This would have averaged out within 
a bigger sample but the indicator group sample size was limited. ‘Subject’ (participant ID) 
was fixed in the model to account for the repeated measures. This yields a conservative 
estimate of the season effect, which underestimates the effect, detecting only genuinely 
significant associations. This might have affected the ability to detect significant 
seasonality in some of the dietary intakes. All plasma biomarkers were shown to be 
seasonal, but the obtained estimates could be potentially less accurate (due to the 
reduction in power). A further drawback was the relatively small sample size, affecting the 
power for the detection of associations between the dietary intake and plasma 
biomarkers.  
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4.4.2. Dietary intake  
In this section, further consideration of the factors affecting the dietary intake is 
given. With the exception of methionine and B12 (and betaine, which does not have a 
recommended intake), the dietary intakes observed in this population are considerably 
below the current recommendations. Few women reached the EARs for B2, choline and 
folate (6.2%, 2.8% and 1.2% respectively were beyond the EAR, see Table 4.1 in research 
paper II, Section 4.1.3.2). In comparison with other populations, mean intake of choline of 
women in other LIC such as Jamaica (278 mg/d) (129) was below recommended Adequate 
Intake of 450-550 mg/day (147) and similar to the choline intake of the lowest quartile of 
women in the USA (<293 mg/d in 1984 - Nurse’s Health Study (148)). The mean intake in 
The Gambia was nearly half this value (155 mg/day). Mean intakes B2, B6 and folate of 
women in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort 
throughout 10 Western European countries were of 1.6  mg/day, ~1.2–2.3  mg/day and 
~175–331 µg/day respectively in women (149), compared to 0.3 mg/day, 0.92 mg/day 
and 155 µg/day in The Gambia. 
A statistically significant seasonal variation in dietary intake was shown for B2, 
choline, betaine and folate. B2 (mainly present in milk and meat) intake is lowest during 
the peak of the rainy season and increases from September onwards. This is not an 
isolated observation, as discussed in Section 4.1.4.2, but is consistent with previous 
findings (95). Based on personal observation, a potential explanation for the seasonality 
patterns is that it seems preferable not to milk / slaughter cows at the end of the dry 
season and the beginning of the rainy season, due to the poor condition the animals are at 
after a long period of scarcity of grass. The B2 intake is poor throughout the year. 
However, it is not unusual to see villagers sending containers of milk to the coast 
(personal observation). Thus, it is possible that milk could be sold at the coast in exchange 
of cash, reducing the local availability even during times of plentiful supply. For folate, the 
increase along the second half of the dry season seems to coincide with the brief local 
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availability of mangoes, which is consistent with previous findings (95). The post-harvest 
dry season coincides with the time when choline seems to be driven by free choline 
(Figure 4.8), which is more frequent in ingredients of vegetal origin. Conversely, the 
choline peak in September appears to be driven by the choline metabolites which are 
more present in foods of animal origin. One also has to be bear in mind that, as discussed 
in Section 4.1.3.2, Ramadan in 2009 fell in the middle of the rainy season (between August 
20th and September 20th 2009) and might therefore have introduced bias. It has been 
reported by Gambian women that during Ramadan there is increased consumption of 
certain foods such as beans, vegetable oil dishes, fish, potatoes or meat (150). From 
observation of the annual trends (Figure 4.3) the choline and betaine peaks in September, 
could very well be driven by the Ramadan dietary practices. Conversely, methionine 
intake is very stable throughout the year and, B2, folate and B6 daily intakes seem mostly 
unaffected by the fasting. 
The usual diet in rural Gambia relies on a relative small number of ingredients. 
This leads to a degree of overlap in the main sources of the different nutrients, 
concentrated in fish, meat, green leaves, groundnuts and milk (see food composition table 
in S1 in Section 4.1.3.2, Table 4.3 and Annex X). However some of the richest foods (eggs, 
meat, milk) are consumed very seldom by women, as they are expensive and only 
temporarily available. Furthermore, most of the nutrient-rich foods are not consumed in 
large quantities, resulting in less rich foods (i.e. rice or millet) being the major 
contributors to the diet. This probably explains the high intake correlations of B6, folate 
and methionine. 
An effect of village was not considered in the regression model used to analyse 
dietary intakes (GLS regression) because of the little impact it seemed to have, but B12 
and betaine, intake appeared to be higher in Keneba, followed by Jiffarong and finally 
Janneh Kunda. In terms of access to fish, which is the main B12 source, all three villages 
have access to river fishing catches to a certain extent. However, Jiffarong and Keneba 
have better access than Janneh Kunda to goods brought from the coast (e.g. a lorry which 
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regularly brings sea fish from the coast) and from the big rural markets on the main road 
(where a variety of dry fish is sold). Differences in cash availability could also play a role, 
with generally higher income for Keneba residents, due to the presence of the MRC as the 
main employer in the area, as well as the International Trypanotolerance Centre (ITC), 
also located in this village. The betaine sources that explain differences in betaine intake 
are bread (48% and 69% more was attributable to bread in Keneba than in Janneh Kunda 
and Jiffarong, respectively), probably due to higher bread availability in Keneba – there is 
a baker who makes bread almost every day- and cash availability to purchase it) and green 
leaves (27% and 61% more was attributable in Janneh Kunda than in Keneba and Jiffarong 
respectively). The higher consumption of green leaves in Janneh Kunda could be to a good 
organisation of communal gardens, together with more difficult access to markets. 
Therefore, they might be more likely to eat what they produce, as opposed to selling it.  
In terms of cooking smoke exposure, the anecdotal data collected would not 
suggest much intra-individual variation (across season) but greater inter-subject variation 
instead. These observations could be biased due to the variable length of follow-up per 
participant. Owing to drop-outs, some participants were followed only during one season, 
and therefore there is insufficient longitudinal data across the year to assess smoke 
exposure accurately. 
Given the limited range in dietary practices (ingredients and food preparation 
diversity) in the region, two days of dietary assessment were deemed to be sufficient 
(151). Such assessment is subject, as in most settings, to methodological limitations 
inherent to nutritional studies. Although 24-hour weighed records are considered the gold 
standard, this method is by no means exempt of problems, particularly behavioural 
changes. In a society where shared bowls is common practice, individual measurements 
become more challenging. The separation of the subject’s portion, particularly when 
assessed by someone from their community, might have put the subjects under pressure 
to deliberately under-eat. Alternatively, being observed could lead to subjects over-eating 
as they do not have to share the food with others. The observation of the cooking can also 
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induce substantial behavioural changes such as simplification of the cooking procedures 
or, conversely, the preparation of a more complex (potentially better) meal. In either case, 
each person would have tendency to one or the other, and therefore this should have a 
constant effect along the year, with high inter-subject variation but much less intra-
individual variation.  
One way to assess obvious under- or over-reporting is to look at the calculated 
energy intakes among the women. The average reported energy intake was 1830 kcal/d. 
Previously, a total daily energy expenditure of approximately 1650 kcal/d has been 
reported in non-pregnant, non-lactating women (89, 152). This was measured by 24-hour 
whole-body calorimetry, with 60 minutes of compulsory exercise. The current 
measurements of intake would allow an additional 180 kcal/d of discretionary activity. 
This is inadequate during the intense physical activity of farming season (153), but is 
probably close to the requirement for the year as a whole. Therefore, although 
underestimation of food intake is a well-know limitation of dietary intake methods (139, 
153), it is unlikely that the current estimates of intake represent an error of more than 
10% of the average.  
Although this is not thought to have had a major effect, food composition data 
could also introduce error in the dietary intake estimation, due to the limited number of 
samples and the high processing which was required (i.e. cooking, freeze-drying, 
preparing composite samples). 
 
4.4.3. Blood biomarkers 
In terms of secular trends, EGRAC coefficients are much higher (indicating greater 
deficiency) now than in the past (95). Although the poor biomarker status detected 
reflects the poor intakes observed, there is evidence that the move to an automated 
laboratory method yields higher EGRAC values that consequently tend to overestimate the 
prevalence of B2 deficiency (122, 133) compared to historic data available. In addition, it 
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has been argued that an improved B2 status, as measured by EGRAC, could take place 
during the rainy season when tissue resorption (weight loss) takes place, with potential 
release of B2 from tissue turnover (e.g. muscle) and transfer to enzymes such as 
glutathione reductase. Conversely, during the dry season, tissue restoration would lead to 
increased B2 demands, and would lower the circulating B2 (95). 
The only previous study looking at plasma folate, B12 and total homocysteine, 12 
years prior to the current study, was limited to a three month period during the dry 
season of 1997 (97). The geometric mean for folate (17.5 nmol/l) seems higher than in the 
current study (14.9 nmol/l). However, the previous study took place from April to June 
and in the current data, the monthly mean plasma folate concentration ranged between 
13.91 in April and 23.32 mean nmol/l in June, suggesting that a lot of variability seems to 
exist across this time period, so these differences in values seem plausible.  The same 
study reported substantially lower levels for B12 (262 pmol/l vs. 342 pmol/l) for both 
pregnant and non-pregnant women. This could potentially be due different 
analytical/sample collection and processing techniques used (IMx kit assay compared to 
AxSYM in this study). However, substantial equivalence between assays has been claimed 
by Abbot, manufacturer of both assays (154). If methodological reasons are ruled out, 
higher plasma concentration found in this sample population could be due to a higher B12 
intake nowadays, as a consequence of increasing cash availability and/or a more regular 
supply of fish from the coast as mentioned above. However, no data are available on past 
B12 intakes and therefore it is difficult to ascertain what the reasons could be. In any case, 
and supported also by the dietary intake data, B12 levels are adequate throughout the 
year and are probably not limiting for one-carbon metabolism. The past values for tHcy 
were slightly higher (8.92 g/l) than the values observed in the current study (8.03 g/l), 
and this could be explained by the timeframes investigated and the variation over that 
period (mean homocysteine ranged between 9.88 g/l in April and 6.94 g/l in June).  
Large ‘phase’ differences (i.e. with different patterns of peaks and troughs along 
the year) can be observed between the different biomarkers. This can be to a certain 
 137 
extent explained by seasonal variability in the diet, but also by physiological use and 
turnover. This makes defining a globally ‘advantageous’ or ‘restricted’ time period of the 
year difficult. Therefore, the use of SAM:SAH ratio as a methylation capacity index to 
summarise one-carbon metabolism is very useful. In Table 4.5, it can be observed that the 
SAM:SAH ratio seems to be only positively associated with B2 and betaine concentrations, 
whilst negatively with choline and methionine concentrations. The opposite direction in 
the association between SAM:SAH and the different methyl-donors (e.g. choline and 
betaine), is difficult to explain. This finding is consistent with the correlations of choline 
and betaine for other biomarkers (i.e. SAH, homocysteine and cysteine) with the exception 
of DMG, for which both show positive association. In this respect, choline shows similar 
effects to methionine, suggesting that the explanation might be in the alternative biological 
functions (e.g. protein building) that these two metabolites have, thus making the 
interpretation more complex.  
The strong negative association of B2 with DMG supports the observation based 
on the seasonal graphs (Figure 4.4) indicating that low B2 could lead to enhanced activity 
of the betaine-dependent pathway. B12 in this population is not limiting (i.e. beyond the 
established cut-off, Table 4.2 Section 4.1.3.3.) which might explain why it does not show an 
effect on the SAM:SAH ratio or in the shift to the betaine-pathway (increased DMG). 
However, B12 seems to be associated with SAH and homocysteine. Plasma B6 not did 
predict any of the selected biomarkers other than cysteine. Even if, from one-carbon 
metabolism, cysteine could be considered an ‘outcome’ of the transsulfuration (via B6 
regulation), cysteine, as methionine, also comes from the diet and is present in body 
protein pools for other functions. Nevertheless, B12 concentrations seemed to respond to 
folate, choline, betaine, methionine and B6 concentrations. 
Choline in plasma was measured as free choline. It has been recently observed that 
elevated total plasma choline (which is primarily phosphatidylcholine and sphingomyelin 
since they tend to occur as much bigger pool than free choline) was associated with lower 
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risk of NTD, not plasma free choline (155). The relationship between different choline 
pools is not fully understood.  
 
4.4.4. Dietary intake and blood biomarkers 
It seems somehow paradoxical that while some of the dietary intakes reported for 
Gambian women participating in this study are considerably below the current EARs, 
these are not accompanied by seriously deficient biochemical or physiological indices for 
most of the metabolites. An exception is intracellular B2. The EGRAC coefficient is very 
high (the average value in this group is almost twice the established cut-off), seemingly 
reflecting the very poor intake in this population (with an average intake three times 
below the EAR). Furthermore, there is a seeming lack of response of blood concentrations 
to dietary intakes for some of the nutrients, as shown by the weak or lack of correlation 
between values in intake and in blood. These mismatches between low dietary intake and 
yet comparably limited deficiency in blood biomarker level, with lack of correlation 
between both measurements could be explained by: 
1) Measurement error inherent to dietary intake measurement. The limitations of 
the dietary assessment methodology have already been highlighted in Sections 
4.1.4.2 and 4.1.4.5. Figure 4.2. clearly illustrated the poor reliability and limited 
stability existing for all dietary intake data collected, in contrast with the 
reliability and stability observed for those nutrients in blood. The local dietary 
practices (i.e. eating from a shared bowl) are undoubtedly disrupted by the 
procedures followed to measure individual intakes of the women in the study. 
Similarly, regular eating choices can be affected during the days of 
measurement by the presence of the field worker in the compound (e.g. 
participants eating more, or less, or preparing foods differently to usual 
practices in front of guests; or conversely oversimplifying the cooking on the 
measurement days to avoid the burden of the measurement) or could be 
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misrecorded if women decided not to report certain things eaten when not in 
front of the fieldworker. Beyond the actual recording of intake, the 
transformation of food intake into nutrients intake also can lead to error, from 
the calculation of nutrients during the food preparation to the variety in food 
composition. The study tried to overcome this by analysing local foods, 
prepared the local way, but this was not exempt to error either, due to the 
limited sample size used, and the high processing and weighting of the samples 
(when prepared, cooked, freeze-dried, analysed, etc.) that could introduce 
error at any stage. These limitations in the dietary measurements have 
consistently been observed in dietary assessment (156). With the clear 
potential for over/under reporting, the lack of good correlation between 
nutrient intake and blood level variables is unsurprising, and the choice of 
blood levels as better and more reliable status markers becomes undeniable; 
also  
2) Biomarkers being subject to physiological utilisation and to tight regulation, 
which could not be measured based on the sampling method employed here. 
The dietary intake may not always directly reflect in blood for biological 
examples. An example of this are the blood concentrations of betaine and 
choline which can, as discussed in the research paper II in Section 4.1.4.2, also 
be explained by endogenous synthesis and turnover. Indeed, choline is not 
essential in women of reproductive age, as it can be synthetised from 
phosphatidylethanolamine via PEMT enzymatic action. This endogenously 
produced choline, as well as dietary choline, can transform into betaine. Yet, 
betaine intake is associated with blood biomarker concentration in this study, 
although this association is not very strong. However, this example illustrates 
that these substances are not solely dependent on diet, and given the 
interdependence of all the substances in the one-carbon metabolism, this could 
also have an effect on the levels in blood of other substances. 
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B2 as measured by the EGRAC assay is commonly reported to correlate well with 
dietary intake and also shows an association with dietary B2 in this study. The EGRAC 
assay (which alters in accordance with erythrocyte half-life), reflects availability of B2 
stored intracellularly, giving a good estimation of long-term B2 status (118). Thus, while 
the other nutrients under study are assumed to be more directly related to recent intake, 
the B2 level is assumed to reflect longer-term intakes. However, the association observed 
is not unexpected since B2 can rapidly cross the RBC membrane. Folate, B12 and 
methionine blood levels seem unaffected by diet. As discussed above (Section 4.1.4.3), the 
metabolism of the different nutrients is highly interrelated, and the deficient levels of most 
could be due to the metabolism of others. For instance, methionine is an essential amino 
acid, which can be obtained from the body protein pool or through the remethylation of 
tHcy. Finally, genetic variation could modify folate and choline metabolism resulting in 
individuals whose nutrient turnover may differ (136). Such genetic variation needs 
further study in this population.  
The associations observed for the functional biomarkers are also somewhat 
paradoxical. For example, it was surprising not to find correlations between SAM, SAH or 
tHcy with the dietary intakes of folate, B6 or B2 (157), especially given the apparent 
severe deficiency of B2 in this population. Only tHcy was found to be associated with the 
choline and betaine intake, but this association was positive. This is contrary to what has 
been previously reported in the Netherlands and in a US population prior to folate 
fortification (131, 158, 159). Thus the findings of this study should be considered with 
caution and need further assessment, e.g. if supplementation studies are to be considered 
in this population. 
One of the main objectives of this study group was to provide dietary predictors of 
biomarkers that could be extrapolated to the main group, to estimate their intakes for a 
given blood concentration, in the next Chapter. The reliability and stability of some of the 
intakes and biomarkers needs to be considered (see Sections 4.1.4.1 and 4.1.4.2). Further, 
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the poor correlation between dietary intake and biomarker levels might make it difficult 
to extrapolate the data from the indicator group for use and estimation of the potential 
dietary intake in the main group. Dietary data was shown clearly to be more imprecise and 
variable than the biomarker measurements, which look more robust than the dietary 
intake. Therefore, the use of biomarkers in the main study seems more appropriate.  
 
4.4.5. Conclusions 
This study expands on the findings from an earlier pilot study (160) on methyl-
donor and cofactor intake during the Gambian rainy season, to provide information on the 
annual variation in the nutrient intake. Further, dietary intake in this study is coupled with 
blood biomarkers on each month. The combination of both provides evidence that the 
rainy season, traditionally considered the nutritionally challenged season, is less deficient 
in terms of methyl-donor supply. However, the dietary intakes do not always correlate to 
the plasma status and, from this study it can also be concluded that the biomarkers are 
more appropriate than the dietary intake to determine the methyl-supply status. 
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CHAPTER 5: MAIN GROUP 
This Chapter describes and discusses the ‘main group’ study. The main group 
investigates the association between season of conception and DNA methylation outcomes 
in offspring. Maternal blood biomarkers of one-carbon metabolism (measured in blood 
samples collected as close as possible to conception) are hypothesised to explain the effect 
of season in DNA methylation previously observed (79). The main findings have been 
written as a paper (Section 5.1.), to be submitted to PLoS Medicine. The remainder of 
Chapter 5 provides study detail beyond that presented in the prepared manuscript 
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ABSTRACT  
Periconceptional maternal supplementation with folic acid, vitamin B12, choline and 
betaine can induce DNA methylation changes in mice, resulting in phenotypic differences 
in their offspring. We investigated whether seasonally-driven natural fluctuations in the 
nutritional status of rural Gambian women, when occurring during the initial stages of 
embryonic development, can lead to detectable differences in DNA methylation patterns of 
their infants. 
Women (n=167) who conceived at the peak of either the rainy (July-September) or dry 
(February-April) season were enrolled. Blood samples collected at 8.6 weeks after 
conception (± 0.12 weeks) were used to assess the concentrations of choline, betaine, 
folate, methionine and vitamins B2, B6 and B12, as well as S-adenosylhomocysteine 
(SAM), S-adenosylmethionine (SAH), homocysteine and dimethylglycine (DMG). DNA was 
obtained from infants born to these women for evaluation of locus-specific DNA 
methylation at metastable epialleles, by pyrosequencing. Seasonal variation was observed 
for maternal biomarker levels and infant DNA methylation. The rainy season was 
associated with higher infant DNA methylation levels (4.92% for PAX8 and 3.49% for 
RBM46), as well as maternal SAM:SAH ratio (55.8%) and concentrations of most methyl-
donors (folate (42.2%), betaine (23.3%) and methionine (12.5%)) and cofactors (B2 and 
B6). Other maternal biomarkers did not show seasonal variation (choline) or were higher 
in the dry season (e.g. active B12). DNA methylation at the loci studied was associated 
with the SAM:SAH and DMG:betaine ratios, with B2 and with cysteine, but not with the 
rest of the biomarkers. 
These data indicate that one-carbon metabolite status varies seasonally (as expected). 
Observation of differences in DNA methylation pattern by season was replicated and there 
are associations between maternal biomarker status and infant DNA methylation. 
Confirmation of a causal relationship requires supplementation trials. 
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5.1.1. INTRODUCTION 
An adverse prenatal environment can programme disease susceptibility in 
adulthood and such processes are likely regulated – at least in part – by epigenetic 
mechanisms (19). Epigenetic marks regulate gene expression without altering DNA 
sequence. Growing evidence is accumulating on the sensitivity of epigenetic marks to 
external influences such as nutrition (161), and on the importance of epigenetic 
dysregulation in diseases such as cancer (162) and diabetes (163). It is thought that 
epigenetics may account for at least some of the missing heritability of complex diseases 
and act as the interface between early environmental cues and genes. DNA methylation is 
the best-characterised mechanism of epigenetic modification (110). Methyl-groups (-CH3) 
originate from diet via one-carbon metabolism (Figure 4.1) and bind covalently to 
cytosines within cytosine-phosphate-guanine (CpG) dinucleotides. Two complementary 
pathways exist (folate- and betaine-dependent) to make available methyl groups by 
remethylating homocysteine into methionine. Yet, how DNA methylation operates and is 
regulated throughout early development is poorly understood (111). Environmentally 
induced DNA methylation changes are not limited to the periconceptional period (75), but 
it has been shown that early after fertilisation, at least in mice, a critical window exists for 
the establishment of new DNA methylation marks (111). Maternal supplementation of 
dams with methyl-donors and cofactors has been demonstrated to modify offspring gene 
expression and hence phenotype (68, 112).  
In humans, direct evidence exists for nutritional deficiencies of methyl-donors and 
cofactors in pregnancy and offspring outcomes such as neural tube defects (164) and 
orofacial clefts (165), which are thought to be epigenetically mediated. Further, 
epidemiological evidence from survivors of the Dutch Hunger study suggests that severe 
famine during the prenatal period can lead to alterations in DNA methylation in the 
offspring, dependent on offspring sex and gestational age at the time of exposure (74, 75). 
Moreover, periconceptional folic acid supplementation has been shown to increase DNA 
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methylation in the IGF2 gene in newborns (166). In The Gambia, micronutrient 
supplementation during pregnancy was associated with variations in global DNA 
methylation (104) and DNA methylation at imprinted loci in the offspring (105). 
DNA methylation can be cell-specific, thus methylation patterns of one tissue may 
not reflect systemic DNA methylation (19). So-called metastable epialleles (MEs) are 
genomic loci at which the epigenotype is established stochastically in the early embryo, 
prior to gastrulation, and subsequently maintained across all germ-layer cell lineages. 
Thus, MEs exhibit inter-tissue concordance and allow the use of DNA from easily 
accessible venous blood for analysis. MEs are thought to be particularly sensitive to 
environmental exposures, and are therefore suitable candidates for foetal programming 
studies (167). In rural Gambia, we previously reported an effect of season of conception 
on DNA methylation at MEs (79). Mean DNA methylation was consistently higher (up to 
10% difference) for five genes (BOLA3, FLJ20433, PAX8, SLITRK1 and ZFYVE28) in children 
conceived during the rainy season months of August to September. We have also reported 
that seasonal variation exists in dietary intake and metabolic blood biomarkers of methyl-
donors in rural Gambia (research paper II, Section 4.1). It remains unclear, however, 
whether the observed season-of-conception effect on DNA methylation is caused by 
variation in maternal nutrition and/or by other factors.  
The natural pattern of seasonality in rural Gambia provides an experimental 
setting to explore the role of maternal nutritional status on epigenetic programming in 
their infants. Here, we aim to: i) replicate and expand on previously identified associations 
between season of conception and infant DNA methylation; ii) explore whether seasonal 
differences exist in a comprehensive set of maternal biomarkers of methyl-donor status 
around the time of conception; and iii) investigate whether such variations could explain 
the associations between conception season and offspring DNA methylation.  
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5.1.2. METHODS 
5.1.2.1. Study population 
This was an observational prospective cohort study, conducted between July 2009 
and July 2011 in 34 villages across the rural West Kiang District of The Gambia.  
 
Mothers: All women of reproductive age (18-45 years) registered in the West 
Kiang Demographic Surveillance System (DSS) were invited to participate. Exclusion 
criteria included confirmed pregnancy at time of recruitment, menopause, or likely 
migration (short- or long- term) away from West Kiang. Each month from enrolment, 
consenting women were visited at the village health post for height and weight 
measurement (Tanita DH305 scales (Tanita Corporation, Japan) and Leicester height 
measure (Seca 214, UK)) and to answer a short questionnaire on the date of their last 
menstrual period (LMP). On the first report of a missed menses, a 10ml fasting venous 
blood sample was collected for the purpose of blood biomarker assessment. Following a 
second consecutive missed period the next month, a urine sample was collected for 
pregnancy testing (this system was set-up to avoid early disclosure of pregnancy). If the 
test was negative the woman continued to be visited monthly, and her blood sample from 
the previous month was discarded. If the test was positive, the woman was invited to the 
MRC Keneba field station for confirmation of pregnancy by ultrasound examination and, 
where indicated, a full antenatal check. Women who conceived during the peak of the 
rainy (July-September 2009) or dry (February-April 2010) season and with a maternal 
blood sample collected within the first 16 weeks from conception were then fully enrolled. 
Multiple pregnancies were excluded. Recruitment into the study ran in tandem to a 
supplementation trial on Early Nutrition and Immune Development (the ENID Trial) 
(ISRCTN49285450). Supplementation (including iron-folate, as per national policy) only 
started after confirmation of pregnancy, i.e. after sample collection for this study. 
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Infants: Between 3-9 months after delivery, an infant sample of venous blood (3 
ml) was collected for DNA extraction by a trained nurse. Based on previous birth rates, we 
anticipated recruiting up to 100 women-infant pairs in each of the two 3-month peak 
season time windows. 
The Scientific Coordinating Committee of the MRC Unit, The Gambia, granted 
scientific approval and the joint Gambian Government/MRC Unit The Gambia Ethics 
Committee (SCC/EC 1151) and the LSHTM Ethics Committee (EC 5525) granted ethical 
permission. Following community approval in each village, written informed consent was 
obtained from all study participants and their parents or guardians. 
 
5.1.2.2. Maternal blood biomarkers 
Conception date was calculated by adding 14 days to the estimated date of onset of 
the last menses, based on the gestational age determined by ultrasound at the time of the 
first antenatal check. The first day of the last menses is estimated to be 14 days prior to 
fertilisation. A cut-off for ‘early pregnancy’ defined at 16 weeks from conception at the 
time of the blood sample collection was implemented, to allow for late detection of 
pregnancy.  
Blood biomarker measurements included folate, B2, B6, B12, active B12 
(holotranscobalamin, the biologically active form of B12), choline, betaine and methionine, 
as well as homocysteine (tHcy), S-adenosylmethionine (SAM), S-adenosylhomocysteine 
(SAH) and dimethylglycine (DMG). Maternal samples were collected in the field and 
transported on ice to the MRC Keneba laboratory for immediate processing. SAM may 
convert into SAH over time and therefore special care was given to process and freeze the 
plasma sample without delay. All plasma biomarkers were assessed at the Department of 
Pediatrics, University of British Columbia, Canada, as previously described (research 
paper II, Section 4.1). Briefly, SAM, SAH, free choline (it has been observed that high 
concentrations of free choline are present in foetal plasma (168, 169)), betaine, DMG, total 
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homocysteine (tHcy), methionine, cysteine and B6 (measured as pyridoxal (PL), pyridoxal-
5’-phospahate (PLP) and 4-pyridoxic acid (PA)) were analysed by liquid chromatography-
tandem mass spectrometry (LC-MS-MS) as previously reported (114-116). B12 and active 
B12 and folate were analysed by a microparticle enzyme intrinsic factor assay and by ion 
capture assay respectively, on an AxSyM analyser (Abbot Laboratories, Chicago, IL). B2 
status was determined in red blood cells (RBC) at MRC Human Nutrition Research (HNR), 
Cambridge, UK, using the erythrocyte glutathione reductase activation coefficient (EGRAC) 
assay, performed on a microplate. Higher EGRAC values denote B2 deficiency. 
 
5.1.2.3. Infant DNA methylation 
DNA was extracted from venous blood using a standard salting-out method (170). 
Extracted DNA was cleaned using the Chelex-100 (BIO-RAD) protocol (171). DNA 
methylation analysis was carried out at the Baylor College of Medicine, USDA/ARS 
Children's Nutrition Research Center, Houston, USA. 
 Four previously described MEs, namely BOLA3, PAX8, EXD3 (FLJ20433 in the 
current human genome assembly HG19) and ZFYVE28 and three newly identified MEs, i.e. 
RBM46, PARD6G and ZNF678, were investigated. Briefly, these MEs were determined 
through a custom methyl-specific amplification microarray (MSAM) screening procedure 
with validation by bisulfite pyrosequencing (172). Loci with tissue-specific methylation, 
and CpG affected by polymorphisms that could confound the MSAM detection scheme, 
were not considered (79). CpG-specific methylation in the current infant DNA samples was 
measured by quantitative bisulfite pyrosequencing (Pyro Gold reagents and a PSQTM HS 
96 pyrosequencer, from Biotage), as described elsewhere (172). Briefly, 0.5-2 g of DNA 
was bisulfite treated, followed by locus-specific PCR amplification and pyrosequencing to 
measure methylation at 4 to 12 CpG sites per locus (see Table 5.1 for details). Each 
pyrosequencing assay covered 50-70bp of DNA and was validated by inclusion of 0, 25, 50, 
75 and 100% methylated standard human DNA samples.  
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Table 5.1: Details for the PCR and Pyrosequencing conditions for DNA methylation analyses (79) 
Locus name and location 
(chromosomal position 
based on human genome 
build 19) 
Number  
of 
CpG sites  
Forward Primer Reverse Primer Product 
size  
(bp) 
Annealing 
temperature 
(°C) 
Pyrosequencing Primer 
BOLA3 
(5kb downstream) 
chr2:74,357,770 
5  
GGTGTATTTAAGTAT
AGAGAAGGTGGAGAT 
Btn-
AAAACAACTAAAACTCA
CAAACCACTACTA 
206 61 GTGGAGATGGAGGGA 
PAX8 
(Intron 9) 
chr2:113,992,770 
5 3’: 
GGGGTGGATGAGATT
GAGGTTAGA 
3’: Btn-
CCTTCAATACCTTTCCCC
ATACTACC 
171 67 3’: GGTTTGTTTTGAGGAT 
RBM46 
(Intron 1) 
chr4:155,703,000 
12 3’: 
TTGTATGGTGAGGGT
TTAG 
3´: 
TCTAAAACCAAACTACT
AAATCT 
293 51 3´: GTGTTATTTTTTTGATA 
ZFYVE28 
(Promoter CGI) 
chr4:2,366,687 
5 5´: 
TTTAGTAGGGGYGGYG
TAGTTTTAGTTATA 
 
5´: Btn-
AAACCTAACRCCTAAAA
AATAACC 
 
82 59 5´: GGYGTAGTTTTAGTTATAGAGT 
 
EXD3 
(Intron 1) 
chr9:140,312,195 
5 Btn-
AGGTTATTGAGTTGG
GTTTTTT 
 
CTCCTCAAATCCTCAAA
CTCTATCC 
134 53 CCTCAAACTCTATCCTTTC 
PARD6G 
(Last exon)  
chr18:77,918,167 
6 5´: 
GTAGATGGAATAGTA
GTGTTAGGTGTATGA 
 
5´: 
TCATTCACAACCAACAA
CC 
 
437 53 5´: GGGTTGGAGAAGGTG 
 
ZNF678 
(5kb upstream) 
chr1:227,746,190 
4 5´: 
GGGTGTTGAAGGTTT
TTT 
 
5´: 
CAAACCAAACTCCTAAT
ACTAT 
 
220 55 5´: CTACCTAATAATACTACAATC 
 
bp: base-pairs; chr: chromosome; CpG: cysteine-phosphate-guanine  
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5.1.2.4. Statistic analysis 
All analyses were performed in Stata 11.0 (StataCorp, College Station, TX). The primary 
exposure was season of conception (rainy vs. dry season) and DNA methylation the outcome 
measure. Maternal blood concentrations of one-carbon metabolites acted as both an outcome 
of season and a intermediate exposure for DNA methylation. 
 
Study population characteristics: Demographic characteristics within both seasonal 
groups were compared using the Wilcoxon-Mann-Whitney non-parametric test (for continuous 
variables) and Chi-square test (for categorical variables). Body mass index (BMI) was 
calculated in kg/m2. The infant Z-scores of weight-for-length (WLZ) and length-for-age (LAZ) 
were calculated using the 2006 WHO Growth Standards (173).  
 
Maternal blood biomarkers: In addition to the 15 individual biomarkers under 
investigation, two further variables were created: the SAM:SAH and the DMG:betaine ratios, as 
measures of methylation activity and betaine-pathway activity, respectively. All blood 
biomarkers showed signs of a positively skewed distribution and were therefore 
logarithmically transformed and reported as geometric means. Because it would have been 
impossible to draw blood samples timed to coincide with the immediate post-conception days 
we enrolled a separate group of non-pregnant women (the indicator group) and studied their 
diets and plasma biomarker status at monthly intervals (full details described in research 
paper II, Section 4.1). This allowed us to extrapolate the biomarker levels of the pregnant 
women back to the levels likely to have been present at conception. To achieve the adjustment 
we first assessed the accuracy of the autocorrelation in the indicator group (reliability and 
stability of each biomarker) and then tested how much the seasonal patterns (Fourier series 
terms, namely sin1 cos1 sin2 cos2) matched between the indicator group and pregnant women 
by fitting the same seasonal patterns (research paper II, Section 4.1). Then we used the non-
pregnant women seasonal data for the back extrapolation, according to the following equation: 
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log_yadj= log_y + mean (at conception)SInd –mean (at measurement)SInd 
yadj: outcome variable adjusted for weeks since conception and seasonality 
MeanSInd: mean of Seasonal non-pregnant women (Indicator) group 
 
Differences in maternal biomarker concentration were tested by comparing both 
seasonal groups of pregnant women (rainy vs. dry season conception) with one-way ANOVA. 
Potential predictors of blood biomarker concentration (e.g. age, BMI) were determined by 
multiple regression analysis. This was conducted on the biomarker data prior to back-
extrapolation, to explore the independent effects of season and weeks since conception. 
Correlations were calculated amongst (unadjusted) biomarkers to assess their 
interdependence.  
 
Infant DNA methylation: Loci that had more than one CpG site failing the quality control 
cut-off, and individuals with more than one ME that failed to be screened, were excluded from 
the analysis. Methylation at the majority of CpG sites showed signs of a skewed distribution 
and hence a logit transformation was performed. For the seasonal comparison of methylation 
at each ME, multivariate analysis of variance (MANOVA) was used, including all existing CpG 
sites for each locus. The mean methylation at each locus was then calculated. Correlations were 
also assessed between mean DNA methylation at each ME to assess their interdependence. 
Finally, a multilevel Generalised Estimated Equations (GEE) model analysis was used to 
explore the association between the different non-nutritional predictors (e.g. infant sex or 
ethnicity) and mean methylation at all MEs jointly, standardised (by dividing by the standard 
deviation for its variation between women). This multilevel model assumes independence 
between the variables. Therefore, given that correlation between the different MEs exists, an 
unstructured correlation matrix was used to fit the model (i.e. with unconstrained conditions 
in the correlation).  
 154 
Interrelationships between maternal blood biomarkers and infant DNA methylation: 
An equivalent multilevel analysis model was used to explore the association between each 
individual maternal biomarker and methylation at all standardised MEs jointly. All multilevel 
GEE regressions were adjusted by infant sex and maternal BMI. This model was also used to 
examine whether the biomarker effects differed by ME. Given the interrelations that can exist 
between the different metabolites, principal component analysis (PCA) was used to allow 
compressing of biomarker data into ‘component’ variables. This reduces the number of 
dimensions and simplifies the interrelationships between biomarkers, without important loss 
of information, for the analyses of the effect all biomarkers on DNA methylation. To account for 
the multiple testing, a Bonferroni correction was applied, with a cut-off of significance of 
0.0005 (p-value = 0.05/(13 biomarkers x 7 loci)).   
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5.1.3. RESULTS 
5.1.3.1. Study population 
Mothers: 2047 women were consented and visited monthly. During the follow-up 
period, 335 participants were excluded due to self-reported onset of menopause not identified 
at consent, out-migration or self-withdrawal. The total number of women conceiving during 
the a priori selected months and having a blood sample collected during the first 16 weeks of 
pregnancy from conception was 167, recruited across 24 villages. Of these, 84 women (50.0%) 
conceived during the rainy season. The mean age of all the women was 29.2 years, the majority 
of which were of self-reported Mandinka ethnicity (86.2%), the remainder being Fula or 
’Other’. The average BMI of women, measured at a mean gestational age of 8.6 weeks from 
conception (at the time of the blood collection) was 21.2kg/m2 (range 15.08- 33.45). 
Infants: 167 infants were recruited prenatally, but only 136 of these made it to follow 
up; the rest were lost through miscarriage, infant death, difficulty to collect blood sample or 
withdrawal (see Figure 5.1). The majority of infants were of maternally-reported Mandinka 
ethnicity (80.7%) and 52.9% were male. The mean (SD) age of infants at bleeding was 3.5 (+/-
0.98) months (range 2.0-8.2 months). The mean (SD) WLZ was -0.43 (+/-1.32) and the LAZ was 
-0.55 (+/-1.01).  
The summary statistics of the study sample groups are provided in Table 5.2. No 
significant differences in demographic characteristics were found for either mothers or infants 
by season.  
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Figure 5.1: Participants enrolment 
 
MDEG: Methyl-Donors and EpiGenetics study (current study (SCC/EC 1151)) 
ENID: Early Nutrition and Immune Development trial (ISRCTN49285450) 
Rainy season (in green): July-September 2009; Dry season (in yellow): February-April 2010; Inclusion 
and exclusion criteria are described in Section 5.1.2.1 
Maternal withdrawals N=335 
Reasons for loss to follow up of infants: miscarriage (n=6), inability to get infant blood (n=9) or other 
reasons including infant death, participants moving-away, self-withdrawal (n=7). Some infants (n=9) 
were bled but the extracted DNA quality was not adequate for the DNA methylation analysis. 
 
  
West	Kiang	women	consented	
N=2047	
RAINY	SEASON	
Bled	women		
N	=	478		
Eligible	pregnant	women	
MDEG	only	=	84	
Infants		
MDEG	only	=	68	
DRY	SEASON	
Bled	women		
N	=	290		
Eligible	pregnant	women	
ENID/MDEG	=	74	
MDEG	only	=	9	
Infants		
ENID/MDEG	=	59	
MDEG	only	=	9	
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Table 5.2: Baseline characteristics of study population by season 
 Rainy season Dry season  
Characteristics N (%) Mean 
(95% range) 
 
N (%) Mean 
(95% range) 
 
P-value of the 
difference 
between seasons 
Mothers 
Age, years 
84 (50.3%) 
29.4 
(15.4-43.3) 
83 (49.7%) 
29.1 
(16.5-41.7) 
0.960a 
Ethnicity* 
Mandinka 
Fula 
Other 
 
52 (81.3%) 
11 (17.2%) 
1 (1.6%) 
- 
 
48 (92.3%) 
4 (7.7%) 
0 (0%) 
- 0.200b 
Weeks  
from conception 
84 (50.3%) 
8.4 
(-0.3-17.1) 
83 (50.3%) 
8.9 
(7.4-16.3) 
0.546a 
BMI at bleeding 
73 (47.4%) 
21.2 
(14.8-3.2) 
81 (52.6%) 
21.1 
(14.6-27.6) 
0.546a 
Infants 
Males 39 (57.4%)  33 (48.5%)  0.303b 
Age, months 
65 (53.3) 
3.9 
(1.7-6.1) 
57 (46.7%) 
3.1 
(1.9-4.4) 
0.546a 
Ethnicity: 
Mandinka 
Fula 
Other 
 
47 (73.4%) 
11 (17.1%) 
6 (14.1%) 
 
 
44 (88%) 
3 (6%) 
3 (6%) 
 0.254b 
Weight for length  
(Z-score) 
64 (53.3%) 
-0.4 
(-3.4-2.5) 
56 (46.7%) 
-0.4 
(-2.6-1.8) 
0.979a 
Length for age  
(Z-score) 
64 (54.2) 
-0.7 
(-2.7-1.2) 
54 (45.8%) 
-0.3 
(-2.4-1.7) 
0.045a 
*Ethnicity only available for women with infants; 95% range = Mean  2SD 
aWilcoxon-Mann-Whitney non-parametric test; bChi-square test 
 
5.1.3.2. Maternal blood biomarkers 
Plasma samples were frozen on average 179 minutes after collection in the field (range 
38 to 380 minutes). The effect of time of processing (between sample collection and storage in 
the freezer) was assessed and found to affect DMG, which decreased ( = -0.191 µmol/l per 
hour, p-value=0.034) and SAH, which increased ( = 0.880 nmol/l per hour, p-value=0.001) 
with processing time. Linear regressions were used to correct these two variables to time zero. 
Seasonal patterns of biomarker levels in the pregnant women were tested against our non-
pregnant women group to assess the degree of appropriateness of the back-extrapolation of 
biomarker level to time of conception. The age of this ‘indicator’ group women ranged from 18 
to 45 years (mean (SD) 31.2 (8.0) years). Folate, choline, betaine, B12, Active B12, SAM and the 
DMG/betaine ratio showed similar patterns in pregnant women compared to the non-pregnant 
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group (p-value >0.05), whilst methionine, DMG, SAH, B2, B6 vitamers (PL, PLP and PA), 
SAM:SAH ratio, homocysteine and cysteine differed significantly (p-value <0.05). Seasonal 
patterns for both the non-pregnant and the pregnant women are shown in Figure 5.2.  
The differences in blood biomarker concentrations between women who conceived 
during the rainy and the dry season prior to (unadjusted data) and after the back-extrapolation 
for seasonal trends (based on the data from the group of non-pregnant women) are shown in 
Tables 5.3 and 5.4. After back-extrapolation, geometric mean levels of the following 
biomarkers were higher in the rainy season when compared with the dry season: SAM:SAH 
ratio (55.8%), betaine (23.3%), folate (42.2%), methionine (12.5%), PL (41.9%) and PA 
(29.1%). EGRAC was lower (19.1%), denoting a higher B2 status. Conversely, plasma 
concentrations of DMG (39.1%), SAH (34.4%), active B12 (17.8%), homocysteine (17.7%) and 
the DMG:betaine ratio (53.3%) were lower during the rainy than during the dry season. No 
significant differences were observed between seasons for the remainder of the biomarkers. 
As illustrated in Figure 4.1, one-carbon metabolites are highly interdependent. Pairwise 
univariate correlations between biomarkers (unadjusted data) were examined and the 
correlation matrix is shown in Table 5.5. It was observed that homocysteine correlated 
negatively with markers of the folate pathway (r=-0.374 for folate, r=-0.117 for B12 and 
r=0.195 for B2 status (positive correlation with EGRAC)), but positively with betaine (r=0.308), 
choline (r=0.177) and DMG (r=0.330) whilst SAM:SAH ratio correlated negatively with both 
pathways (r=-0.123 for folate, r=-0.224 for choline and r=0.330 for DMG. Looking at 
correlations between the folate dependent and independent pathways, concentrations of DMG 
were negatively correlated with folate (r=-0.178) and with B2 (positively correlated with 
EGRAC, r= 0.120).  
Predictors of biomarker levels were assessed by multiple regression (of unadjusted 
logged outcomes), including maternal age, BMI, weeks since conception at bleeding and season 
(sin1, cos1, sin2, cos2) as continuous variables, as well as infant sex (binary variable). Maternal 
age appeared to affect homocysteine (coef. =0.016 µmol/l per year, p-value<0.0001) and 
cysteine (coef =-0.011 µmol/l per year, p-value=0.027), but not any of the other biomarkers. 
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BMI was significantly associated with blood concentrations of B12 (coef =-0.031 pmol/l per 
year, p-value=0.008) and active B12 (coef = -0.041 pmol/l per year, p-value=0.007) only. 
Weeks since conception (i.e. pregnancy stage) at bleeding had an effect on several of the blood 
biomarkers, as shown in Table 5.3. There was no association between infant sex and maternal 
biomarkers, except for SAM (coef = 0.075 nmol/l per year, p-value=0.018). 71.9% of women 
reported to have maintained an overnight fast prior to bleeding. However, fasting status did 
not affect the biomarker concentrations (data not shown). 
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Figure 5.2: Comparison of seasonal patterns in the blood biomarker concentrations between the 
‘indicator group’ and the pregnant women. 
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Thick line: geometric mean of the biomarker 
Thin lines: 95%CI 
Indicator: annual trends for the group of non-
pregnant women (n=30) 
Rainy/dry: groups of pregnant women enrolled in 
the study (n=167) 
Variables were logarithmically transformed 
(unadjusted data) 
Study period: July 2009- July 2010 
Statistical test of the difference between groups: 
p-value <0.05 indicates significant difference: in B2, 
DMG, methionine, SAH, SAM:SAH ratio, 
homocysteine, cysteine, B6. 
p-value>0.05 indicates non-significant difference: 
folate, B12, active B12, choline, betaine, 
DMG/betaine ratio and SAM.  
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Table 5.3: Differences in blood biomarker concentration between women conceiving during 
the rainy vs. dry season, with adjustment for time of bleeding (approximation to conception 
time), and effect of the weeks of gestation on the biomarker levels 
Biomarker N Rainy season 
GMa adjusted 
(95%CI) 
Dry season 
GMa adjusted 
(95% CI) 
Between 
season 
difference 
adjusted 
Effect of time (weeks) 
since conception on 
biomarker levels 
unadjusted 
 coef (p-value)b 
Folate  
nmol/l  
163 
18.47 
(16.81-20.29) 
12.99 
(12.04-14.01) 
5.48* 0.023 (0.020)* 
B12 
pmol/l  
164 
307.73 
(280.73-337.33) 
335.04 
(306.56-366.17) 
-27.31 -0.034 (0.004)* 
Active B12 
pmol/l  
164 
63.83 
(57.19-71.24) 
77.64 
(70.26-85.80) 
-13.81* 0.004 (0.760) 
B2 deficiency1 
EGRAC coef  
155 
1.98 
(1.87-2.09) 
2.44 
(2.32-2.57) 
-0.47* -0.002 (0.323) 
Choline 
mol/l  
163 
6.62 
(6.23-7.03) 
6.86 
(6.39-7.36) 
-0.24 -0.002 (0.807) 
Betaine  
mol/l  
164 
21.21 
(19.13-23.52) 
17.21 
(15.21-19.46) 
4.00* -0.094 (<0.0001)* 
DMG 
mol/l  
164 
1.83 
(1.63-2.05) 
3.00 
(2.73-3.30) 
-1.17* -0.037 (0.002)* 
DMG:betaine 
164 
0.08 
(0.07-0.09) 
0.18 
(0.16-0.20) 
-0.10* 0.057 (<0.0001)* 
Methionine 
mol/l  164 
25.47 
(24.33-26.66) 
22.65 
(21.74-23.59) 
2.82* 
 
-0.010 (0.068) 
SAM 
nmol/l  
163 
77.48 
(74.59-80.47) 
75.77 
(72.91-78.76) 
1.70 
 
-0.013 (0.010)* 
SAH 
nmol/l  
163 
7.55 
(6.97-8.19) 
11.50 
(10.50-12.60) 
-3.95* 
 
-0.021 (0.053) 
SAM:SAH 
163 
10.26 
(9.59-10.98) 
6.59 
(6.06-7.16) 
3.67* 
 
0.009 (0.367) 
Homocysteine 
mol/l  
163 
6.18 
(5.76-6.62) 
7.50 
(7.03-8.01) 
-1.33* 
 
-0.031 (<0.0001)* 
Cysteine 
mol/l  
164 
199.11 
(193.32-205.07) 
197.18 
(191.27-203.26) 
1.93 
 
-0.019 (<0.0001)* 
PL 
nmol/l  
164 
4.74 
(4.46-5.04) 
3.34 
(2.99-3.73) 
1.40* -0.007 (0.522) 
PLP 
nmol/l  
164 
22.69 
(20.77-24.80) 
25.63 
(22.64-29.02) 
-2.94 -0.022 (0.052) 
PA  
nmol/l  
164 
9.30 
(8.75-9.88) 
7.21 
(6.35-8.17) 
2.09* 0.006 (0.590) 
SAM:Hcy 
163 
12.61 
(11.65-13.66) 
10.05 
(9.34-10.82) 
2.56* 
 
0.019 (0.045)* 
aGM: geometric mean back-extrapolated with time of bleeding; bRaw data (non-back-extrapolated), log-
transformed adjusted by BMI, time to processing, seasonality (sin1, cos1, sin2, cos2) and fasting; * p-
value for significance <0.05 
1B2 def: B2 deficiency as assessed by EGRAC; DMG, dimethylglycine; Hcy, homocysteine; PA, 4-pyridoxic 
acid; PL, pyridoxal; PLP, pyridoxal-5’-phosphate; SAH, S-adenosylhomocysteine; SAM, S-
adenosylmethionine.
Table 5.4: Differences in blood biomarker concentration between women conceiving 
during the rainy vs dry season, without back-extrapolation for time of bleeding  
Biomarker N Rainy season 
GMa unadjusted  
(95%CI) 
Dry season 
GMa unadjusted 
(95%CI) 
Between season 
difference 
unadjusted data 
Folate  
nmol/l  
163 
14.41 
(13.33-15.56) 
18.69 
(17.21-20.30) 
-4.28* 
B12 
pmol/l  
164 
300.13 
(273.91-328.87) 
337.37 
(309.08-368.24) 
-37.24 
Active B12 
pmol/l  
164 
61.93 
(55.67-68.89) 
78.33 
(70.86-86.59) 
-16.4* 
B2 deficiency1 
EGRAC coef  
155 
2.17 
(2.04-2.29) 
2.17 
(2.06-2.28) 
0 
Choline 
mol/l  
163 
7.37 
(6.95-7.82) 
6.35 
(5.92-6.82) 
1.02* 
Betaine  
mol/l  
164 
20.92 
(18.75-23.35) 
18.31 
(16.27-20.62) 
2.61 
DMG 
mol/l  
164 
1.71 
(1.53-1.91) 
1.82 
(1.59-2.07) 
-0.11 
DMG:betaine 
164 
0.10 
(0.09-0.11) 
0.13 
(0.12-0.15) 
-0.03* 
Methionine 
mol/l  164 
24.11 
(23.01-25.26) 
22.92 
(22.02-23.87) 
1.19 
SAM 
nmol/l  
163 
75.97 
(73.21-78.83) 
81.35 
(78.38-84.48) 
-5.38* 
SAH 
nmol/l  
163 
10.43 
(9.85-11.05) 
13.64 
(12.74-14.59) 
-3.21* 
SAM:SAH 
163 
10.09 
(9.44-10.79) 
7.41 
(6.85-8.03) 
2.67* 
Homocysteine 
mol/l  
163 
6.94 
(16.54-7.36) 
6.67 
(6.23-7.15) 
0.27 
Cysteine 
mol/l  
164 
189.22 
(183.57-195.05) 
205.31 
(199.43-211.37) 
-16.09* 
PL 
nmol/l  
164 
4.45 
(4.29-4.62) 
4.29 
(3.88-4.75) 
0.15 
PLP 
nmol/l  
164 
21.71 
(20.10-23.46) 
32.32 
(28.84-36.21) 
-10.60* 
PA 
nmol/l  
164 
9.63 
(9.21-10.07) 
9.31 
(8.21-10.55) 
0.33 
SAM:Hcy 
163 
10.97 
(10.26-10.72) 
12.20 
(11.24-13.26) 
-1.24* 
aGM: geometric mean non-back-extrapolated with time of bleeding;; * p-value for significance <0.05 
1B2 def: B2 deficiency as assessed by EGRAC. DMG, dimethylglycine; Hcy, homocysteine; PA, 4-
pyridoxic acid; PL, pyridoxal; PLP, pyridoxal-5’-phosphate; SAH, S-adenosylhomocysteine; SAM, S-
adenosylmethionine 
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Table 5.5: Pairwise univariate correlations between maternal biomarkers 
Biomarker Folate B12 
Active 
B12 
B2 def1 Betaine Choline DMG 
DMG: 
betaine 
Met SAM SAH 
SAM: 
SAH 
Hcy Cys PL PLP 
B12 -0.141** 1.000               
Active B12 -0.057 0.503** 1.000              
B2 EGRAC -0.053 -0.181** -0.148** 1.000             
Betaine -0.118** 0.108**º -0.160** -0.059 1.000            
Choline -0.070* -0.200** -0.202** 0.043 0.372** 1.000           
DMG -0.178** 0.094** 0.039 0.120** 0.397** 0.188** 1.000          
DMG:betaine -0.002 -0.042 0.226** 0.092** -0.674** -0.294** 0.410** 1.000         
Met -0.176** 0.012 0.023 -0.163** 0.369** 0.216** -0.035 -0.370** 1.000        
SAM 0.173** 0.030 0.095** -0.155** 0.119** 0.075* 0.079* -0.031 0.072* 1.000       
SAH 0.209** 0.053 0.033* -0.099** 0.007 0.248** 0.101** 0.075 0.063* 0.487** 1.000      
SAM:SAH -0.123** 0.019 0.008 -0.002 0.046 -0.224** -0.082* -0.118** -0.009 0.169** -0.751** 1.000     
Hcy -0.374** -0.117** -0.047 0.195** 0.308** 0.177** 0.330** -0.044 0.191** -0.026 0.142** -0.188** 1.000    
Cys  0.131** 0.200** 0.242** -0.014 0.278** 0.058 0.192** -0.096** 0.186** 0.056 0.186** 0.148** 0.535** 1.000   
PL 0.132** -0.016 -0.058* 0.065 0.081* 0.068 0.031 -0.046 0.057 0.225** -0.080** 0.083* 0.060* 0.217** 1.000  
PLP 0.338** 0.072* 0.120** -0.014 0.118** -0.157** 0.055 -0.013 0.065* 0.008 0.093** -0.013 0.009 0.392** 0.641** 1.000 
PA 0.264** -0.082* 0.044 -0.034 -0.091** 0.005 -0.025 0.075* 0.140** 0.238** 0.138** -0.003 0.146** 0.071* 0.574** 0.510** 
Coefficient correlations and significance are shown *P<0.05; **P<0.005.Variables logarithmically transformed (unadjusted data), n=1641Higher values of EGRAC B2 
measurement indicate deficiency of B2. Cys, cysteine; DMG, dimethylglycine; Hcy, homocysteine; Met, methionine; PA, 4-pyridoxic acid; PL, pyridoxal; PLP, pyridoxal-5’-
phosphate; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine 
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5.1.3.3. Infant DNA methylation 
Methylation at mean gene DNA methylation at each locus was compared by season 
of conception, and showed consistent trends for increased methylation in infants 
conceived during the rainy season, however not all these associations reached statistical 
significance (see Table 5.6). Mean methylation was significantly different between season 
only for RBM46 and PAX8. The same trend was observed in individual CpG sites (Table 
5.7). The seven loci investigated were observed to have different degrees of mean 
methylation, ranging from low (29.73% ZFYVE28) to high (80.85% for EXD3). Similarly, 
we observed substantial variation in the proportion of CpG site methylation within the 
same locus, particularly for BOLA3 (range 27.9%-82.6%), as shown in Table 5.7. Within 
each locus, methylation of individual CpG sites was significantly and strongly correlated 
(r≥ 0.6), for all loci with the exception of ZNF678 (see Tables 5.8 A-G). The correlations 
between mean methylation at each locus were examined in Table 5.9. Only 65% were 
significant and the effect size observed was modest (r<35% in all cases). With multilevel 
regression, it was observed that there was no interaction between mean methylation at 
different genes and season, and no statistically significant difference in effects between 
MEs. Other predictors of infant DNA methylation were analysed by multiple regression 
multilevel analysis. Maternal BMI at bleeding had a negative effect on methylation ( =-
0.044 per %methylation/BMI unit, p-value=0.007). Infant sex did not have a significant 
effect for all MEs analysed together, but when MEs were looked at individually (for all 
CpGs within a loci) with MANOVA, a higher methylation was observed for RBM46 ( = -
0.193, p=0.033) and ZNF678 ( =-0.242, p=0.009) in females and higher methylation in 
males for EXD3 ( = 0.245, p=0.016). No significant interactions were found between sex 
and season of conception (data not shown) and there was no association between infant 
DNA methylation and maternal age or ethnicity. 
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Table 5.6: Mean DNA methylation at metastable epialleles and season of conception 
a Mean absolute difference in DNA methylation between dry and rainy season; b Effect size: 
observed difference in DNA methylation divided by the SD; * p-value < 0.05 
N = 67 for rainy season and n=61 for dry season unless otherwise indicated 
1N rainy season= 65; N dry season =56; 2N rainy season= 66; 3N dry season= 60 
Locus  
(N CpG site) 
Rainy season mean 
methylation %  
(95% CI) 
Dry season mean 
methylation %   
(95% CI) 
Between 
season 
difference 
%a (SD) 
Effect 
size 
SD unitsb 
P-value 
BOLA3 (5) 51.37  
(48.12-54.62) 
50.46  
(46.65-54.28) 0.9 (14.05) 0.064 0.2263 
PAX8 (5) 76.79  
(75.04-81.92) 
71.87 
(66.50-77.25) 4.92 (17.68) 0.278 0.0099* 
RBM46 (12) 71.56  
(69.58-73.54) 
68.07 
(65.56-70.57) 3.49 (8.92) 0.391 0.0104* 
ZFYVE28 (5) 29.16  
(26.03-32.29) 
25.29  
(22.07-28.50) 3.61 (12.64) 0.286 0.2692 
EXD3 (5) 80.85  
(78.95-82.76) 
79.13 
(77.12-81.14) 1.72 (7.80) 0.220 0.4008 
PARD6G (6) 53.49  
(50.24-56.74)1 
48.66  
(44.27-53.05)1 4.83 (14.73) 0.328 0.2055 
ZNF678 (4) 31.68  
(29.55-33.81) 
29.73 
(27.28-32.18) 3 1.95 (9.06) 0.215 0.1148 
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Table 5.7: DNA methylation at individual CpG sites of the metastable epialleles analysed 
and season of conception 
Locus CpG site Rainy season mean 
methylation  
%  (95%CI) 
 
Dry season mean 
methylation  
%  (95%CI) 
 
Between 
season 
difference 
%a(SD) 
Effect 
size 
SD unitsb 
P-valuec 
BOLA3 CpG1 58.28  
(54.41-62.14) 
57.91  
(53.40-62.43) 
0.36  
(16.65) 0.022 0.9026 
BOLA3 CpG2 82.56 
(80.53- 84.58) 
81.92 
(79.51-84.32) 
0.64  
(8.81) 0.073 0.6832 
BOLA3 CpG3 51.13 
(47.24-55.011) 
50.29 
(45.94-54.64) 
0.83  
(16.38) 0.051 0.7747 
BOLA3 CpG4 27.96  
(24.91-31.02)  
26.24  
(22.46-30.02) 
1.73 
(13.58) 0.127 0.4757 
BOLA3 CpG5 36.91 
(32.92- 40.90) 
35.96  
(31.12-40.79) 
0.95  
(17.54) 0.054 0.7600 
PAX8 CpG1 76.79  
(73.35-80.23) 
69.74  
(64.36-75.13)3 
7.05  
(17.70) 0.398 0.0266* 
PAX8 CpG2 79.09  
(75.65-82.53) 
71.98  
(66.51-77.44) 
7.12  
(17.78) 0.401 0.0261* 
PAX8 CpG3 79.69  
(76.21-83.16) 
72.48  
(66.80-78.16) 
7.2  
(18.41) 0.391 0.0292* 
PAX8 CpG4 78.13 
(74.57-81.68) 
71.31  
(65.84-76.78) 
6.82  
(18.08) 0.377 0.0355* 
PAX8 CpG5 78.69 
(75.13-82.26) 
73.99  
(68.67-79.31) 
4.7  
(17.77) 0.264 0.1382 
RBM46 CpG1 78.30 
(76.20-80.39) 
74.25 
(71.38-77.12) 
4.05  
(9.90) 0.409 0.0228* 
RBM46 CpG2 79.89 
(78.24-81.53) 
76.81 
(74.68-78.93) 
3.08  
(7.49) 0.411 0.0222* 
RBM46 CpG3 76.37 
(74.18-78.56)  
74.59  
(71.81-77.38) 
1.78  
(9.89) 0.180 0.3135 
RBM46 CpG4 71.28 
(68.74-73.81)  
66.04  
(62.72-69.36) 
5.24  
(11.65) 0.450 0.0125* 
RBM46 CpG5 70.62  
(68.43-72.80) 
66.79  
(63.89-69.69) 
3.83  
(10.13) 0.378 0.0352* 
RBM46 CpG6 81.44  
(79.06-83.81) 
78.48  
(75.60-81.35)3 
2.96  
(10.38) 0.285 0.1119 
RBM46 CpG7 73.45 
(70.90-76.01) 
68.08  
(65.16-71.00) 
5.38  
(10.89) 0.494 0.0063* 
RBM46 CpG8 72.14 
(69.95-74.32) 
66.90  
(64.20-69.61)  
5.23 
(9.73) 0.538 0.0030* 
RBM46 CpG9 72.34  
(70.06-74.61) 
68.55  
(65.67-71.43) 
3.79  
(10.25) 0.370 0.0394 
RBM46 CpG10 75.43  
(73.01-77.85) 
71.91  
(68.91-74.90) 
3.52  
(10.77) 0.327 0.20678 
RBM46 CpG11 50.93  
(48.89-52.98) 
49.12  
(46.63-51.62) 
1.81  
(9.02) 0.201 0.2604 
RBM46 CpG12 56.56  
(54.74-58.31) 
55.47 
(53.40-57.55) 
1.05  
(7.67) 0.137 0.4405 
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a Mean absolute difference in DNA methylation between dry and rainy season; b Effect size: 
observed difference in DNA methylation divided by the SD in the rainy season; c One-way ANOVA; 
* p-value < 0.05 
N = 67 for rainy season and n=61 for dry season unless otherwise indicated; 1N rainy season= 65; 
N dry season =56; 2N rainy season= 66; 3N dry season= 60 
  
Locus CpG site Rainy season mean 
methylation  
% (95%CI) 
Dry season mean 
methylation  
%  (95%CI) 
Between 
season 
difference 
%a(SD) 
Effect 
size 
SD unitsb 
P-valuec 
ZFYVE28 CpG1 30.27  
(26.65-33.89) 
25.55  
(21.95-29.15) 
4.72  
(14.41) 0.328 0.0677 
ZFYVE28 CpG2 28.05  
(24.80-31.30) 
24.09  
(20.41-27.78) 
3.95  
(13.80) 0.286 0.1091 
ZFYVE28 CpG3 36.91 
(33.06-40.75) 
30.58  
(26.54-34.61) 
6.33  
(15.70) 0.403 0.0250* 
ZFYVE28 CpG4 26.12  
(23.22-29.01) 
24.43  
(21.67-27.19) 
1.69  
(11.32) 0.149 0.4030 
ZFYVE28 CpG5 24.45 
(21.00-27.92) 
21.78  
(17.82-25.74) 
2.67  
(14.77) 0.181 0.3107 
EXD3 CpG1 85.01  
(83.06-86.95) 
82.50 
(80.35-84.66) 
2.51  
(8.15) 0.308 0.0863 
EXD3 CpG2 77.76 
(76.26-79.26) 
76.22  
(74.63-77.81) 
1.54  
(6.15) 0.250 0.1610 
EXD3 CpG3 82.33 
(80.307-84.36) 
80.47  
(78.25-82.69) 
1.86  
(8.45) 0.220 0.2165 
EXD3 CpG4 78.02  
(75.47-80.58) 
77.05  
(74.82-79.29) 
0.97  
(9.64) 0.101 0.5722 
EXD3 CpG5 81.13  
(79.18-83.08) 
79.40  
(77.32-81.47) 
1.73  
(8.01) 0.216 0.2250 
PARD6G CpG1 60.25  
(56.94-63.56)1 
57.01 
(52.58-61.44)1 
3.24  
(14.90) 0.217 0.2354 
PARD6G CpG2 50.98  
(47.70-54.26)1 
46.05  
(41.43-50.67)1 
4.93  
(15.23) 0.324 0.0782 
PARD6G CpG3 55.91 
(52.47-59.34)1 
49.23 
(44.21-54.25)1 
6.68  
(16.33) 0.409 0.0265* 
PARD6G CpG4 51.11  
(47.47-54.74)1 
46.75  
(42.10-51.37)1 
4.37  
(15.92) 0.274 0.1352 
PARD6G CpG5 57.66  
(54.37-60.94)1 
52.72  
(48.29-57.15)1 
4.94  
(14.87) 0.332 0.0710 
PARD6G CpG6 45.03  
(41.14-48.92)1 
39.34  
(34.65-44.04)1 
5.69  
(16.45) 0.346 0.0623 
ZNF678 CpG1 36.08  
(33.49-38.66) 
36.12  
(33.67-38.58)3 
-0.04 
(10.05) -0.004 0.9798 
ZNF678 CpG2 24.58  
(22.30-26.85) 
22.83  
(19.96-25.69)3 
1.75  
(10.17) 0.172 0.3365 
ZNF678 CpG3 26.75  
(24.37-29.12) 
23.66  
(21.08-26.24)3 
3.09  
(9.82) 0.315 0.0808 
ZNF678 CpG4 39.51 
(36.91-42.11)2 
36.31  
(33.39-39.22)3 
3.20  
(10.87) 0.294 0.1027 
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Table 5.8 A to G: Correlation coefficients between CpG sites within each metastable 
epiallele methylation percentage 
A) BOLA3 
BOLA3 CpG1 CpG2 CpG3 CpG4 CpG5 
CpG1  1.000     
CpG2 0.921 1.000    
CpG3 0.932 0.860 1.000   
CpG4 0.878 0.830 0.884 1.000  
CpG5 0.915 0.827 0.916 0.909 1.000 
 
B) PAX8 
PAX8 CpG1 CpG2 CpG3 CpG4 CpG5 
CpG1  1.000     
CpG2 0.931 1.000    
CpG3 0.956 0.946 1.000   
CpG4 0.951 0.918 0.944 1.000  
CpG5 0.961 0.930 0.942 0.950 1.000 
 
C) ZFYVE2 
ZFYVE28 CpG1 CpG2 CpG3 CpG4 CpG5 
CpG1 1.000     
CpG2 0.787 1.000    
CpG3 0.850 0.830 1.000   
CpG4 0.671 0.663 0.658 1.000  
CpG5 0.705 0.709 0.748 0.683 1.000 
 
D) EXD3 
EXD3 CpG1 CpG2 CpG3 CpG4 CpG5 
CpG1 1.000     
CpG2 0.952 1.000    
CpG3 0.961 0.951 1.000   
CpG4 0.859 0.866 0.897 1.000  
CpG5 0.932 0.942 0.960 0.941 1.000 
 
E) ZNF678 
ZNF678 CpG1 CpG2 CpG3 CpG4 
CpG1 1.000    
CpG2 0.538 1.000   
CpG3 0.706 0.795 1.000  
CpG4 0.530 0.547 0.639 1.000 
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F) PARD6G 
PARD6G CpG1 CpG2 CpG3 CpG4 CpG5 CpG6 
CpG1 1.000      
CpG2 0.868 1.000     
CpG3 0.829 0.909 1.000    
CpG4 0.827 0.858 0.872 1.000   
CpG5 0.765 0.814 0.864 0.833 1.000  
CpG6 0.754 0.752 0.753 0.795 0.782 1.000 
 
G) RBM46 
RBM46 CpG1 CpG2 CpG3 CpG4 CpG5 CpG6 CpG7 CpG8 CpG9 CpG10 CpG11 CpG12 
CpG1 1.000            
CpG2 0.884 1.000           
CpG3 0.865 0.813 1.000          
CpG4 0.801 0.758 0.720 1.000         
CpG5 0.887 0.856 0.785 0.821 1.000        
CpG6 0.826 0.828 0.809 0.859 0.818 1.000       
CpG7 0.769 0.793 0.645 0.778 0.822 0.831 1.000      
CpG8 0.819 0.826 0.773 0.837 0.841 0.855 0.831 1.000     
CpG9 0.786 0.824 0.690 0.801 0.787 0.828 0.771 0.835 1.000    
CpG10 0.817 0.783 0.744 0.777 0.848 0.817 0.839 0.812 0.719 1.000   
CpG11 0.739 0.710 0.689 0.702 0.797 0.711 0.686 0.717 0.634 0.753 1.000  
CpG12 0.763 0.744 0.719 0.742 0.820 0.727 0.693 0.777 0.691 0.777 0.809 1.000 
 
P-value< 0.0001 for all correlations shown in the above tables 
 
Table 5.9: Correlation coefficients between mean methylation percentage across the loci 
assessed 
Locus BOLA3 RBM46 PAX8 ZFYVE28 EXD3 PARD6G ZNF678 
BOLA3 1.000       
RBM46 0.343** 1.000      
PAX8 0.023 0.094 1.000     
ZFYVE28 0.117 0.286* 0.236* 1.000    
EXD3 0.114 0.178 0.145 0.542** 1.000   
PARD6G 0.059 0.277** 0.244* 0.311** 0.144 1.000  
ZNF678 0.217* 0.352** 0.178* 0.197* 0.165 0.372** 1.000 
N= 128 infants; Logit transformation of variables; *P< 0.05; **P< 0.005 
 
5.1.3.4. Maternal biomarkers and infant DNA methylation 
We investigated the impact of maternal blood biomarker status (i.e. one-carbon 
metabolites and cofactors) on DNA methylation patterns in their infants. To compress the 
information for the biomarkers PCA was performed. Table 5.10 shows the coefficients by 
which each variable was multiplied to define the first principal component (i.e. the PC1 
eigenvectors) of the biomarkers. Most biomarkers contributed positively to PC1, but the 
importance differed, from lowest for active B12 (0.074) to highest for homocysteine 
(1.525). The coefficients for folate, methionine and B2 (positive for EGRAC) had a negative 
sign. The PC1 of the biomarkers was significantly associated with season (p<0.001) and 
with methylation (p=0.019) (Table 5.11). However, when season and PC1 were included 
in the model together, neither was significant indicating possible correlation of PC1 with 
season. Interactions of DNA methylation with the PC1 of the biomarkers was also 
investigated, but none was significant. The PC1 of the biomarkers explained 22.6% of the 
overall variation in biomarkers.  
To investigate whether there were common associations of each individual 
biomarker exposure with mean DNA methylation at MEs, all seven loci were tested jointly 
against each of the maternal biomarker variables separately, adjusted by infant sex and 
maternal BMI. Results with a p-value<0.05 are shown in Table 5.11.   
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Table 5.10: Principal component (PC1) coefficients for maternal biomarkers 
Biomarker 1st principal component 
(PC1 c1j) 
PC1 c1j/SD 
Folate -0.3441 -0.856 
B21 0.2864 1.116 
Active B12 0.0314 0.074 
Choline 0.2738 0.901 
Betaine 0.1468 0.258 
DMG 0.4794 0.950 
Methionine -0.1070 -0.586 
SAM 0.1315 0.699 
SAH 0.4132 0.967 
Homocysteine 0.4874 1.525 
PLP 0.0959 0.081 
Cysteine 0.1611 1.105 
For each individual PC1=∑j c1j.zj,where zj= concentration for the jth biomarker 
logarithmically transformed and c1j are the principal component coefficients for 
the jth biomarker for PC1. This table tabulates c1j and c1j/SD to standardise the 
coefficients. 
1Coefficient for EGRAC (thus deficiency of B2 because higher EGRAC denotes 
greater deficiency) 
Only active B12 and PLP (pyridoxal-5’-phosphate) were included in the model for 
B12 and B6 respectively 
 
We previously observed in the group of non-pregnant women in The Gambia 
(research paper II, Section 4.1), that at times when B2 reaches the lowest concentrations, 
activity of the betaine-pathway is enhanced. We therefore investigated whether 
interactions existed between pathways, particularly between DMG concentration and 
lower/higher status for B2, but this was non-significant (results not shown). 
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Table 5.11: Associations between infant DNA methylation at seven metastable epialleles 
and environmental / maternal predictors 
Biomarker/ 
Predictor 
ß coefficient 
(95% CI) 
P-value 
Season -0.323 
(-0.517 - -0.1294) 
0.001 
Infant sex  -0.090 
(-0.291-0.111) 
0.382 
Maternal BMI 
[years] 
-0.044 
(-0.076- -0.012) 
0.007 
Maternal age 
[kg/m2] 
-0.001 
(-0.017-0.014) 
0.850 
Ethnicity mother -0.117  
(-0.514-0.279) 
0.563 
B2*  
EGRAC coef 1 
-0.393 
 (-0.770- -0.017) 
0.040 
DMG:betaine 
ratio* 
-0.213 
(-0.366- -0.060) 
0.006 
SAM:SAH ratio* 
0.319 
(0.037- 0.601) 
0.027 
Cysteine* 
mol/l  
-0.840 
(-1.555- -0.125) 
0.021 
PC1* 
-0.067 
(-0.130- -0.012) 
0.019 
PC2* 
-0.052 
(-0.017- 0.121) 
0.139 
PC3* 
0.011 
(-0.076- 0.099) 
0.798 
*Adjusted for infant sex and maternal BMI; Multilevel regression 
analysis; N=115; Biomarkers log-transformed 
1 Deficiency of B2 because higher EGRAC denotes greater deficiency); 
DMG, dimethylglycine; SAH, S-adenosylhomocysteine; SAM, S-
adenosylmethionine; PC, principal component 
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5.1.4. DISCUSSION 
Our study reveals that seasonality in rural Gambia affects methyl-group supply (as 
assessed by blood biomarkers of one-carbon metabolism) and DNA methylation in 
pregnant women and their infants, respectively. This demonstrates the importance of 
seasonality in this population setting and replicates our previously reported association 
between season of conception and DNA methylation at MEs. Contrary to our prior 
understanding, the rainy (‘hungry’) season was associated with higher methylation 
potential (as assessed by the SAM:SAH ratio and methyl-donors) and higher DNA 
methylation generally. Although a causal relationship between periconceptional maternal 
nutritional status and infant DNA methylation cannot be formally demonstrated with the 
current data, they appear to be associated and support the hypothesis of methyl-groups 
availability mediating the establishment of DNA methylation patterns. 
 
5.1.4.1. Maternal blood biomarkers 
All plasma biomarkers, except choline, B12 and cysteine, varied significantly 
between seasons and, with the exception of methionine and SAM, the direction of the 
seasonality is consistent with our findings in non-pregnant women (research paper II, 
Section 4.1). The SAM:SAH ratio is substantially higher (55.8%) in the dry season, 
suggesting a better methylation potential in the rainy season, possibly reflecting the 
higher availability of betaine, methionine, folate and B2 at this time of year. Conversely, 
the DMG:betaine ratio is lower (53.3%) during the dry season, suggesting higher activity 
of the betaine-dependent pathway, at a time when folate and B2 are lower. The extent of 
the differences between seasons differs by metabolite.  
Regardless of the degree of matching of their seasonal patterns, the intercepts of 
most biomarkers are generally lower for pregnant than for non-pregnant women, as 
illustrated in Figure 5.2. This agrees with previous reports (118, 145, 169), and is 
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probably due to increased maternal and embryonic requirements and/or to physiological 
adaptations (e.g. hemodilution, increased glomerular filtration rate, and endocrinological 
changes (174)). These observed differences are unlikely to be explained by assay 
differences, since both sets of samples were analysed using the same protocols and 
equipment and at the same time. The effect of weeks of pregnancy since conception on 
biomarker levels (Table 5.3) agrees with those differences in intercepts shown in Figure 
5.2, with negative association with the concentrations of B12, betaine, DMG, SAM, 
homocysteine and cysteine as weeks of gestation progress, whereas the association for 
folate is positive. Usually, pregnancy leads to a decline in folate status (118) over time. 
Whilst an increase in folate concentrations with pregnancy as seen in this study has been 
reported previously (145), it cannot be attributed here to the use of folic acid 
supplements, since blood collection was prior to antenatal registration and the 
administration of folic acid-containing supplements. Of note, the natural inter-seasonal 
difference in plasma folate levels observed in this population (5.48 nmol/l) is considerably 
higher than that found in Dutch women, supplemented or not with the currently 
recommended dose of 400 g of synthetic folic acid during the periconceptional period 
(2.5 nmol/l) (166).  
A strong negative correlation between homocysteine and folate concentration was 
observed (r=-0.374), as well as with B2 (r=0.195 correlation with EGRAC indicator of 
deficiency), which is consistent with other studies (175). Conversely, choline, betaine and 
DMG correlations with homocysteine are positive, as opposed to what has been found in 
The Dutch Antilles (145). It would be predicted a priori that folate and choline and betaine 
would both act similarly and decrease the plasma concentrations of homocysteine, by 
supplying methyl-groups. These positive correlations with the betaine-dependent 
pathway are difficult to interpret, as these substances are also involved in other metabolic 
pathways. Surprisingly, the SAM:SAH ratio seems independent of most of the biomarkers 
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and correlates only, negatively as would be expected, with choline (r=-0.225) and folate 
(r=-0.123). B2 does not seem to affect the SAM:SAH ratio despite being limiting in this 
setting (research paper II, Section 4.1).  
 
5.1.4.2. Infant DNA methylation  
In this study, we have expanded our previous research (79) on the season of 
conception effects on DNA methylation at MEs. Based on a different and larger cohort 
(born more than 10 years later than infants included in our earlier study (79)), we 
successfully replicated the observation of higher methylation at four previously reported 
MEs in infants conceived during the rainy season. We further present data on three newly 
identified MEs. The seasonal differences did not reach statistical significance for all seven 
loci (Table 5.5), but the clear and consistent pattern between loci suggests that seasonal 
factors play an important role in this setting. The consistency in response to season differs 
from the case reported by Tobi et al. on the Dutch Hunger Winter where the different loci 
varied in different direction in response to severe maternal malnutrition (75), and might 
be specific to MEs. A weaker effect within the current study for all four of the loci 
previously reported (79) can be observed and the reasons could be several. Firstly, this 
could be a result of a real secular variation in the seasonality (possibly nutritional but also 
of any other potential factor by which a seasonal effect on DNA methylation could be 
mediated, such as aflatoxin exposure (176, 177)). If the region is experiencing at least 
partly a nutritional transition, the seasonality could be subtler now than it used to be due 
to changes in accessibility, cash availability or in eating patterns, which could thus have 
reduced the effect of season of conception on differences in DNA methylation, compared to 
our previous study (79). Few data are available to try to elucidate this possibility, but a 
study on pregnant women from 1997 showed lower concentrations of B12 and 
homocysteine, and higher folate (97) compared to those observed in pregnant women 
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sampled in 2009-2010. Earlier data from 1978-80 indicated higher prevalence of folate 
deficiency but less of B2 (178, 179). However, these differences in biomarker 
concentration could also partially be due to technical differences in biomarker analysis. 
Secondly, it is possible that the Islamic Holy month of Ramadan played a role in the 
differences observed. During Ramadan, a period of fasting is observed from dawn until 
dusk and dietary practices are also know to vary with, for example, a greater consumption 
of sugary foods at the time of breaking the fast (180). In the current study, Ramadan 
occurred during August-September 2009, i.e. the rainy season period. However, the 
previous study (79) used samples from several years, of which 4 (namely 1991 to 1994) 
had Ramadan taking place during the dry season months. If Ramadan has any effect in 
terms of methyl-donors availability due to the qualitative and quantitative changes, it 
would have affected differently both studies (i.e. if Ramadan was favourable for DNA 
methylation it could have enlarged the differences and vice versa). 
From our departure hypothesis of methyl-donor availability explaining the 
seasonal effect, we would expect that all MEs responded similarly to season and maternal 
biomarkers. From our data (Table 5.6), methylation at some individual loci appears more 
sensitive to environmental influences. The mean methylation of the two loci which 
showed statistically significant associations with season (PAX8 and RBM46) were not 
correlated. Similarly, the poor pairwise correlation coefficients between mean DNA 
methylation across all seven MEs studied would suggest that methylation is not strongly 
driven by any individual external factor such as, for example methyl-donors availability. 
Thus, strong regulatory factors or random processes could exist, leading to variable 
responses to environmental factors for each locus. However, interactions between 
methylation and season, and differences in response between loci, were statistically 
tested. These were found not to be significant, indicating there is no difference in the 
response to season between the different MEs under study. Therefore it cannot be 
 178 
concluded that individual loci respond differently to season. The power to detect such 
interactions was, however, relatively weak. 
Interestingly, BMI was the maternal predictor of infant DNA methylation level with 
strongest statistical significance, above any of the maternal biomarkers under study. This 
indicates for the first time a (negative) association of a maternal nutritional condition in 
early pregnancy with methylation at MEs and supports the importance of maternal 
nutrition in the establishment of foetal DNA methylation patterns. This is contrary to 
findings from Argentina where maternal BMI appeared to be positively correlated to 
PPARGC1A promoter methylation in DNA from umbilical cord blood (181). However, 
PPARGC1A is not known to be an ME and so, not directly comparable. Furthermore, our 
findings are in line with our knowledge of the weight loss that takes place during the rainy 
season (126). 
The specific loci assessed in this study were chosen solely on their characteristic of 
being MEs (and thus sensitive to environmental changes during early pregnancy and with 
no intra-tissue variability). Yet, proteins encoded by genes described here are known to 
have metabolic effects and even to be related to disease (e.g. PAX8 is involved in 
hypothyroidism (182). However, whether higher or lower DNA methylation at those genes 
is more desirable phenotypically was not considered within this proof of principal study 
and would form the focus of future work. The focus of this study was in the biological 
determinants of such methylation. 
 
5.1.4.3. Maternal biomarker relationship with infant DNA 
methylation 
The ultimate aim of this study was assessing, in humans, whether observed effects 
of season of conception on infant DNA methylation are related to one-carbon metabolite 
status of their mothers during early pregnancy. The different MEs under study (and their 
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CpGs) could be differently regulated by or protected from environmental cues. However, a 
reasonable first assumption would be that biomarkers had a common effect on MEs. 
Interestingly, when methylation across all loci combined was assessed, we did see an 
association with the SAM:SAH ratio (indicating the methylation potential) and the 
DMG:betaine ratio, as well as with cysteine and B2. Further, the PCA showed that one-
carbon metabolism biomarker PC1 was significantly associated with methylation. B12 was 
not indicative of lower infant DNA methylation at MEs in our study, in contrast to a recent 
report on global DNA methylation (78). SAM, which has a central role as substrate the 
provision of methyl-groups (Figure 4.1) and its product, SAH, were not associated with 
DNA methylation individually. This substrate and product role in methyltransferase 
reactions is why the ratio between SAM and SAH has been proposed as metabolic 
indicator of cellular methylation status, representing the activity of both pathways 
simultaneously in an intrinsically complex metabolic process. It is thought that SAH 
regulates transmethylation and it has been shown that chronic elevation of SAH, 
secondary to the homocysteine-mediated reversal of the SAH hydrolase reaction can 
reduce methylation of DNA (183). The severity of B2 deficiency seems to limit folate use in 
this population as well as DNA methylation, which in this population seems more 
associated to the betaine pathway (DMG:betaine ratio).  
The degree of inter-individual variation in prenatal DNA methylation and the 
factors that regulate and affect the establishment of methylation patterns in early 
development are poorly understood to date and evidence is scarce. Our findings support 
the hypothesis that methyl-donor supply could drive the DNA methylation in early 
development. However, both the effect size and the significance are weak and could be due 
to confounding in this observational study. Therefore, the data have to be interpreted with 
caution, and require replication. For example, the association observed between the 
biomarker PC1 and the MEs might be due to PC1 picking up on the seasonality as the 
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strongest common factor between biomarkers. In fact, PC1 seems to be correlated with 
season (r = 0.569, p-value< 0.0001), and both become non-significant if both are included 
in the regression model. 
In addition, PC1 coefficients for folate, B2 and methionine are negative, suggesting 
that methyl-group availability could not be the main explanation. In this population, 
women do not smoke and are not exposed to environmental arsenic, which are known 
factors to affect DNA methylation. However, women are highly exposed to cooking smoke 
(184, 185), although exposure does not seem to differ by season (pilot data, not shown). 
The effect of one-carbon metabolism could respond to: 1) methyl-group availability for 
DNA methylation, or 2) deliberate programming in response to inappropriate 
environment, as assessed by methyl-group deficit (and/or other environmental seasonal 
effects). Due the critical role of the DNA methylation pattern establishment in early 
development and the redundancy of methyl-groups supply paths and variety of sources to 
ensure supply, the existence of tightly regulation in these epigenetic processes is 
reasonable.  
Additionally, the variation in nutritional status between seasons observed in this 
population, although clearly significant and of importance (research paper II, Section 4.1), 
is limited in comparison for example with the dramatic dietary intake reduction during a 
state of severe malnutrition as was the case during the Dutch Hunger Winter (74). This 
might explain why the strength of the association of maternal nutritional status with MEs 
is limited in our current data. Furthermore, it is possible that maternal one-carbon 
metabolites could have a stronger effect on global DNA methylation (currently under 
investigation) or on imprinted genes. 
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5.1.4.4. Limitations of the study 
Our hypothesis was that DNA methylation at MEs is established close to 
conception. Adjustment of the plasma biomarker data by back-extrapolation to the date of 
conception using data from a separate group of women seemed therefore necessary. We 
acknowledge that there is variability in the suitability of these biomarkers for back-
extrapolation from the group of non-pregnant women. Particularly, our measures of SAH 
and DMG were shown to have limited reliability and stability, either due to intra-
individual fluctuations or to measurement issues (research paper II, Section 4.1), which 
can introduce error. Pregnancy could also distort the seasonal patterns observed in the 
biomarkers as discussed above. The current study has an increased sample size compared 
to the previous report (79), however it remains a relatively small study, which might 
reduce the ability of our study to detect significant effects. Still, this represents the largest 
study of this kind in humans. In addition, due to the cyclic and dynamic nature of one-
carbon-metabolism, the redundancy of pathways and complex regulation, a static single 
measurement may be insufficient to give us a real picture of the methylation capacity. 
Incorporation of serial measurements as well as enzymatic activity could help in the 
interpretation. 
Finally, key factors to look at in this or in future studies are maternal and infant 
genotype in this population relative to SNPs of interest. We have not determined the 
maternal or infant genotype for SNIPs in 5,10-methylenetetrahydrofolate reductase 
(MTHFR) and other choline and one-carbon metabolism genes, which affect their blood 
levels and thus could perhaps explain some of the findings (175). Frequency information 
on such SNPs is sparse in our study population has been sparsely studied in our 
population or other comparable African populations.  
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5.1.4.5. Conclusions 
This study replicates and expands on the findings from our previous study (79) 
(research paper II, Section 4.1) that the Gambian rainy season, traditionally considered 
harder and more nutritionally challenging, is associated with higher levels of methyl-
group supply and DNA methylation. Further, this study provides evidence in humans that 
maternal nutritional status (including BMI and plasma one-carbon metabolites) predicts 
infant DNA methylation at MEs in early development. The replication and the consistency 
of the seasonal effect on DNA methylation indicate the important role of the environment. 
In order to explore whether causal relationships exist, supplementation trials will be 
needed.  
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5.2.ADDITIONAL METHODS 
5.2.1. Study population 
This main group study was conducted in tandem to the ENID trial (see Section 
3.2.2): the round of meetings in each village to explain to the local community the full 
details of the studies and to seek their approval, the recruitment waves and the monthly 
LMP questionnaire rounds were done in tandem. Participants were given the option to 
participate in both, one or neither of the studies. Owing to a delay with the manufacture of 
the prenatal supplements, the ENID trial only started in full late-April 2010. Since the 
study was designed to ensure that women were not forced to disclose their pregnancy 
early, all blood sampling for the purpose of the current study was performed prior to 
pregnancy confirmation and thus prior to supplementation as part of ENID. Once the 
women were identified as positive by urinary dipstick (Appendices III (D) and XII), they 
were invited to MRC Keneba for confirmation of pregnancy, gestational age assessment by 
ultrasound examination and a full antenatal examination. Focused antenatal care was 
offered to the enrolled women during their pregnancy through the routine trekking 
service, with women brought into MRC Keneba at 35 weeks gestational age for a final pre-
delivery check. 
 
5.2.2. Maternal blood biomarkers 
Once every four weeks, women enrolled into the Methyl-Donors and Epigenetics 
(MDEG) study were invited to a central location in their village of residence for an LMP 
questionnaire by a fieldworker resident in or near their village. Women were requested to 
fast prior to the visit. A trained nurse collected blood samples from all women who 
reported a missed menses, but without an ‘exempting reason’ (see Figure 3.3). All village 
women attended throughout the morning and therefore, the time from collection to 
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storage, after transport to MRC Keneba and processing varied between samples collected 
at the beginning or at the end of the morning. Women who did not attend the call were 
visited in their homes during the following days by the posted fieldworkers. Only when 
the participants were known to be eligible (as assessed later by their conception date and 
their gestational age at blood sample collection), their samples were sent for analysis to 
the collaborating laboratories in Canada or the UK. The remaining samples were excluded. 
Methods for the processing and analysis of blood samples were the same as the indicator 
group (Section 4.1.2.3) and the samples were treated identically (i.e. using the same 
protocols and techniques for processing and analysing, stored and shipped together, and 
analysed within the same timeframe). 
 
5.2.3. Infant DNA methylation 
DNA methylation patterns are the key outcome in this study. The choice of MEs 
was based on their particular nature. MEs are loci at which systemic interindividual 
epigenetic variation occurs independently of genotype. Animal models showing an effect 
of maternal diet in fetal programming were mostly based in this type of loci (69). As 
discussed in Section 2.3.4. previous research (104) was successful in identifying loci in 
humans that fulfilled the established definition to be an ME:  
(i) stochastic establishment (resulting in dramatic and systemic 
interindividual variation in locus-specific epigenetic regulation, with 
discordance in monozygotic twins);  
(ii) established early in development (around the time of conception);  
(iii) no tissue-specific methylation (established in the early embryo and 
then maintained in all germ-layer lineages); and 
(iv) observed susceptibility to nutrition and other environmental cues (i.e. 
responding to season of conception) (79).  
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These characteristics make MEs good candidate loci to test epigenetic mechanisms 
in the developmental origins hypothesis and where used as criteria to identify candidate 
MEs from a MSAM screen of the genome, after a round of eliminatory steps to test: i) 
systemic interindividual variation through correlation across tissues in autopsy samples; 
ii) substantial discordance in monozygotic twins; and iii) persistent epigenetic effects of 
an environmental exposure (i.e. Gambian seasonality) (79).  
Since the publication of the first five MEs (Figure 2.7) by Waterland et al. (79), further 
analyses have been conducted on liver, kidney and brain tissues from additional donors 
(n=17) for further assessment of inter-tissue correlation of methylation and formalise the 
definition of candidate MEs. SLITRK1 was exceptional in that methylation in brain did not 
correlate with that in liver and kidney (79). Therefore this gene was dropped according to 
a stricter criterion on inter-tissue correlation and not investigated in the current larger 
sample cohort, however, the other four previously described loci were tested in this study. 
Additionally, three newly identified (and as yet unpublished) MEs were also included in 
the present sample set (PARD6G, RBM46 and ZNF678). 
As yet it is not known whether variation at these MEs lead to any functional 
consequences in phenotype. PAX8 is known to be involved in hypothyroidism (186) but 
the role of other loci in their metabolic pathways is unclear. 
The role of methyl-donor supply in modifying DNA methylation at MEs and 
phenotype/disease outcomes thereof has been shown in animal models (69). The goal in 
this exploratory work was to assess as a first step whether – as in animal models – 
methyldonor supply affects methylation patterns at MEs in humans. The aim was not to 
identify implications of MEs, which will be considered in further analyses beyond of the 
scope of this proof-of-principle thesis (as discussed in Section 6.3.).  
Infants were brought to MRC Keneba at 3-9 months of age for blood collection and 
anthropometric measurements (weight, length, mid-upper arm circumference (MUAC)), 
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all performed using regularly validated equipment and following standard procedures. 
Their personal welfare card, which tracks the infant’s progress from birth as a part of the 
national Maternal and Child Health Programme, was copied and relevant information 
extracted (i.e. birthweight and follow up measurements of weight and length, when 
available). The information included in the welfare card was, however, incomplete and 
was therefore not used. 
 
5.2.4. Statistical analysis 
Study population 
Based on previous information of birth rates, 100 individuals per season was an 
achievable number. The initial power calculation for these 100 individuals per group is 
shown in Table 5.12. Unfortunately, it was not possible to reach this target, and the 
reasons for this are discussed in Section 5.3.1. Approximately 83 women and 65 infants 
per group (depending on the biomarker and the loci considered respectively) had their 
biomarker concentrations and DNA methylation analysed. The different potential sample 
sizes are compiled in Table 5.12 with the difference detection allowed for each. To test the 
main hypothesis (differences in DNA methylation between infants born in the rainy and 
dry season), the current sample of 60-65 infants allowed us to detect a difference of 0.57-
0.59 standard deviations, with power 90% at 5% significance. 
 
The statistic methods for the biomarkers and DNA methylation are described in 
the Methods section of the paper in Section 5.1.2.4. 
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Table 5.12: Difference detection (in standard deviations) for different sample sizes for a 
two-group comparison, with any given reliability 
 
N Reliability 
(per 
group) 
1 0.8 0.6 0.4 0.2 
60 0.59 0.66 0.76 0.94 1.32 
65 0.57 0.64 0.73 0.90 1.27 
80 0.51 0.57 0.66 0.81 1.15 
85 0.50 0.56 0.64 0.79 1.11 
100 0.46 0.51 0.59 0.72 1.03 
 difference in means;  standard deviation of the variation between individuals 
N: sample size 
(N x reliability/2) 
 inverse of the standard normal distribution function 
 (probability of a Type I error occurring or significance) 
probability of a Type II error occurring or power) 
 
Maternal blood biomarkers 
Full details of the analysis performed on maternal blood biomarkers are given in 
Section 5.1.2.4. 
 
Infant DNA methylation  
Full details of the analysis performed on infant DNA methylation are given in 
Section 5.1.2.4. 
 
Maternal biomarkers and infant DNA methylation 
Full details of the analysis performed on the influence of maternal biomarkers and 
infant DNA methylation are given in Section 5.1.2.4.  
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5.3. ADDITIONAL RESULTS 
5.3.1. Study population 
Two waves of recruitment took place. Most women were recruited in the first 
wave (July 2009), when all women 18-45 years of age throughout West Kiang were 
approached for consent. The second wave (February 2010) aimed at recruiting new 
women moving into West Kiang, or women who were not eligible for recruitment during 
the first wave (i.e. pregnant at the time, below 18 years or temporarily out of the region). 
Table 5.13 compiles the information on the recruitment data, based on the inclusion / 
exclusion criteria described in Section 5.1.2.1. If women moved after they had been 
identified as pregnant and were eligible for either of the pre-defined seasons and had a 
gestational age at blood sample collection below 16 weeks, they stayed in the study and 
their infants were invited to come to MRC Keneba after they were born. 
As discussed in Section 5.2.4., the number of mother-infant pairs participating in 
the study was lower than initially planned. This was mostly due to the difficulty in the 
early identification of pregnancies, and was regardless of the prevention measures taken 
to avoid this (i.e. sensitisation meetings by the midwife and confidentiality assurance). 
Despite efforts to follow women up each month, sometimes missed menses passed 
undetected because women were temporarily travelling and thus were not seen. Further, 
it was sometimes reported that menses were being seen even when the women were 
several months pregnant. This could be due to the social issues relating to early pregnancy 
disclosure (187), with some women even withdrawing from the study once they suspected 
they were pregnant. Of all the children participating in MDEG and being conceived during 
the dry season, 52 (40.6%) were co-enrolled in the ENID Trial.  
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Table 5.13: Recruitment summary 
 Women 
approached2 
Pregnant at 
consent 
(excluded) 
Eligible 
women for 
consent 
Consented 
women 
Participants 
leaving the 
study3 
1st wave of 
recruitment1 
2233 143 2090 1630 295 
2nd wave of 
recruitment1 
813 40 773 417 40 
Total 3043 183 2863 2047 335 
1The 1st wave of recruitment started in July 2009 and the second in February 2010 
2Women 18-45 years of age in West Kiang 
3Up to July 2010: this includes women withdrawn by the study (i.e. mostly found to be menopausal, 
but also moving out from the region or long-term travel) as well as self-withdrawal (main causes 
being husband disapproval and, occasionally, specific factors such as divorce or hysterectomy). 
 
5.3.2. Maternal blood biomarkers 
Table 5.14 shows the overall geometric means of the biomarkers for the pregnant 
women in the main group, including levels of sufficiency from reference values.  
 
5.3.3. Infant DNA methylation 
The results are described in the manuscript presented in Section 5.1.3.3. The 
boxplot graph in Figure 5.3 shows graphically the correlations within each gene among its 
CpG sites (Table 5.9). It can be observed that there were few ‘outlying’ correlation values. 
Mean values of DNA methylation were very high for PAX8, EXD3, BOLA3 and PARD6G 
(>80.0%). The lowest level of methylation was seen for ZNF678 (60.38%). 
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Table 5.14: Mean blood biomarker concentration in rural Gambian women 
Biomarker Geometric mean 95%CI 
% of women 
below cut-off 
values 
Folate nmol/l  16.45 15.50 - 17.46 12.19% 
B12 pmol/l  318.43 298.92 - 339.23 17.68% 
Active B12 pmol/l  69.75 64.74 - 75.15 7.32% 
B2 deficiency1 
EGRAC coef  2.17 2.09- 2.25 
98.71% 
Choline mol/l  6.83 6.52 - 7.16 90.85% 
Betaine mol/l  19.56 18.05 - 21.20 - 
DMG mol/l  1.76 1.62 - 1.92 - 
Methionine mol/l  23.50 22.79 - 24.24 - 
SAM nmol/l  78.63 76.57 - 80.75 - 
SAH nmol/l  11.94 11.37 - 12.53 - 
SAM:SAH 6.59 6.29 - 6.89 - 
Homocysteine mol/l  7.10 6.77 - 7.43 0.61% 
Cysteine mol/l  197.20 192.96 - 201.53  - 
PL nmol/l  4.37 4.14 - 4.61  - 
PLP nmol/l  26.56 24.64 - 28.62  31.7% 
PA nmol/l  9.47 8.86 - 10.12  - 
N ranging between 163-164 depending on the biomarker 
1B2 def: B2 deficiency as assessed by EGRAC; DMG, dimethylglycine; 
Hcy, homocysteine; SAH, S-adenosylhomocysteine; SAM, S-
adenosylmethionine. 
(-) is indicated where not suitable cut-off could be identified 
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Figure 5.3: Boxplot of intra-gene correlations between CpG sites 
 
Logit transformation of variables for the correlations 
 
5.3.4. Maternal blood biomarkers and infant DNA methylation 
The initial assumption was that MEs, by definition, would act similarly in response 
to the shortage / availability of methyl-groups, and this was investigated in the research 
paper III (Section 5.1.3.4), combining the average loci methylation of the seven MEs. 
Nevertheless, there is a possibility that different CpGs / loci might have different levels of 
protection / susceptibility to stochastic changes to regulation of methylation. Therefore, 
the individual associations of each biomarker exposure with average DNA methylation at 
each ME was also assessed by multilevel regression, including all the individual CpG sites 
for each ME. Results with a p-value<0.05 are shown in Table 5.15. It was observed that 
only cysteine was significantly (negatively) associated with methylation across several 
genes, namely BOLA3, RBM46 and ZNF678. Other biomarkers were only associated with 
methylation of one single gene (mostly RBM46, which is the locus with more potential for 
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variation since the number of CpGs (12) is much higher than for the other loci under 
study, varying from 4 to 6). At only one ME (RBM46) DNA methylation was associated 
with SAH and no ME was corrrelated with SAM or the SAM:SAH ratio. The significances 
were weak and none was below a p-value of 0.0005 (following Bonferroni correction). 
Furthermore, when the interactions between methylation at the different loci and the 
individual biomarkers were assessed, the differences between loci resulted non-
statistically significant, suggesting that the MEs under analysis are not likely to exhibit 
differential associations with biomarkers. 
Assessing the effect of biomarker interactions on methylation outcome in this set-
up is difficult due to the limited sample size and the multiple testing that this involves. 
However, I did some explorative analysis to see whether any very strong interaction were 
apparent. The interactions between each pair of biomarkers on the DNA methylation at 
each locus were thus assessed. The regression analyses were all non-significant at the 
p<0.0005 level (following Bonferroni correction) and the data are not presented here. 
Bonferroni correction is known to be very restrictive; however, even with a 10-fold higher 
significance cut-off (p-value<0.005), only the following interactions were significant: 
active B12-homocysteine ( =0.565; p= 0.004), B2-SAH ( =-0.852; p= 0.001), choline-
cysteine ( =2.360; p= 0.004), and DMG-cysteine ( =1.620; p= 0.004), each one in a 
different gene. These data do not thus show consistency or any clear trend that can explain 
any pattern in inter-metabolite interactions. When all loci were assessed with multi-level 
analysis, only the interaction between B2 and SAH was below p-value<0.005 ( =-1.353, 
p=0.003). 
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Table 5.15: Associations between mean infant DNA methylation at metastable epialleles 
and maternal biomarkers 
Biomarker/ Predictor Methylation 
outcome 
 
N ß coefficient 
(95% CI) 
P-value 
B2 
EGRAC coef  
RBM46 113 -0.273  
(-0.483 - -0.063) 
0.011 
Betaine  
mol/l  
ZFYVE28 115 
0.079  
(0.012 - 0.145) 
0.021 
DMG 
mol/l  
RBM46 108 -0.164  
(-0.257 - -0.036) 
0.010 
Methionine  
mol/l  
PARD6G 110 0.355  
(0.034 - 0.676) 
0.031 
SAH  
nmol/l  
RBM46 108 
-0.145 
(-0.271 - -0.019) 
0.025 
Homocysteine 
mol/l  
RBM46 114 
-0.287  
(-0.456 - -0.117) 
0.001 
Cysteine 
mol/l  
BOLA3 115 
-0.519  
(-0.952 - -0.085) 
0.019 
RBM46 115 
-0.476 
(-0.878 - -0.074) 
0.021 
ZNF678 114 
-0.229  
 (-0.414 - -0.045) 
  0.015 
B6  
nmol/l  
BOLA3 115  -0.173 
(-0.323 - -0.022) 
0.025 
Adjusted for infant sex and maternal BMI; Biomarkers log-transformed 
Multilevel regression analysis 
Cut-off of significance with Bonforroni correction = 0.0005 
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5.4. ADDITIONAL DISCUSSION 
5.4.1. Maternal blood biomarkers 
A major limitation of the maternal blood biomarker assessment was the difficulty 
in collection of a close-to conception blood sample. The low numbers of participants 
recruited early in pregnancy led to a forced expansion of the cut-off initially set (up to 12 
weeks), up to 16 weeks. This had two implications to the results: firstly, the women were 
in a more advanced stage of gestation than planned in the original study design which may 
be relevant given that certain aspects of physiology (including one-carbon metabolism) 
are notably different from non-pregnant women (169). Secondly, this led to a wider time 
variation in the window of actual sample collection and hence biomarker assessment. For 
example, within the rainy season months of July to September, a time gap of almost 6 
months may exists between a woman conceiving on 1st July and bled one week post 
conception to a woman conceiving on 30th September and bled at 16 weeks post 
conception, with implications for the assessment of seasonal differences. Only 42 women 
for the rainy season and 27 women for the dry season had their blood sample collected 
within the established timeframe (between July and September and between February 
and April respectively). Hence, the correction (by back-extrapolation using indicator 
group data) is appropriate and in fact essential. Correction of the recorded values is the 
best option for the analysis to be meaningful, without distortion induced by seasonality. 
Not considering the nutritional status at the right season of conception would jeopardise 
the whole objective of the study. Unfortunately, such extrapolation has its own caveats and 
introduces a different type of error, as discussed in 5.1., particularly for those biomarkers 
where reliability and stability is poor (e.g. SAH or DMG, see Figure 4.2). Figure 5.2 showed 
that the appropriateness for this back-extrapolation could differ widely between 
biomarkers, from those showing very similar patterns between main group and indicator 
group (folate, B12, active B12, choline, betaine, DMG/betaine ratio and SAM) to those 
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where patterns seem to differ (B2, DMG, methionine, SAH, SAM:SAH ratio, homocysteine, 
cysteine and B6). Both SAH and DMG are the least informative biomarkers, as assessed by 
their reliability and stability, and therefore they need to be considered with special care. 
This can lead to over- or under-estimation of the seasonal differences and of the 
biomarker concentrations at conception, affecting downstream analyses of these as 
exposure. Although the sample size was very limited, a sensitivity test was done by 
repeating the analyses, using only the women whose sample was drawn within the 
defined season windows. It was observed that most biomarkers showed the same 
directionality of differences as the initial back-extrapolated analyses when values from 
women at each season were compared. The exceptions were cysteine, choline and B2, all 
of which were biomarkers with divergence of seasonal pattern from the indicator group. 
This indicates the need to interpret these biomarkers with caution. However, these 
divergent differences between seasons was only significant for cysteine (p-value = 
0.0011). Thus, the use of back-extrapolated data was deemed an appropriate means to 
employ in the overall analyses. 
Adjustment was applied for those variables which varied with time of processing, 
namely DMG and SAH (see Section 5.1) for all subsequent analyses. The ideal time from 
sample collection to storage at -80ºC, particularly for SAM and SAH stability and avoidance 
of interconversion of SAM to SAH, is two hours, according to experience from the Innis 
laboratory (data not published). Due to geographical area of recruitment and distances, as 
well as field conditions (quality of roads and population spread), there were more issues 
with longer time of processing in the main group compared to the indicator group. Thus, 
the adjustment for the main group becomes more important.  
Regarding biomarker status, concentrations of B2 and choline seem particularly 
low in this population, as compared to recommended cut-offs (120, 122). Bates et al. (95) 
described a widespread B2 deficient status in pregnant and lactating women in The 
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Gambia 30 years ago, and a higher prevalence of deficiency (higher EGRAC) during the 
peak of the dry compared to the peak of the rainy season (95). B2 deficiency can impair 
the folate dependent pathway within one-carbon metabolism, potentially leading to a 
switch to the folate-independent (betaine-dependent) pathway (111), which might be 
impaired by the low choline. The apparent choline deficiency is probably compensated for 
by betaine in the methyl-group donation, since the women in the current study do not 
show elevated plasma homocysteine (>15 mol/l) and B-vitamins deficiencies do often 
result in disturbance of one-carbon metabolism, reflected in a rise in homocysteine (111).  
Interestingly, when looking at the relative plasma concentrations of choline, 
betaine and DMG in non-pregnant women in this population (1:4.9:0.4 (Section 4.1)), 
these were similar to the proportions reported in Canadian non-pregnant women 
(1:4.5:0.3) ((169)). However, for the pregnant women the proportions differed 
substantially (1:2.5:0.3) in relation to Canadian pregnant women (1:0.9:0.1), where 
choline becomes the major plasma metabolite. This is probably linked to the fact that in 
the Canadian women, choline increased in pregnancy whilst in the Gambian women it 
decreased. In contrast with the steady increase of choline that has been shown in 
pregnancy in other populations (145, 169) due to oestrogen-induced upregulation of 
endogenous synthesis, the values for choline for these women were lower for pregnant 
(the geometric means in both seasonal groups were below 7 mol/l) than for non-
pregnant women (geometric mean 8.2 mol/l) (Section 4.1.3.3). The fact that these 
samples were collected in earlier stages of pregnancy is likely to explain this finding. It is 
possible, however, that in a more nutritionally challenged population, homeostatic 
systems protect one-carbon metabolism to a certain extent. The demand for choline is 
high during pregnancy due to its critical role in embryonic life, not only for DNA 
methylation regulated gene expression, but also for the appropriate development of the 
brain and the nervous system (choline is involved in building cell membranes and in 
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acetylcholine for cholinergic transmission and transmembrane signalling ((188)). Given 
the very limited choline intake from diet in West Kiang women (Section 4.1.), it is 
plausible that the endogenous synthesis is not enough and thus, a maternal plasma 
decrease is observed due to placental transfer to the foetus.  
The plasma biomarker levels studied here are static measurements at a single 
point in time. As such, these levels mainly reflect recent intakes (118), more than the 
mid/long-term status, with the exception of the RBC B2 EGRAC. In order to assess more 
accurately one-carbon metabolism status in a dynamic fashion, the metabolites should be 
looked at together with the activity of the enzymes that control the processes. Disruptions 
to any of the pathways could considerably distort the scene, and the dynamic relationships 
would give us information not only on the pools but also the flux. One-carbon metabolism 
is linked to the larger protein pool mainly via methionine, which could suggest that 
sufficient methionine availability exists. One-carbon metabolism also related involves 
other amino acids such as glycine or threonine, which intervene in the folate-dependent 
pathway and can affect the SAM:SAH ratio balance (189). SAM and SAH plasma 
concentrations are frequently used as markers of global DNA methylation potential (183). 
It is believed that SAH could be more critical than SAM in the regulation of methylation. 
This makes sense, since DNA methyltransferase enzymes (DNMT) bind SAH with higher 
affinity than SAM and, therefore, they are subject to potent product inhibition by SAH 
(190). Higher levels of homocysteine that do not get remethylated via betaine- or folate-
dependent pathways or, alternatively, transsulfuration, due to deficiencies, could reverse 
to SAH and slow methylation processes (111). BMI has shown to be a strong determinant 
of SAM and SAH (175), but did not show any effect in our study on any of the biomarkers 
assessed, other than B12 (total and active). 
The potential influence of the Ramadan has been discussed in Section 5.1.4.2. in 
the context of differences in DNA methylation between this study and the past study on 
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DNA methylation at MEs (79). With respect to the biomarkers, the Ramadan taking place 
during the peak of the rainy season 2009 is also worth a mention, since it could have 
affected those plasma biomarkers sensitive to recent dietary changes. Pregnant women 
are exempt from fasting if they are worrying about their own health, or the health of their 
foetus (191). Information was not collected on women who fasted or not to control for this 
potential confounder. However, in the past, it has been observed that 90% of pregnant 
Gambian women would fast (180) in this particular setting. The tendency is to fast as far 
as pregnant women feel physically well, at least during the first 6 months of pregnancy. 
This is because Ramadan whilst a religious event, is also a social one. Pregnant women 
who choose not to fast during those days, would have to fast later in the year to 
compensate, once the pregnancy is over, as well as, paying back a compensation with alms 
(gift in the form of money or food to the poor) (191). It is certainly more difficult to fast 
outside the Ramadan period, when all the rest of the family / community is not fasting 
(192). As discussed for the indicator group, some evidence supports that no major 
quantitative changes take place during the Ramadan (i.e. similar energy intake). However, 
qualitative changes and thus micronutrient contents could be more affected (150) and 
because Ramadan occurred in the peak of the rainy season, this fact might have faded out 
or increased seasonal differences. 
5.4.2. Infant DNA methylation 
Differences (reduced seasonal effects on methylation) compared to previously 
published data (79) could be due to methodological issues, namely the use of slightly 
different conception timeframes considered for this study (i.e. July-September vs. August-
September in the previous study and February-April vs. March-May previously used). 
Thus, the identical analyses were repeated with the data from the present study, but using 
only the those samples from infants with comparable conception dates, that is, conceived 
between August and September and March and April (for the previous study, the time 
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window was March to May, but May samples were not available for the present study). 
The results obtained were not dramatically different from the results presented in Section 
5.1.3.3 in terms of the statistical significance of the seasonal differences, and there were 
only two MEs statistically significant, but these were two different MEs (see Table 5.16). 
Using the alternative cut-offs, again methylation was consistently higher during the rainy 
season. The total level of gene DNA methylation was generally higher in the rainy season, 
and mostly lower in the dry season, but these differences were slight and did not generally 
reach the methylation levels of the previous study. Data from May, had they existed for the 
present study, might have led to more important changes, but this cannot be ascertained. 
The lack of comparability in the results obtained suggests that the differences seen 
between the earlier and the current data are more likely to be related to other factors (e.g. 
secular differences since 1991) rather than to protocol differences.  
 
Table 5.16: Mean DNA methylation at metastable epialleles and season of conception 
according to cut-offs set in Waterland, PLoS 2010. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Mean absolute difference in DNA methylation between dry and rainy season; * p-value < 0.05 
N = 45 for rainy season and n=57 for dry season unless otherwise indicated 
 
Locus  
(N CpG site) 
Rainy season mean 
methylation %  
(95% CI) 
Dry season mean 
methylation %   
(95% CI) 
Between 
season 
difference 
%a 
P-value 
BOLA3 (5) 51.93 
(47.23-56.62) 
51.33 
(46.37-56.29) 
0.6 0.8604 
PAX8 (5) 77.54 
(72.04-83.04) 
74.24 
(68.25-80.22) 
3.3 0.4172 
RBM46 (12) 70.45 
(67.37-73.53) 
67.79 
(64.71-70.87) 
2.66 0.2223 
ZFYVE28 (5) 31.61 
(27.11-36.10) 
23.57 
(19.48-27.65) 
8.04 0.0089* 
EXD3 (5) 81.42 
(78.91-83.92) 
79.09 
(76.44-81.73) 
2.32 0.2028 
PARD6G (6) 55.06  
(50.54-59.58) 
47.08  
( 41.72-52.45) 
7.98 0.0251* 
ZNF678 (4) 32.03 
(28.75-35.32) 
28.62  
(26.19-31.06) 
3.41 0.0909 
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As shown in Figure 2.7, the previous study found a higher average level of DNA 
methylation levels for three of the four loci also assessed in this study (i.e. 50-51% for 
BOLA3 in our study as opposed to 55-61% in the past study; 71-76% for PAX8 as opposed 
to 70-80%; and 25-29% for ZFYVE28, as opposed to 27-38%) (79) and similar for EXD3. 
However, the broad ranges of methylation at these three loci is very comparable between 
the studies, again pointing towards the reproducibility of the results from the earlier work 
in this population.  
Therefore, it is unlikely that differences with the previous study are due to sample 
size. It is not unrealistic to think that a seasonality effect might have faded out over time or 
that any other specific environmental factor relevant to the period of study could have 
played a role. As previously discussed, Ramadan affected the last month of the rainy 
season peak window. It has been shown in a pilot study in Turkey that effect of Ramadan 
fasting during the second trimester does not seem to have a significant effect on maternal 
oxidative stress, foetal development or birth weight (193). However, it does not exclude 
that Ramadan can induce these or other changes in early pregnancy, which could be more 
sensitive period in terms of DNA methylation, as indicated in the Dutch Hunger Winter 
study (74). In fact, Almond et al. (194) have recently shown that Ramadan fasting during 
the first month could be associated with lower birth weights. Then, hypothetically, if this 
fasting during the rainy season did affect negatively the birth weight and potentially DNA 
methylation, this could worsen the rainy season, weakening the inter-season differences. 
Tobi et. al (75) found sex-specific differences in levels of DNA methylation in 
humans (75, 195), an observation which is important to consider in DNA methylation 
studies. Further, recent DOHaD research has suggested that males could be more ready 
than females to trade off visceral development in utero to protect somatic and brain 
growth, as well as being more responsive to their mother's current diet than females, who 
are more responsive to their mother's life-time nutrition and metabolism (196). Here, we 
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found sex-specific DNA methylation for three genes; higher levels for males at EXD3 
(81.5% vs. 78.5%), and higher for females at RBM46 and ZNF678 (72.5% vs. 67.5% and 
33.2% vs. 28.5% respectively). However, sex did not seem to interact with the seasonal 
effect (i.e. the sex-specific differences did not vary by season). Recent evidence also 
suggests that DNA methylation can be influenced by various other factors, which were 
investigated. However, none of the genes seemed to be affected by total length of gestation 
(78, 111), supporting that MEs do not change their methylation status over time. Maternal 
age at pregnancy (197) and self-reported ethnicity (198) had no effect on methylation 
status. Ethnicity in West Kiang is predominantly Mandinka, although Fula and Jola’s are 
also present, as shown in Figure 2.4. For the infants we asked specifically for the mother 
and father’s ethnicity separately, but it must be noted that in the case of mixed couples, the 
ethnicity reported would be that of the father. Finally, in this study data was not collected 
on several other covariates, that would have been interesting to look at, such as birth 
weight and final gestational age (76). Collection of this data should be considered for 
future studies.  
 
5.4.3. Maternal blood biomarkers and infant DNA methylation 
Association between maternal biomarkers and offspring DNA methylation at MEs 
was investigated, under the hypothesis that availability of methyl-groups could modulate 
DNA methylation. DNA methylation is important for gene expression regulation and DNA 
integrity and stability. The association between one-carbon metabolism and DNA 
methylation has been shown through epidemiological, clinical and animal studies looking 
at methyl-donors and cofactors availability and disease, but the mechanistic links remain 
unclear. SAM channels the methyl-group transfer, and deficiency or excess of methyl-
donors and co-factors can impair the methyl-group supply and affect the ability to 
maintain DNA methylation patterns in replicating cells.. The complexity of this process has 
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already been highlighted in the introduction (Section2.2.2). The existing redundancy of 
pathways to ensure methyl-group supply (164) for methylation of DNA, amongst other 
reactions, and the tight regulation of one-carbon metabolism (199) suggest that this is a 
crucial process requiring a robust system. Yet, the effects of methyl-groups deficiency on 
DNA methylation have shown to be highly complex: they appear to be dependent on cell 
type and organ, the stage of cell transformation (e.g. in cancers,) and are gene- and site- 
specific (200). Most of the studies (including supplementation trials) have investigated in 
the context of cancer research, where the divergence in direction (i.e. global 
hypomethylation coexistent with targeted hypermethylation) clearly suggests that this 
aberrant methylation is not random, although much remains unknown about the 
regulation. Different studies have been conducted on the effect of depletion/repletion of 
folate in DNA methylation, but the findings suggest that responses can vary largely 
depending on age, genotypes, duration and magnitude of the exposure (199).  
The same theoretical dependence of DNA-methylation on methyl groups and one-
carbon metabolism is expected to happen in the developing fetus, and as a result of the 
erasure and resetting of the DNA methylation patterns and the rapid growth rate in this 
period, need for methyl-donors intake could be higher. From a biological point of view, 
however, it would seem unreasonable that gene methylation changes are so vulnerable to 
discrete dietary variation, particularly if the genes are involved in important phenotypes 
in terms of survival. Animal models, nonetheless, seem to indicate the contrary (68, 201, 
202). For example, it has been suggested in mice that maternal dietary supplementation 
may positively affect health and longevity of the offspring (68, 69). Both this potential 
protection of relevant genes and the success of MEs in animal studies enforce the case for 
the use of MEs.  
Due to the tissue-specificity of one-carbon metabolism, it could be argued that 
maternal blood concentrations might not be an accurate reflection of the overall maternal 
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one-carbon metabolism activity or at other maternal tissues, such as the liver (111). 
However, for this type of epidemiological model, where the focus is in maternal nutritional 
exposure, blood biomarkers are relatively easy to investigate, compared to other 
potentially more invasive sampling methods. In addition, the maternal-foetus exchange 
happens through the placenta via maternal blood, and therefore it would expected that 
maternal blood concentrations are a good reflection of the maternal availability, and 
particularly of the potential which might be transferred to the foetus. In fact, it has been 
shown that maternal SAM, B12 and homocysteine concentrations were associated 
respectively with infant DNA methylation (78, 166) and foetal cord blood (203). In this 
sense, further study on the transplacental transport of all the different metabolites into 
the developing fotus and the foetal pools would help in this area of research, although this 
might be difficult to do in humans. For example, choline is known to be transported across 
the placenta through choline transporters (169, 204-206), but betaine and DMG transfer 
remains unclear. Still, because in this study a sample was obtained only at one time point, 
the data could be underestimating other existing maternal pools available for use. 
Nevertheless, it is a useful epidemiological model with relatively easy available maternal 
biomarker measurements, when measurements in the foetus would be unfeasible to use.  
The key findings of the main study are presented in Section 5.1. Most of the 
biomarkers under study had acceptable levels in this population, with the exception of B2. 
The severely deficient B2 maternal status observed was associated with infant DNA 
methylation, when assessing all MEs combined, as were the SAM:SAH and the 
DMG:betaine ratios, and cysteine. It is important to note that both SAH and DMG are the 
most challenging biomarkers, due to quite poor reliability and stability and subsequent 
issues regarding the back-extrapolation to time of conception. Surprisingly, these two 
biomarkers seem to be the key biomarkers presenting a clearly significant association 
with DNA methylation, suggesting that this association could be even stronger. 
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Associations with other biomarkers of known importance, such as folate or choline were 
not identified in these data. Nevertheless, the data of this study seem to suggest that B2 
could be the key limiting factor in this population, and that the more severe the B2 
depletion is (higher EGRAC values), the more impaired the DNA methylation is. 
Additionally, B2 deficiency would impair the folate-dependent way, leading to a switch to 
the betaine-dependent pathway. The use of this betaine-pathway is also negatively 
associated (i.e. the higher DMG:betaine ratio) with the DNA methylation, suggesting that 
this pathway might not be coping with the maintenance of DNA methylation, leading to a 
lower rate of remethylation of homocysteine, that would go through the transsulfuration 
pathway to avoid homocysteine accumulation. This could explain also the apparent 
negative association of cysteine (which is product of the transsulfuration and would 
increase with a greater use of the transsulfuration pathway) with DNA methylation. 
Since the primary assumption was that MEs would respond similarly to methyl-
group availability, all MEs were analysed combined. In addition, a second step was taken 
in the analysis, looking at the associations of biomarkers with individual MEs to identify if 
they responded differently to biomarkers. This analysis showed considerable differences 
in the association between biomarkers and the different MEs, with RBM46 identified as the 
locus most sensitive to differences in biomarker concentrations. This would suggest that 
the different loci are not similarly affected by nutritional status and that, therefore, other 
regulatory / adaptive mechanisms may trigger the response (or lack of response). In fact, 
during the Dutch Hunger winter study, increases and decreases of DNA methylation as a 
response to undernutrition were reported, suggesting this possibility (75). When 
interactions were checked between methylation at the different loci and each of the 
different biomarkers, and differences tested for each loci, the results were non-significant, 
indicating that such differences in response of different loci to biomarkers do not exist. It 
is thus possible that these individual associations shown in Table 5.15 could be just due to 
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chance (since the associations presented although significant are generally weak). 
Furthermore, of all of the individual biomarkers, the one which was most frequently 
associated with DNA methylation was cysteine, with significant associations and the same 
directionality of association at three loci: BOLA3, RBM46 and ZNF678. However, given that 
cysteine is not on the remethylation pathway but in the transsulfuration pathway, this 
association could be due to confounding rather than via genuine causation. It is also 
interesting to note that the RBM46 sequence analysed contains more than twice the 
number of CpGs than the other loci sequences. This could lead to higher potential variation 
and partly explain differences in response.  
Finally, the lack of interactions (by pairs of biomarkers) could be due to a real lack 
of effect, or, if an effect of biomarkers existed, because of a higher complexity of 
interactions between pathways, as a result of the cyclic and complementary nature of one-
carbon metabolism (see Figure 4.1) or due to too small a sample to detect such effects. 
Indeed, some of the findings regarding associations between biomarkers are inconsistent 
and appear paradoxical and this needs further research. 
Observational studies can be used to detect rapid large effects but also subtle 
effects so long as there is a suitable source of variation in exposure (106, 107). In this 
study, changes during development in infant DNA methylation at MEs are thought to 
happen within a short time frame around conception (79). Also the ranges of exposure 
observed (i.e folate plasma) are not large but are comparable to other studies (111, 166). 
Finally, even if the size effect in DNA methylation change necessary for phenotypic 
alteration remains largely unknown (76), the DNA methylation changes induced by 
maternal malnutrition have been proved to be detectable (74, 75). Therefore, an 
observational design such as this one is value, but it is prone to bias and confounding that 
needs to be considered.  
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As discussed is Section 3.2.2., the dry season conception group were additionally 
enrolled within the ENID trial (see Section 5.2.1). It is thus important to consider any 
possible bias arising from this difference between the groups. Women enrolled into ENID 
were randomised to either of both intervention groups from booking (<20 weeks 
gestation) until delivery: either placebo (Iron-folate (FeFol = standard care, given to all 
participants), energy-protein supplement, multiple micronutrients (including, B2, B6 and 
B12), or both energy-protein and micronutrients (207). Then their infants were further 
randomised at six-months of age to a lipid-based nutritional supplement, with or without 
additional micronutrients. However, for the hypotheses under investigation and the 
results presented in this thesis (DNA methylation at MEs) supplementation group 
information was purposely not included into the analysis. DNA methylation at MEs is by 
definition established around conception and would not be affected by supplementation 
after 12 weeks. Further, and in relation to the biomarkers, the sample collection in 
mothers took place prior to any supplementation and thus, maternal biomarkers were not 
affected by supplementation status. In infants, the blood sample was also collected before 
postnatal supplementation. However, their DNA methylation patterns outside MEs could 
be affected by maternal supplementation during pregnancy. Thus, this needs to be taken 
into account in future analyses (e.g. global methylation, as discussed later in Section 6.3.) 
though an analysis with four supplementation arms may decrease substantially the power 
of this study. 
In addition to the biomarkers under study, other nutritional/dietary factors have 
been postulated to affect DNA methylation. Examples are the effects of nutrients through 
indirect modifications of one-carbon metabolism (e.g. zinc or selenium) and via activity of 
DNMT enzymes (e.g. polyphenols), and have been reviewed by McKay & Mathers (208). 
Zinc in The Gambia is not found in high concentrations in foods which are seasonally 
available (209) but there is no available data showing seasonality in the status of selenium 
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or polyphenols. Non-nutritional factors, that may also exhibit seasonal confounding could 
include exposure to aflatoxin or cooking smoke, both of which are known to have the 
potential to influence DNA-methylation (184, 185, 210). Aflatoxin is a mycotoxin produced 
by Aspergillus spp. and found as contaminant in staple foods in The Gambia and other 
parts of sub-Saharan Africa, where staples are stored in hot and humid conditions (211). 
Aflatoxin-DNA adducts have been significantly correlated in Taiwanese hepatocellular 
carcinoma patients with the DNA methylation of the tumour suppressor gene RASSF1A 
(212), and of MGMT, a gene that encodes O6-methylguanine-DNA methyltransferase (210, 
213). If aflatoxin exposure does result in changes in DNA methylation, independent of 
methyl-group availability, it would be a potential confounder, since the exposure to 
aflatoxin could also differ considerably between seasons (e.g. recently harvested 
groundnuts vs. long-time stored or imported groundnuts: as the local food availability 
varies, the sources of food vary too). Regarding the cooking smoke exposure, it was 
observed within the non-pregnant indicator group study (Section 4.2), that the majority of 
kitchens were mud brick huts with variable but generally poor ventilation and that wood 
was used for fuel in 100% of cases. Weather conditions / season did not seem to effect 
location of cooking (inside / ouside), and thus this exposure seems to be mostly 
homogeneous throughout the year. A further potential seasonal difference is the workload 
of the women, which is much more intense during the rainy season, and which might have 
had an impact on the daily dynamics and indirectly on the total cooking smoke exposure. 
For example, the time spent cooking, the number of times that they cook a day or even the 
distribution of the workload at the household amongst the different members of the family 
(e.g. younger girls and older women) could have the potential to vary considerably. 
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5.4.4. Conclusions 
Evidence for the causal effects of methyl-donors and cofactors on DNA methylation 
in humans comes mostly from intervention studies on cancer and aging (214, 215) and, 
overall, DNA methylation at specific loci correlates positively with methyl-group 
availability (208). However, the duration and the intensity of the exposure necessary to 
provoke epigenetic changes remains largely unknown, particularly in foetal development, 
where studies are also required to identify of optimal timings in pregnancy where DNA 
methylation is sensitive to nutritional exposures. This observational study is subject to 
confounding and causality cannot be inferred from the data. However, it highlights some 
important and interesting associations that should be investigated further. Certainly, a 
more comprehensive investigation should be conducted to assess the association between 
season and one-carbon metabolites and new DNA methylation outcomes, and provide 
deeper insights into the determinants of prenatal DNA methylation patterns. In summary, 
this study presents evidence for associations of infant DNA methylation at MEs with 
environmental influences (i.e. season), including nutritional maternal condition as 
assessed by maternal BMI in early pregnancy and SAM:SAH or DMG:betaine ratios, B2 and 
cysteine. The results from this study are not definitive and conclusive, given its 
observational nature but clearly support the hypothesis that environmental factors during 
pregnancy influence the DNA methylation in infants. As such, replication and expansion in 
this area is vital. 
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Part III:  
GENERAL DISCUSSION 
 
 
CHAPTER 6: GENERAL DISCUSSION 
 
 
‘We believe fervently that improving nutrition for pregnant women and children 
under two is one of the smartest investments we or anyone can make’ (Hillary Clinton, 
September 20, 2011) 
 
 
This Chapter summarises the main findings from this PhD thesis and interprets the 
findings beyond the scope already covered in earlier sections. The importance of these 
data within the wider context of health across the life-course is discussed and future 
research areas arising from this project are suggested. 
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6.1. SUMMARY 
The DOHaD research field has steadily attracted attention over the past years, 
largely due to the increasing prevalence and burden of NCDs and the global attempts at 
disease prevention at every life-stage. To develop appropriate prenatal strategies, a better 
understanding of the biological mechanisms of developmental programming is needed. 
Among the underlying mechanisms so far proposed, alterations to DNA methylation 
patterns appears as a strong candidate. Evidence is growing on the influence of nutrition 
on inter-individual variation in DNA methylation patterns throughout life in humans 
(208), but the establishment in utero of such patterns is still poorly understood. The 
purpose of the research presented in this thesis was to contribute to the existing evidence 
base on environmentally-driven epigenetic changes during the human prenatal period.  
The research hypothesis under investigation was that season of conception affects 
DNA methylation and that this can be explained, at least partly, by changes in maternal 
nutrition-related one-carbon metabolism. The study was designed as two complementary 
research projects in rural Gambia (the ‘indicator’ and ‘main group’ studies), to appraise in 
combination the relationships between maternal dietary intakes of methyl-donors and 
cofactors, maternal nutritional status as assessed by biomarkers of one-carbon 
metabolism and infant DNA methylation at MEs. The blood biomarker data was the 
common feature linking both studies. The two studies were purely observational and, 
therefore, not intended to determine causal associations, but should rather be seen as 
opportunity for hypothesis generation in the enquiry of links between maternal one-
carbon status and infant DNA methylation. This is a fast moving field and since this study 
was designed, further progress has been made in epigenetics (216), such as the analysis of 
the DNA methylome of different normal (217) or cancerous (218) human cell types. 
Knowledge on the role of maternal methyl-donors and cofactors in the establishment of 
offspring DNA methylation patterns has also expanded over the last 3 years (78, 166, 219). 
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Yet, our understanding remains very limited and much is still to be learned about the 
complexity of epigenetic regulation (including DNA methylation), thus highlighting the 
need for further, focused research in this area.  
 
6.1.1. Synopsis of findings 
A main finding of this study was that the diet of women of child-bearing age in 
West Kiang (as assessed in the ‘indicator’ group) was moderate to severely deficient for 
several of the methyl-donors and cofactors, namely folate, B2, choline and B6, in 
comparison to the EARs, whilst intake was adequate for B12 and methionine. 
Furthermore, intakes of folate, B2, choline and betaine were subject to significant 
fluctuation throughout the year, whereas methionine, B6 and B12 intakes were stable 
throughout the year. Patterns of seasonality varied in phase (time of the variation) and 
amplitude (magnitude of the variation) amongst nutrients under study, the rainy season 
being richer in some (betaine and B12), and the dry season in others (folate, B2 and B6). 
Maternal blood biomarkers were assessed in both sub-studies, as an outcome of 
season and dietary intake in the indicator group, and as an intermediate exposure in the 
main group. From the indicator group data, it could be concluded that diet does not 
translate strongly into blood biomarkers. In addition, reliability and stability were 
generally good for blood biomarkers, whilst for dietary intakes reliability and stability 
were limited. Despite the observed deficiencies in dietary intakes, concentrations of blood 
biomarkers of one-carbon metabolism in Gambian women were mostly adequate. 
However, important deficiencies in B2 and choline were observed, both in pregnant and 
non-pregnant women. All blood biomarkers were subject to significant seasonal 
fluctuation throughout the year, and such seasonal patterns were similar in pregnant and 
non-pregnant women for several of the biomarkers (folate, choline, betaine, B12, active 
B12 and DMG:betaine ratio), but differed for the other substances under study. The trends 
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between seasons for the different biomarkers were similar in non-pregnant and pregnant 
women, except for choline, methionine, SAM and cysteine. However, absolute biomarker 
levels were generally lower (except for folate, B2 and SAH) in pregnant compared to non-
pregnant women. Of all the biomarkers, special attention was given to the SAM:SAH ratio 
as an index of methylation. This was based on the hypothesis that the SAM:SAH ratio 
would be a meaningful summary measure of methyl-groups availability and reflecting 
maternal methylation capacity, which could be ‘transmitted’ to the foetus and thus 
correlating with infant DNA methylation levels. The SAM:SAH ratio was higher during the 
rainy season in both sub-studies (pregnant and non-pregnant women), suggesting a 
higher methylation potential at this time of the year.  
Finally, previously published findings of an effect of season of conception on infant 
DNA methylation (79) were successfully replicated in a bigger, independent sample, and 
expanded with the presentation of three new MEs. A consistent effect of season on the 
DNA methylation at MEs was observed, with higher methylation levels seen in infants 
conceived during the rainy season, with the effect size (methylation proportion) and 
significance varying by locus. Further investigation on likely intermediate exposures 
highlighted that maternal nutritional status, as assessed by BMI and one-carbon 
metabolism biomarkers in blood, appeared to affect DNA methylation patterns. Several of 
the individual biomarkers, namely SAM:SAH ratio, DMG:betaine ratio, B2 and cysteine, as 
well as all biomarkers jointly (condensed as the first principal component) were 
associated with infant DNA methylation across all MEs. Although the approach taken does 
not allow us to establish causality in the relationship between maternal biomarker status 
and infant DNA methylation, the findings strongly support the hypothesis that maternal 
nutritional status plays an important role in early epigenetic processes in the offspring. 
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6.2. DISCUSSION 
The final aim of this thesis was to identify whether links exist between the 
periconceptional seasonal maternal diet and infant DNA methylation (objective 5, Section 
2.5.). For ethical and practical reasons (as discussed in Section 5.3.1) the dietary intake 
was only assessed in the indicator group of non-pregnant women and could thus not be 
directly related to infant DNA methylation. The measurements were however thought to 
represent a good estimation of dietary intake of women in rural Gambian including, 
importantly, at time of conception. As outlined earlier, intakes of betaine and B12 were 
higher during rainy season, and diet during the dry season was richer in folate, B2 and B6. 
Dietary intake levels do mostly not agree well with the findings on blood levels of these 
substances in non-pregnant or pregnant women. Tables 4.2 and 5.3 show that blood 
betaine, folate and B2 were higher during the rainy season, and conversely, B6 and B12 
were higher during the dry season. Correlations between dietary intake and blood 
biomarker levels could be tested formally in the indicator group. This confirmed that 
betaine, B6, B2 and B12 intakes were associated with the levels in blood, although the 
effect size (regression coefficients) was not as strong as expected. This lack of consistent 
correlations and the limited reliability and stability of the dietary intake data suggests that 
the biomarker data is preferable over the dietary intake data for this type of study, at least 
in this population. 
Regarding biomarkers, the high interdependence of one-carbon metabolites means 
that different ‘road blocks’ can impact on the biomarker profile and lead to different 
scenarios according to limiting metabolites. For example, severe deficiency of B2 in this 
population might impair the biological availability or metabolic utilization of another 
nutrient (e.g. within the folate pathway), but this limitation might be buffered by the 
availability of yet another metabolite (e.g. those in the betaine-pathway) (220). This also 
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suggests that associations between biomarkers could be different in other populations 
with different dietary deficiencies and intake patterns.   
Furthermore, in view of the intra-individual biological variability in the blood 
biomarkers (118), which could have been further exacerbated by sample handling 
(particularly processing time due to the field conditions), the risk of using one single time 
point of measurement should also be considered. The plasma concentrations measured 
give information of a specific moment (and thus reflecting only partial view of a complex 
process), without information on flux or turnover and ignoring conversion rates and 
allosteric regulation. Most of the metabolites involved in one-carbon metabolism make up 
part of a bigger body pool (e.g. body proteins) and also play other roles in the body (e.g. 
choline function in cell membrane or brain development). This makes the blood levels 
perhaps unrepresentative of the real status. Analysis of serial samples or studies looking 
at metabolite kinetics could be more illustrative of the actual biomarker status and 
methylation potential over a period of time (i.e. in early pregnancy). In addition, less 
invasive methods would be more appropriate for this kind of sampling, particularly in 
participants who have not yet been confirmed as pregnant. The availability of appropriate 
laboratory techniques based, for example on urine would be an important improvement in 
this respect. 
This study included the assessment of a comprehensive set of biomarkers and 
focused on methyl-donors and cofactors, as well as the functional biomarkers of one-
carbon metabolism. However, the list of substances of interest could be expanded further 
for a better understanding within the context of the overall demands for one-carbon units. 
For example, a substantial competitive demand for methyl-groups exists from endogenous 
synthesis of substances such as creatine (221). In case of shortage in the availability of 
methyl-groups, constrictions on the synthesis of such substances might spare methyl-
groups for DNA methylation. Creatine acts as a storage fuel for skeletal muscle and might 
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be associated with body weight and lean mass and thus with seasonality (222). In this 
setting, patterns in physical activity are very dependent on the season, particularly with 
women working intensively the fields during the rainy season (153), and this could 
potentially affect the muscle mass. Furthermore, other nutrients such as serine and glycine 
are involved in the methyl supply to the folate-dependent pathway (see Figure 4.1), which 
were not measured, as well as measures of the transsulfuration cycle (e.g. cysteine 
glutathione).  
The nature of one-carbon metabolism is an unusually complex network, with 
redundancy of interlocking cyclic pathways and ongoing recycling of metabolites (e.g. the 
remethylation of homocysteine, the endogenous synthesis of choline (111, 223)). 
Understanding the highly intricate nutrient-nutrient interactions within this context 
requires a comprehensive approach and, ideally, a larger sample size. Deeper analysis of 
higher level interactions (i.e. involving several of the biomarkers) could be done using a 
sophisticated modelling approach which was beyond the scope of the current thesis, but 
may be explored in future analyses.  
The inter-individual variations in DNA methylation epigenotype at birth can be 
explained by environmental, genetic or stochastic factors (78, 111). However, at MEs, by 
definition, epigenotype is not genetically determined, but established stochastically and is 
sensitive to environment (224). Infant DNA methylation was generally higher in the group 
of infants conceived during the rainy season, as seen in an earlier study within the same 
population setting (79). However, compared to previously reported findings the 
methylation proportions and the statistical significance of observed differences between 
seasons were weaker. Furthermore DNA methylation levels, irrespective of season, were 
observed to be lower in the present study. The reasons why this could be the case are 
discussed in detail in Chapter 5, with the most plausible explanation being that secular 
trends between the time points that the infants under investigation were conceived 
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(1991-1998 and 2009-10) has diminished seasonal differences. Yet, seasonal differences 
in methylation patterns still exist, and thus this present work represents a replication, 
albeit at reduced statistical significance, in this rural Gambian population. The association 
of DNA methylation at MEs with the principal component of one-carbon metabolism 
biomarkers, which provides with a helpful means for the reduction of random noise in 
complex data, can be difficult to interpret (225). Nonetheless, DNA methylation was also 
associated with availability of individual nutrients such as B2. This would seem logical, 
given that B2 is the most limiting nutrient under study, although in theory this deficiency 
could potentially be compensated by the betaine-dependent pathway. DNA methylation 
was also associated with plasma cysteine and with the two ratio measures, SAM:SAH and 
DMG:betaine, employed as indicators of the transmethylation (or transfer of methyl-
groups for biological methylation) and betaine-dependent remethylation pathways, 
respectively. However, these biomarkers and ratios are all correlated with season, so it is 
difficult to ascertain, for example, whether the SAM:SAH ratio explains the seasonal effect 
on DNA methylation or whether season explains the relationship of DNA methylation with 
SAM:SAH (i.e. the association of DNA methylation with SAM:SAH ratio might be spurious 
and simply due to its correlation with season or with some other seasonal unmeasured 
factor exerting the true effect on DNA methylation). Despite the various considerations in 
the interpretation of the data outlined above, this study provides us with some initial 
evidence of associations of infant DNA methylation at MEs with prenatal environment and 
maternal nutritional status, which precipitates the need for further study. Other studies 
have found associations of DNA methylation with different prenatal one-carbon 
metabolism biomarkers (78, 166). For example, Jing et al. (219) have recently reported 
that higher maternal choline intakes (930 vs. 480 mg/d) in the third trimester of 
pregnancy may modify foetal epigenetic state of cortisol-regulating genes and their 
expression in the placenta (219). In this study, choline affected placental gene promoter 
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methylation and was associated with higher global DNA methylation in the placenta (219). 
There is also evidence of genetic components to the regulation of DNA methylation 
patterns (208). In addition, other factors could also be involved in the effect of season of 
conception on DNA methylation (i.e. factors explaining adaptive responses with broader 
physiological response to a difficult environment, where low methyl-groups availability 
could perceived as limiting).  
The project described in this thesis has been very successful at: i) surveying and 
sampling every month, for one calendar year, 30 women with a high degree of detail 
(indicator group), and ii) screening and following up the menstrual cycle of 1630 women 
to identify eligible women, conceiving within the established timeframe. This is quite 
remarkable in the given setting, and must be viewed as a strength of the study, which 
required an enormous logistic effort. This was made possible by coordinating resources 
with other projects and utlizing the existing research platforms (e.g. the DSS) at MRC 
Keneba. With respect to the findings described, this study has produced novel data on a 
comprehensive set of one-carbon metabolites and co-factors in terms of both dietary 
intakes and plasma biomarker levels. Such data were not available for this population 
before. The study also provided information on Gambian indigenous food concentrations 
of substances under study, which contributes to the relatively limited food composition 
information existing on West African foods and African foods more generally and, in the 
case of choline and betaine, to the global database, recently started by USDA (141). 
MEs are thought to be established very early in gestation (224). Therefore the 
ideal time to measure nutritional exposure would be around conception. The study 
samples were collected up to 16 weeks post-conception. Hence, it was deemed imperative 
to correct the biomarker concentrations in the main group women for seasonality, after 
assessing whether the indicator group is representative of the main group, and the 
measurement error (stability and reliability). The limitation of this back-extrapolation 
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process has been discussed in Chapters 4 and 5. Given the environment in which the 
research was conducted, collecting blood samples closer to conception will always be a 
challenge, unless different sampling methods are used, as discussed above, based perhaps 
on saliva or urine, with less processing required, and which would allow for blanket 
sample collection (less resource heavy than venous sampling), as well as being more 
discrete and allowing more frequent sampling. Such alternative methods need further 
exploration. However, such developments, and the interpretation of data obtained, would 
need to consider the issue of tissue specificity of one-carbon metabolism. Blood 
concentration of biomarkers might be a limited reflection of the general maternal 
methylation potential in the different tissues but it is more likely to reflect what 
biomarker levels are available to the foetus via placental transfer.  
In addition, the 16 weeks cut-off for early pregnancy blood sample collection led to 
some participants conceiving within the a priori specified time frame to be excluded from 
the study. This reduced the sample size and thus the power for detection of association 
between the exposures and outcomes, especially in view of multiple testing. The risk exists 
that associations identified, and these often not being highly significant, could be due to 
chance. Clear statements about allowances for this were made, e.g. the application of the 
Bonferroni correction to some of the analyses. There is also potential for an inability to 
detect true differences, and thus committing type II errors, particularly in the 
investigation of the association between individual biomarkers and DNA methylation, and 
the interactions between biomarkers.  
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6.3. FUTURE RESEARCH  
This thesis is based upon the research conducted within the Gambian MDEG 
project, one of the first studies to look at effects of maternal one-carbon metabolism in the 
establishment of DNA methylation patterns during early development, in a comprehensive 
manner. Using the MDEG study, we continue to ask further research questions, as 
described in the following section. The initial results obtained so far are of limited 
applicative use, but raise ideas for further studies in this area as outlined below. 
 
6.3.1. Ongoing research within the MDEG framework  
Within the framework of the existing study, there are several immediate next steps 
planned and underway using available samples, with the aim to enhance our 
understanding of the data obtained so far. For example, genetic variation in genes involved 
in one-carbon metabolism could add an extra layer of complexity to the interpretation of 
the results. Genetic variation (e.g. single nucleotide polymorphisms or SNPs) can 
substantially affect one-carbon metabolism, leading to the modification of dietary 
requirements. For example, SNPs in the MTHFR gene can lead to a 30-60% reduced 
efficiency of the enzyme methylenetetrahydrofolate reductase, which affects folate and 
homocysteine concentrations (226). Similarly, a polymorphism (rs12325817) in the PEMT 
gene (phosphatidylethanolamine-N-methyltransferase), involved in endogenous liver 
choline production and induced by oestrogen, exists. Almost 75% of the population of 
North Carolina in the US has one variant allele for this SNP, which increases dietary 
requirements for choline (136, 227). However, the frequency of such variants in African 
populations remains mostly unknown. In collaboration with Prof. Steve Zeisel (University 
of North Carolina, USA), we are analysing the maternal DNA to establish the frequency 
distribution of a panel of approximately 300 SNPs in about 18 genes involved in one-
carbon metabolism. This information should expand our understanding of inter-individual 
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variation in levels of one-carbon metabolites and potentially help interpret our data even 
with respect to infant DNA methylation patterns. 
Investigating cross-cultural data in maternal one-carbon metabolism may help 
understand how it adjusts to specific deficiencies within individual population groups. 
Contemporarily to the analyses that were conducted in the MDEG maternal plasma 
samples, identical analyses were carried out by our collaborator, Prof Sheila Innis 
(University of British Colombia, Canada), on a cohort of women of reproductive age from 
Canada. A comparative analysis of biomarker concentrations will be undertaken between 
women from The Gambia (both pregnant and non-pregnant) and Canada (non-pregnant). 
In Canada mandatory folate fortification has been implemented since 1998 (with 
fortification of 150 µg of folic acid per 100 grams of enriched flour and uncooked cereal 
grains). The Canadian dataset also includes information on dietary intake of the methyl-
donors and cofactors, which thus can be compared to data from the indicator group of 
women in The Gambia. Since fortification was introduced in Canada, a dramatic increase 
in blood levels of folate and a substantial decrease in plasma homocysteine levels has been 
observed in the population (228). Our unsupplemented population is likely to respond 
more dramatically to fluctuations in intakes, particularly in pregnancy. Additionally, a 
third cohort of pregnant women from The Netherlands could be investigated, where 
similar biomarker analyses were carried out (175). The Netherlands represents another 
high-income country, but without mandatory folate fortification. A three-way comparison 
of data between Gambian, Canadian and Dutch data could thus shed light on the role of 
dietary intakes (in this case deficiencies and supplementation) of one-carbon metabolites 
and cofactors, as well as pregnancy stage, on blood biomarker levels. 
In terms of DNA methylation, MEs are an obvious target to investigate DNA 
methylation patterns due to their particular characteristics of environmental 
sensitiveness, and establishment in early development that remains thereafter, across 
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tissues. However, a whole genome approach can be considered both complementary and 
more comprehensive than a locus-specific approach. Moreover, the establishment of 
methylation patterns genome-wide may respond differently to methyl-group availability 
than MEs and be subject to different timing (de- and re-methylation may occur over time 
at loci not considered to be MEs). Potentially, genome-wide methylation is less tightly 
regulated than methylation of MEs and thus more sensitive to maternal variation in one-
carbon metabolism. It is not unusual, for example in cancers, to observe global 
hypomethylation coexisting with hypermethylation at specific sites (229). Therefore a 
genome-wide analysis could lead to interesting results complementary to the ones 
presented, particularly if the analyses covered the same loci or CpGs described as part of 
this thesis. The analysis of global DNA methylation for the infant DNA samples is currently 
ongoing (using the Illumina 450K Infinium BeadChip) at the International Agency for 
Research on Cancer (IARC) and in collaboration with colleagues at the University of Leeds. 
The primary aim of this research is to investigate whether maternal aflatoxin exposure 
(plasma aflatoxin-albumin adducts assessed in MDEG maternal plasma samples) affects 
infant DNA methylation. Since the exposure to aflatoxins has previously been reported to 
be seasonal in The Gambia (230, 231), and if it shows to have an effect on infant DNA 
methylation of this cohort, the aflatoxin exposure data could be used to control the current 
analyses, as it could an important source of confounding between season and infant DNA 
methylation.  
To progress further the research of MEs with the Gambian setting, work will 
continue in Rob Waterland’s lab in order to: identify new MEs; verify already identified 
MEs in different tissues in Gambians; evaluate potential phenotypic effects of MEs in the 
infants in follow-up studies.  
Finally and most importantly, the ultimate interest of an effect of maternal diet on 
infant DNA methylation is based on the assumption that this can affect the health 
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outcomes of the offspring long-term. Further research is necessary to establish if there are 
any biological consequences of altered DNA methylation patterns. Identifying differential 
methylation at genes associated with specific phenotypes such as growth or early markers 
of NCDs could help greatly to elucidate potential mechanisms underlying the DOHaD 
hypothesis. Since a strong asset of this research setting is the ability to track and follow-up 
study participants, a new add-on study to MDEG has been granted ethical approval, for 
which we have initiated the fieldwork. We are now collecting blood samples of the study 
children when they reach 2 years of age, together with detailed anthropometric data. The 
specific panel of phenotypic outcomes to be assessed in the blood samples collected, still 
needs to be defined in detail. As an example, the PAX8 gene, one of the MEs investigated, is 
involved in hypothyroidism and future work could investigate as to whether methylation 
at this ME has phenotypical consequences on thyroid function (e.g. levels of thyroid 
stimulating hormone and free thyroid hormones FT3 and FT4). Similarly, the 
hypothalamic-pituitary-adrenal axis that regulates cortisol production, has been shown to 
be sensitive to perinatal epigenetic programming (219) and could therefore be a good 
system to investigate, in order to assess potential consequences of alterations in DNA 
methylation patterns. Data suggests that measures of immunity may be modulated by 
season in this environment (99) and thus immunological outcomes can also be considered 
in the context of epigenetic analyses. Furthermore, phenotypes related to growth and IGF-
axis, and/or early markers of diabetes would also be interesting to investigate (however 
diabetes prevalence is very low in rural Gambia). Remaining DNA stocks could be used as 
basis for in-depth methylation assessment at relevant key genes, e.g. IGF genes, which are 
involved in regulating immune function and growth, if deemed appropriate. 
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6.3.2. Potential future research within the MDEG framework  
As indicated above several lines of research are already under way expanding on 
the work described in this thesis. Still, much additional work could be conducted within 
the framework of the existing study. For example, another outcome to consider is DNA 
methylation at imprinted genes. Imprinted genes control fetal and placental growth 
(among other things) and are involved in the adaptative response to the intra-uterine 
environment (232). Their expression is exclusively from one parental allele. This 
monoallelic expression is initiated by differential methylation between the oocyte and 
sperm in differentially methylated regions (DMR). These DMRs are thought to be 
particularly susceptible to nutritional deficiencies around conception (105). 
Periconceptional micronutrient supplementation seemed to alter offspring DNA 
methylation in a Gambian population (105), although these results were based on a small 
sample, and these genes could be investigated in much greater detail in this present 
cohort.  
As already discussed, one-carbon metabolism is complex and the interpretation of 
the results obtained is limited by the static nature of the data obtained as a part of this 
thesis. Sophisticated mathematical modelling, with data on related enzyme kinetics and 
regulatory mechanisms could help our understanding of the data available. Scientists at 
the Duke University, Durham, US, have developed mathematical simulations of one-carbon 
metabolism with predictions that match experimental data (223) and an in silico 
experimentation model has been designed from those studies (233). We are exploring a 
collaboration with this group to run our data initially through their existing in silico 
model, albeit with the caveat that models developed on Caucasians might not be the best 
fit for our Gambian population 
Another area worth to investigate would be the evolution in the maternal plasma 
concentrations of the biomarkers of interest throughout pregnancy. Although only one 
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maternal sample was collected for MDEG study women, the ENID Trial collects samples at 
booking (< 20 weeks), 20 and 30 weeks gestation. Plasma samples from women who were 
on placebo could thus be analysed at the three consecutive time points to assess the intra-
individual variation throughout pregnancy, which would coexist with the seasonal 
variation.  
 
6.3.3. Further research on one-carbon metabolism and DNA 
methylation in utero beyond the MDEG framework 
Although the association of season of conception with altered DNA methylation 
was replicated in this current study, further corroboration of this type of observational 
study in different human populations is optimal, particularly in less developed countries 
with marked nutritional limitations (e.g. Indian populations, with good folate status and 
yet a noted B12 deficiency (138)).  
Regarding the possible role of one-carbon metabolites in DNA methylation in 
utero, the strongest evidence available for a direct effect so far comes from 
supplementation studies of methyl-donors in murine models and shows both upregulation 
(234) and downregulation of DNA methylation (235, 236). To explore in further detail the 
physiology of one-carbon metabolism related to our findings (i.e. the effects on the 
different pathways when availability of specific methyl-donors and cofactors is modified), 
this research should be complemented with animal work. Animal models would allow a 
specific focus on responses within certain states of severe deficiency, such as B2 deficiency 
(which appeared the most limiting factor within our Gambian population). The mouse 
genomes have a 85% genes of similarity to human genes, making it a powerful and useful 
model (15). However, there are clearly some challenges when inferring from mice trials in 
laboratory conditions to observational studies in a free-living human population.  
 225 
The ultimate goal of this area of research should be, however, to gather enough 
evidence about the effect of maternal nutrition in one-carbon metabolism in humans to 
assess optimal maternal needs. Such evidence can only be obtained via randomised 
controlled trials of nutritional supplementation. Published data from trials conducted in 
developing countries in pregnant women have included B-vitamins (237) that could be 
followed up to look at the DNA methylation in the offspring. Research on the DNA 
methylation of the offspring of supplemented women has already being conducted in the 
Gambia (104, 105). Follow-up of the participants in these studies to assess phenotypic 
outcomes of growth and early markers of chronic disease or other phenotypes (as 
discussed in Section 6.3.1), could be important. So far, supplementation trials in LMICs 
have not included choline and/or betaine. This study suggests that choline and B2 status 
in this population are very deficient and that DNA methylation is associated with the 
betaine-dependent pathway and with B2 (as observed by significance of association with 
DMG:betaine ratio and B2 ratio). In addition, evidence is growing on the importance of 
choline, as suggested by the oestrogen-induced production of phosphatidylcholine in the 
liver (238), the high transplacental transport and high choline levels in breast milk (239). 
Choline is thought to influence hippocampal neurogenesis during fetal development and 
thus memory function in infants lifelong (240-244), partly mediated by changes in DNA 
and histone methylation (241, 245, 246). However, these data need to be supported by 
firm evidence from trials in humans. The initial results of the MDEG study, complemented 
by the planned steps, could provide the basis for a potential choline (and betaine) 
intervention study in The Gambia assessing, for example, infant brain development as an 
outcome measure. Supplementation with B2 should also be considered. However, caution 
is needed until we fully understand the impact of supplementation with one one-carbon 
substances on differing scenarios of status of the other metabolites. We would expect 
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supplementation studies starting even before conception to achieve the greatest effect on 
outcome.  
 
6.3.4. Wider context 
The establishment of DNA methylation patterns during development is a complex 
area of research, where human evidence is scarce and challenging to obtain due to the life-
course approach needed (from pre-pregnancy to offspring adult life). The results of this 
study, whilst exploratory, should stimulate future research into this topic. Ideally, as 
discussed in 6.3.3., randomised controlled trials of nutritional supplementation are 
needed. Should these prove informative, populations with deficient diets are likely to 
benefit most from such interventions (and potentially with less risks of side-effects) than 
those with adequate intakes. Furthermore, particular populations or population 
subgroups with a high frequency of functional genetic variants affecting the dietary 
requirements (227, 244) could benefit from targeted interventions. New opportunities for 
optimising intakes in pregnancy could also be opened up, by translating relevant findings 
into diet-based interventions.  
How in utero epigenetic marks are first established and then modulated by 
subsequent exposures throughout the life-course is also key for the understanding of 
foetal programming and potentially for therapeutic research (247). The DOHaD 
hypothesis is now generally accepted (248), and has led to public awareness of the 
importance of the prenatal period as a critical window in a life-course approach to health, 
exemplified by the ‘1000 days initiative’ (http://www.thousanddays.org). Decision-
makers do now recognise the importance of nutrition during pregnancy and the need for a 
better understanding, to define the specific relevant pathways and help identify useful 
pregnancy strategies for optimal child outcomes that can be scaled up and translated into 
public health policies.  
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In parallel, the growing evidence of the role of DNA methylation in disease 
development, and particularly cancer (216), renders this a topic of global importance. This 
is reflected by enhanced research opportunities in this field. Funding bodies all over the 
world have been launching epigenetic funding opportunities (e.g. US National Institutes of 
Health, Canadian Epigenetics, Environment and Health Research Consortium, etc.), and in 
September 2011,the health-research division of the European Commission launched the 
BLUEPRINT project, its largest-ever project with a €30-million investment human 
epigenome research (249). Given that the epigenome seems particularly sensitive during 
early development, research at this stage is critical and could contribute to effective early 
disease prevention. 
 
6.4. CONCLUSION 
This thesis supports that infant DNA methylation at MEs is sensitive to the effect of 
season of conception in rural Gambia. It also suggests that this effect is associated with 
maternal nutritional status of one-carbon metabolites. However, this association cannot 
easily be attributed to specific nutrients / biomarkers, and further research is required. 
Given the complexities highlighted, this study reflects a good first attempt at investigating 
seasonality of methyl-donors in this population and their role in DNA methylation and, as 
indicated, it provides a departure point for future work. Since this research field is of 
potential importance for health throughout the life-course, further investigation into the 
impact of environmental exposures and timing of their maximal effect is necessary, both in 
The Gambia and elsewhere, for the benefit of future generations.  
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B) Taring method (indicator group)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel A: Staple (rice)
 
Panel B: Sauce (vegetal oil stew)
 
Panel C: Vegetables and/or fish
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Medical Research Council Laboratories 
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alterations in their offspring? 
(SCC 1151) 
 
Subject Information Sheet (Main study participants) 
Version number 02 20th  April, 2009 
(If necessary, to be read to participants in their own language) 
 
What is the purpose of this study? 
 
The diet of many women in West Kiang is often poor. This sometimes leads to problems of 
poor nutritional status during pregnancy, and may also affect the health of their babies 
when they are adult. This is because the mother’s nutrition during the first months of 
pregnancy is very important for the development of her infant. Since the diet in West Kiang 
is not the same during the different seasons, we would like to look in more detail at 
whether the differences in the intake of some specific substances such as vitamins, reflects 
on the mothers level of nutrition and then leads to any differences in the babies. We would 
like to invite you to participate.  
 
Before you decide to participate it is important for you to understand why the research is 
being done and what it will involve. Please take time to listen to this carefully and discuss it 
with others if you wish. Please ask if there is anything which is unclear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
What does participation in the study mean for you? 
 
We are trying to find out whether the diet during the first stages pregnancy is rich in 
certain substances such as vitamins. We also want to find out if this leads to internal 
differences in the babies. To do this, we would like to enrol you in this study and if you 
become pregnant, we would like to conduct a series of tests on you and then on your infant 
when he/she is born. 
 
  
 253 
The following will be required if you agree to take part: 
Once you have consented, you will be asked a short questionnaire on the date of your last 
period and you will be visited every month by a member of the project team with the same 
short questionnaire. When you report a missing period, we would like to collect a small 
blood sample from one of your veins so that we can measure the amount of certain 
nutrients in your blood. The amount we will collect is very small (10mls in total, equivalent 
to two teaspoons). When you report two missing periods, we will ask you to provide a 
small urine sample, which we will used to test for pregnancy. You will then be visited by 
the midwife to confirm the result of this test and, if you are pregnant, you will be enrolled 
in the study. If you are not pregnant, you will continue to be visited by the field worker. If 
you become pregnant during the time of the study, we will collect samples at two further 
timepoints: 
 
1. When you are in labour, an MRC field assistant living in or close to your village will be 
informed. Following delivery, and if we have your permission, he/she will collect your 
placenta from the midwife/traditional birth attendant and will use this to take samples of 
cord blood and placental material.  
 
2. When your infant is 12 weeks of age, we will invite you and your infant to Keneba for 
some further measurements on your infant. We will take a small blood sample from one of 
their veins. The amount we will collect is very small (3mls in total, equivalent to 1 
teaspoon). We will also need to take a buccal swab (gently rubbing the inner cheek with 
cotton), which is painless for your baby. We will collect a sample of his/her faeces and we 
will ask you to pluck some hairs (30) from his/her head. All these samples will be equally 
used to extract DNA. 
 
All samples collected from you and your baby will be processed in the laboratory in Keneba 
for storage. Your blood sample will be used to measure nutrient levels and to extract DNA 
so that we can look for genes such as those that are related to the possible future diseases. 
The samples collected from you baby will be used to measure whether the genes your baby 
is born with are affected by what you eat and what your nutritional status is. 
 
All the samples will be transferred and analysed in laboratories in the UK, US and Canada 
for. This is because we do not have the equipment in The Gambia for measuring the factors 
we are interested in. All of the information obtained from abroad will then be sent back to 
the investigators in The Gambia. 
 
All information which is collected during the course of this study will be kept strictly 
confidential and you will only be identified by an ID number.  
 254 
 
It is up to you to decide whether or not to take part. If you do decide to take part you will 
be asked to sign a consent form. If you decide to take part you are still free to withdraw at 
any time and without giving a reason. If you have any questions, please ask. We hope that 
you will agree to participate. 
 
Thank you very much. 
 
Principal investigator:   
Paula Dominguez Salas & Dr Branwen Hennig on behalf of the Epigenesis study team 
Mobile number for enquiries: 9391334 
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CONSENT FORM FOR WOMEN OF MAIN STUDY 
Medical Research Council Laboratories 
Epigenesis in humans: Can maternal methyl-donor-deficient diets induce epigenetic 
alterations in their offspring? 
 
(SCC 1151) 
Consent Form (Main study participants): 
Version number 02 20th April, 2009 
 
The information sheet has been read to me and I understand it / I have read and 
understood the information sheet. 
I understand what participation in the study means for me and my infant. 
I understand that the information regarding me that is collected in the course of this study 
will remain confidential. 
I understand that laboratory tests will be done on the blood and placental samples from me 
as well as on the blood, hair, faeces and buccal sample taken of my baby.  
I understand that the samples will be sent to the UK, US or Canada for laboratory testing. I 
also understand that part of the blood samples collected will be stored for future genetic 
analyses conducted by the investigators running this study.  
I understand that if either myself or my infant gets sick during the study period, I can go to 
the clinic where study staff are providing care, and that we will be examined and treated 
for free. 
I understand that I am free to take part in the study or refuse, and that I can withdraw 
either myself of my infant from the study at any time, and without giving any reason.  
Deciding not to take part or to withdraw from the study will not affect the care that I or any 
of my family is normally entitled to. 
I have had a chance to ask questions and have them answered. 
 
Signature or thumb print of volunteer:    _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 
This form has been read by / I have read the above to _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
         (write name of volunteer) 
in a language that she understands. I believe that she has understood what I explained and 
that she has freely agreed to take part in the study. 
 
Signature of field worker: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
Name of field worker:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Date:    |___|___| / |___|___| / |___|___|___|___|  
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APPENDIX V: Information sheet and consent form for indicator group 
INFORMATION SHEET FOR WOMEN OF INDICATOR GROUP 
 
Medical Research Council Laboratories 
 
Epigenesis in humans: Can maternal methyl-donor-deficient diets induce epigenetic 
alterations in their offspring? 
(SCC 1151) 
 
Subject Information Sheet (Indicator group participants) 
Version number 02 20th   April, 2009 
(If necessary, to be read to participants in their own language) 
 
What is the purpose of this study? 
 
The diet of many women in West Kiang is often poor. This sometimes leads to problems 
affecting health. Since the diet in West Kiang is not the same during the different seasons, 
we would like to look in more detail at whether the differences in the intake of some 
specific substances such as vitamins, reflects on the women’s level of nutrition. We would 
like to invite you to participate.  
 
Before you decide to participate it is important for you to understand why the research is 
being done and what it will involve. Please take time to listen to this carefully and discuss it 
with others if you wish. Please ask if there is anything which is unclear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
What does participation in the study mean for you? 
 
We are trying to find out whether the nutritional status of women in West Kiang is 
adequate in certain substances such as vitamins, along the year. To do this, we would like 
to enrol you in this study to conduct a series of tests and measures on you. 
 
The following will be required if you agree to take part: 
 
Once enrolled, you will be visited at your household once a month by a fieldworker, so you 
will be visited a total of 12 timed during the year. The field worker will observe the meal 
preparation in the household, and will measure your food intake. This will happen on two 
days (one after the other). It is important that the fieldworker records everything that you 
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eat and drink during each 24 hours, and so they will need to spend the whole day with you 
from when you wake up in the morning until when you go to bed. 
 
It is also important that you do not change your behaviour and you eat the same that you 
would eat if the field worker was not there, because what we need to know is what your 
normal diet is. We may ask you to give us a small amount of specific foods (about a 
handful) if we would like to test the amount of vitamins and other substances in this food 
or to give us information about the origin of the ingredients you used. 
 
On the third day, we would like to collect a blood sample from one of your veins so that we 
can measure the amount of certain nutrients in your blood. The amount we will collect is 
very small (10mls in total, equivalent to two teaspoons).  
 
You will also be asked a short questionnaire on the date of your last period. If you become 
pregnant during the time of the study, you will have to withdraw the study group. If you 
wish so, you can then join the group of pregnant women, whose details will be explained to 
you accordingly. 
 
The samples collected from you will be transported back to the laboratory in Keneba for 
storage. Your blood sample will be used to measure nutrient levels and to extract DNA so 
that we can look for genes such as those that are related to the possible future diseases. All 
the samples will be transferred and analysed in laboratories in the UK, US and Canada for. 
This is because we do not have the equipment in The Gambia for measuring the factors we 
are interested in. All of the information obtained from abroad will then be sent back to the 
investigators in The Gambia. 
 
All information which is collected during the course of this study will be kept strictly 
confidential and you will only be identified by an ID number.  
 
It is up to you to decide whether or not to take part. If you do decide to take part you will 
be asked to sign a consent form. If you decide to take part you are still free to withdraw at 
any time and without giving a reason. If you have any questions, please ask. We hope that 
you will agree to participate. 
 
Thank you very much. 
 
Principal investigator:   
Paula Dominguez Salas & Dr Branwen Hennig on behalf of the Epigenesis study team 
Mobile number for enquiries: 9391334 
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CONSENT FORM FOR WOMEN OF INDICATOR GROUP 
Medical Research Council Laboratories 
 
Epigenesis in humans: Can maternal methyl-donor-deficient diets induce epigenetic 
alterations in their offspring? 
 
(SCC 1151) 
Consent Form (Indicator group participants): 
Version number 02 20th April, 2009 
The information sheet has been read to me and I understand it / I have read and 
understood the information sheet. I understand what participation in the study means for 
me. 
 
I understand that the information regarding me that is collected in the course of this study 
will remain confidential. 
 
I understand that during the time of the study, I will be visited every month to repeat the 
same procedure (12 times in total).  
 
I understand that I will receive fieldworkers at home who will observe the meal 
preparation and will measure my daily intake. I understand that he/she needs to record 
everything that I eat during those 2 days and so they will spend most of the day with me. 
 
I understand that laboratory tests will be done on the blood collected from. I understand 
that the samples will be sent to the UK, US or Canada for laboratory testing. I also 
understand that part of the blood samples collected will be stored for future genetic 
analyses conducted by the investigators running this study.  
 
I understand that if I get sick during the study period, I can go to the clinic where study 
staff are providing care, and that we will be examined and treated for free. I understand 
that if I become pregnant, I will withdraw the study. 
 
I understand that I am free to take part in the study or refuse, and that I can withdraw 
myself from the study at any time, and without giving any reason. Deciding not to take part 
or to withdraw from the study will not affect the care that I or any of my family is normally 
entitled to. 
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I have had a chance to ask questions and have them answered. 
 
Signature or thumb print of volunteer:    _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 
This form has been read by / I have read the above to _ _ _ _ _ _ _ _ _ _ _ _ _ _  
  (write name of volunteer) 
in a language that she understands. I believe that she has understood what I 
explained and that she has freely agreed to take part in the study. 
 
Signature of field worker: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
Name of field worker:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
Date:    |___|___| / |___|___| / |___|___|___|___| 
 
 APPENDIX VI: Recipe collection form 
FORM IG03 RECIPE  COMPOSITION CALCULATION  
Village __________________  Subject’s name: _______________________________ WK ID: |___|___|___|___|___|___|___|___|___|    Name of fieldworker ____________________________ 
MDEG ID: |___|___|___|    Today’s date: |___|___|/|___|___|/|___|___| Sheet number/Total number (day)  |___|/ |___| Recipe code: |___|-|___|___|-|___|___|___|___| 
NAME OF THE RECIPE: ____________________________ 
Weight of empty cooking saucepan  (gr)   |___|___|___|___|  (@)     
Name of ingredients 
added 
Detailed description 
(Please note here if you have collected the labels for any of the 
ingredient) 
Origin (*) Weight (with or 
without container) 
Weight of the 
container if used 
Final weight 
of ingredient 
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
Water added 1st addition (gr) 
 
2nd addition (gr) 3rd addition 
(gr) 
Total water:   
            Total weight of all ingredients (#)________  
(*) (1)Home-garden, (2) bush, (3) shop, (4) rural market, (5) coast, (6) other –specify: |___|  _______________________________________ 
 Detailed instructions for the cooking 
Cooking time-> Start:    |___|___|:|___|___|   Finish:   |___|___|:|___|___| 
Is saucepan cover? Yes/No 
Is water boiling before introducing ingredients? Yes/No 
Descriptive details of the cooking method 
 
 
 
 
 
Finished recipe, ready to be eaten: 
Total weight 
(full saucepan) 
(A) 
Empty saucepan 
weight 
(@) 
Final recipe 
weight  
(A)-(@)=(B) 
 
|___|___|___|___| 
 
|___|___|___|___| 
 
|___|___|___|___| 
 
How is this recipe consumed? Alone/With (staple/additional ingredients) 
______________________________________ 
 
Water losses (gr):  
Total weight of all ingredients (#)|___|___|___|___| - Final recipe weight (B) |___|___|___|___| = 
|___|___|___|___| 
 
-When will the food be eaten?  Date |___|___|/|___|___|/|___|___|   
     |___|___|/|___|___|/|___|___|  
Meal: Breakfast/Lunch/Dinner 
-Do you cook this recipe differently at different times of the year? (Explain what 
and how much) 
 
 
 
-Number of people who will eat from this recipe: Children <5y |___|___| 
 Adults  |___|___|  
-Receiving remittances? Yes/No  
-Cooking place: closed kitchen/ ventilated kitchen/ open air  
-Fuel type: wood/ dung/straw/ charcoal/ kerosene  
Other comments.  
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GUIDANCE FOR USE 
 
Subject will be visited the previous day to be reminded of our visit and to agree the arrival 
time of the observer.  
Please request that she does not start cooking or eating anything before the observer 
arrives.  
Observer will discuss with the subject whether her usual breakfast is re-heated food, or 
some other food (e.g. Bread with butter or porridge). If it is re-heated food prepared the 
previous day, the observer will visit her on the previous afternoon to attend the cooking of 
that recipe which will be used the following day. 
If any of the foods (recipes or snacks) used is a processed product with a label on it (e.g. 
Chocolate bar, mayonnaise, sardines, etc.), please collect it and keep with the records of 
the subjects in her allocated folder.  
 
RECIPES  
1. Observer’s name:  Village assistant or Field worker and Supervisor if present  
2. WK ID: West Kiang Number: provided in the list of subjects of every village, in the column 
on the left of the subjects name  
3. MDEG ID: Study identification number |___|___|___| 
 1st digit:  Village of origin (1= Jiffarong; 2= Janneh Kunda; 3= Keneba) 
 2nd & 3rd digit: Subject number (01-10 + additional recruitments) 
4. Recipe code: The code of each recipe should be linked to the woman who prepared it   
|___|-|___|___|-|___|___|___|___| 
1st digit: Village of origin 
  1= Jiffarong; 2= Janneh Kunda; 3= Keneba 
 2nd – 4th digits: Subject number (01-10 + additional recruitments) 
 5th & 7th digit: Recipe number (0001 to 9999) 
5. Sheet no./Total no. sheets today |___|/ |___| 
6. Before you weigh any food, make sure it is as ready for use (e.g. Vegetables have 
been peeled, fish has been skinned, unedible parts have been removed, etc.) 
7. Description of foods: please, give as many details as possible (e.g. Type of fish/meat, 
with or without skin, etc.).  
8. If the food is weighed directly on the scale, the cross the box for weight of container 
and write the same amount in the final weight column. If the food is weighed with a 
container, then weigh the container once it has been finished and subtract the 
weight of the container for the last column.  
9. Use only the last 3 boxes of the final box for fried recipes (e.g. Pancakes, fishcakes, 
etc. )  
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APPENDIX VII: Dietary intake form 
FORM IG04 24-H WEIGHED RECORDS:         Village ________________ 
Subject’s name: __________________________________ MDEG ID: |___|___|___| 
Observer name: _____________________ WK ID: |___|___|___|___|___|___|___|___|___|     
Today’s date: |___|___|/|___|___|/|___|___| Sheet no./Total no. sheets today  |___|/ |___| 
 
Before eating: Re-heated?   Yes/No  Recipe code: |___|-|___|___|-|___|___|___|___| 
Time weighed:     |___|___|:|___|___| 
Weight of container (gr)     |___|___|___|___| 
Container +  1st food (_________________________________) |___|___|___|___| 
Container + 1st + 2nd food (______________________________) |___|___|___|___| 
Container + 1st + 2nd + 3rd food (__________________________) |___|___|___|___| 
Container + 1st + 2nd + 3rd  +4th food (______________________) |___|___|___|___| 
Container + 1st + 2nd + 3rd  +4th + 5th food (__________________) |___|___|___|___| 
Comments on foods:  
 
After eating:  Time weighed:   |___|___|:|___|___| 
Weight of container+ food but without meat/fish bones:|___|___|___|___| 
Specific left overs*:   Meat/Fish bones weight |___|___|___|___| 
Food:_________________________________ |___|___|___|___| 
Food:_________________________________ |___|___|___|___| 
Food:_________________________________ |___|___|___|___| 
Second attempt:   Time weighed:     |___|___|:|___|___| 
Weight of container+ food but without meat/fish bones:  |___|___|___|___| 
Specific left overs*:   Meat/Fish bones weight  |___|___|___|___| 
Food:_________________________________ |___|___|___|___| 
Food:_________________________________ |___|___|___|___| 
* Only if food items can be easily separated 
Snacks 
Snack 1 (Name/Weight): _____________________________________________|___|___|___|___| 
Snack 2(Name/Weight): _____________________________________________|___|___|___|___| 
Snack 3 (Name/Weight): _____________________________________________|___|___|___|___| 
 
Other comments: (subject sick, fasting, etc.) 
  
Meat/Fish flesh: 
|___|___|___|___| 
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DIETARY INTAKE 
1. Observer’s name:  Village assistant or Field worker and Supervisor if present  
2. WK ID: West Kiang Number: provided in the list of subjects of every village, in the 
column on the left of the subjects name  
3. MDEG ID: Study identification number |___|___|___| 
 1st digit:  Village of origin 
  A= Jiffarong; B= Janneh Kunda; C= Keneba 
2nd & 3rd digit: Subject number (01-10 + additional recruitments) 
4. Sheet no./Total no. sheets today |___|/ |___| 
1st digit: Sheet number –to be filled 1-3 on every visit 
2nd digit: Total number of sheets- to be filled in at the end of the day.  
5. Recipe code: |___|-|___|___|___|___|-|___|___| 
Copy the code from the recipe previously recorded.  
If no recipe was previously recorded, enter 0 in every box (it may be because the 
meal was prepared by someone else, or is re-heated from a previous day, or meal 
is made of bread with butter, etc.)  
It also should be noted to the supervisor when he/she collects the forms. 
6. Food weight:  
Container + 1st + 2nd + 3rd food (__________________________________________________) 
|___|___|___|___| 
Please, ask the subject to always add the meat/fish at the end 
On each line add in brackets the name of the new food added. If more space is 
needed, draw a star and continue in the “Comments on foods” section 
Fill the boxes with the weight in grams. Use the last boxes for it and fill in the 
empty ones with zero.  
Flesh only box should be filled in for the case of meat or fish and only once the left 
overs have been weighed. Then the weight of the bones should be subtracted 
from the total weight. If it is not applicable, leave empty.  
7.  “Specific left overs” section has to be filled in only for those particular ingredients 
which can be separated (e.g. Remaining fish, remaining bitter tomato) and zero 
(0000) should be written if nothing is left (e.g. Sauce finished) 
8. Snacks: Subjects have to be followed the whole day to make sure every snack eaten 
in between meals is weighed and recorded. In this case, if the snack needs a 
container to be weighed, the scale should be put to zero with the empty container 
(tare system), before adding the snack.  
9. Comments section: include here any information which can be useful to understand 
the data (e.g. Whether the women is fasting or sick, whether some adaptation had to 
be made to the procedure in order to cover for an unusual situation, etc.  
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NOTE: When writing the names of the foods, try to give as many details as possible (e.g. 
Name of fish, whether grounds are raw or roasted 
If for any reason the snack weight coudln’t be recorded because the orbserver was not 
present, then ask the subject and record in the form an estimation of the amoung (e.g. Big 
mango, handful of groundnuts, half tapalapa, etc.)  
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APPENDIX VIII: Menses questionnaire (blood collection after 1st missed 
menses) 
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APPENDIX IX: Final version of the Indicator group paper accepted for publication 
at AJCN  
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Appendix X: Food composition tables 
A. One-carbon metabolites and cofactors of common Gambian foods assessed 
(composition per 100g) 
Ingredient 
 
N 
 
Folate 
(µg)1 
Methionine  
(g)2 
B12  
(µg)1 
B2  
(mg)2 
B6  
(mg)2 
Choline  
(mg)3 
Betaine 
(mg)3 
Atayah (green 
tea) 3 <5 <0.02 <0.20 <0.02 0.04 18.23 6.94 
Aubergine 5 <5.0 0.05 <0.20 <0.01 <0.01 8.18 0.13 
Baobab seeds 5 35 0.04 0.44 <0.05 0.04 13.36 0.89 
Beans 5 82 0.36 0.39 0.03 0.18 155.80 3.83 
Biscuits 5 <5.0 0.11 <0.20 <0.01 0.08 13.05 44.20 
Bitter Tomato 5 11 0.03 0.24 0.02 0.05 18.03 0.04 
Black pepper 4 <5.0 0.16 1.6 0.14 0.34 46.67 1.29 
Bread 5 10 0.14 0.78 <0.01 0.03 12.89 44.32 
Butternut 
squash 5 <5.0 <0.02 <0.20 <0.05 0.01 4.10 0.02 
Cabbage 4 32 0.03 1.1 0.01 0.1 14.09 0.31 
Cassava 5 7.2 0.03 5.9 <0.01 0.04 6.33 0.19 
Chilli pepper, 
big 7 12 0.06 <0.20 0.14 0.4 16.63 3.23 
Chilli pepper, 
dried 4 8.4 0.19 0.48 0.15 1.5 101.38 7.02 
Coffee 5 42 0.12 1.9 <0.01 22.2 72.27 13.80 
Condiments 5 <5.0 0.03 <0.20 <0.01 1.55 8.57 2.66 
Egg, dry season 5 <5.0 0.3 1.2 0.22 0.03 231.57 0.83 
Egg, wet season 5 13 0.48 2.9 0.36 0.05 214.30 1.06 
Fish, challo, 
dried 4 <5.0 0.58 <0.20 0.15 0.14 50.36 27.35 
Fish, challo, 
fresh 6 23 0.5 9.8 0.03 0.09 36.10 4.19 
Fish, dried 6 9.7 0.54 21 0.08 0.11 43.84 22.93 
Fish, jeja, 
lambasiso, 
tutuno and 
kotore, fresh 5 12 0.47 7.6 0.04 0.31 38.81 334.49 
Fish, joto and 
furo, fresh 6 15 0.55 4.3 0.15 0.07 39.23 3.08 
Fish, kujalo, 
kunkolongo 
and salango, 
fresh 5 15 0.65 3.4 0.07 0.07 48.95 43.04 
Fish, moroko, 
kong, kungo 
and chalmoroo, 
fresh 5 23 0.56 17 0.07 0.17 43.19 22.26 
Fish, pie 3 <5.0 0.13 1.4 <0.05 0.05 15.51 30.15 
 280 
Ingredient 
 
N 
 
Folate 
(µg)1 
Methionine  
(g)2 
B12  
(µg)1 
B2  
(mg)2 
B6  
(mg)2 
Choline  
(mg)3 
Betaine 
(mg)3 
Fish, smoked 6 7.8 0.91 13 0.1 0.36 57.27 16.39 
Fish, 
tambanjango, 
fresh 6 23 0.45 4.8 0.13 0.06 39.30 4.89 
Garlic 3 6.8 0.06 0.37 <0.01 0.57 22.59 11.70 
Groundnut, 
paste 6 21 0.32 0.24 <0.01 0.35 122.79 3.12 
Groundnut, 
roasted 5 18 0.28 <0.20 <0.01 0.16 99.27 1.74 
Groundnuts, 
cooked 7 11 0.25 <0.20 0.02 0.07 104.19 1.40 
Groundnuts, 
raw, dry season 5 8.4 0.25 <0.20 <0.01 0.07 106.90 1.26 
Groundnuts, 
raw, rainy 
season 5 14 0.28 <0.20 <0.01 0.08 119.05 1.89 
Juice powder 3 <25 <0.02 1.5 <0.05 0.06 0.17 0.11 
Kola nut 4 11 0.03 <0.20 <0.01 0.02 20.77 396.33 
Leaves, baobab, 
dry (naa) 8 55 0.2 4.6 0.33 0.75 29.71 14.95 
Leaves, 
cassava, fresh 5 35 0.17 0.58 0.22 0.17 32.54 1.75 
Leaves, jambo 
nduroo, dried 3 26 0.51 1.7 0.73 1.41 157.10 6.93 
Leaves, jambo 
nduroo, fresh 4 23 0.21 0.99 0.23 0.6 28.79 2.71 
Leaves, kereng 
kereng, fresh 4 23 0.17 1.3 0.17 0.36 25.82 1.28 
Leaves, kucha, 
dried 3 37 0.29 31 0.7 1.1 65.23 479.77 
Leaves, kucha, 
fresh 8 8.1 0.09 0.3 0.06 0.2 13.81 45.87 
Leaves, 
morongo, fresh 6 32 0.19 0.58 0.28 0.19 36.80 128.10 
Leaves, onion, 
fresh 4 38 0.05 0.54 0.06 0.09 10.65 0.91 
Leaves, sweet 
potato, fresh 5 26 0.17 1.3 0.15 0.13 20.34 16.95 
Locus beans 4 210 0.15 3.9 0.19 1.6 35.41 2.32 
Macaroni 5 <5.0 0.13 <0.20 <0.01 0.05 7.16 42.66 
Maize, flour 5 13 0.13 <0.20 0.13 0.11 56.07 3.60 
Maize, roast 5 27 0.15 <0.20 0.04 0.16 29.27 1.20 
Maize, steamed 5 6.2 0.14 <0.20 <0.05 0.09 21.33 0.87 
Mango, bush, 
dried 3 14 0.1 <0.20 0.07 0.06 25.00 18.78 
Mango, fresh 5 14 0.03 <0.20 <0.05 0.06 7.87 0.16 
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Ingredient 
 
N 
 
Folate 
(µg)1 
Methionine  
(g)2 
B12  
(µg)1 
B2  
(mg)2 
B6  
(mg)2 
Choline  
(mg)3 
Betaine 
(mg)3 
Margarine 6 <5.0 <0.02 <0.20 <0.05 <0.01 2.30 0.00 
Mayonnaise 5 <5.0 0.03 <0.20 0.06 <0.01 2.91 0.00 
Meat beef, wet 
season 5 <5.0 0.33 1.5 0.04 0.12 44.34 7.86 
Meat chicken 3 13 0.37 7 0.06 0.1 67.41 3.46 
Meat, beef, dry 
season 3 21 0.4 34 0.14 0.12 88.36 6.42 
Meat, goat 3 24 0.73 12 0.05 0.1 84.40 14.12 
Milk, 
condensed 5 <5.0 0.15 0.48 0.35 0.05 44.80 1.82 
Milk, fresh, dry 
season 5 7.2 0.1 0.6 0.22 0.06 14.12 1.52 
Milk, fresh, wet 
season 2 11 0.19 0.39 0.51 0.07 31.47 2.63 
Milk, powder 4 18 0.55 2.4 0.79 0.55 165.42 6.20 
Milk, sour 5 <5.0 0.13 0.39 0.31 0.06 19.57 2.63 
Millet, dry 
season 5 32 0.16 1.2 0.19 0.17 9.12 5.70 
Millet, flour 5 24 0.13 0.47 0.06 0.16 20.06 3.29 
Millet, porridge 5 15 0.1 0.9 0.04 0.07 10.89 1.84 
Millet, wet 
season 5 13 0.17 0.49 0.05 0.17 14.22 2.58 
Mustard 4 <5.0 0.12 <0.20 0.01 0.02 68.65 0.66 
Nyet 1 13 0.84 12 0.17 0.27 37.67 5652.30 
Okra 4 19 0.04 0.22 <0.01 0.02 11.11 4.90 
Okra, powder 3 12 0.08 0.91 0.07 0.9 26.48 28.08 
Onion 8 7.3 0.02 <0.20 <0.01 0.07 6.40 0.39 
Palm oil 4 <5.0 <0.02 <0.20 <0.01 <0.01 0.62 0.78 
Pancake 3 <5.0 0.1 0.38 <0.01 0.05 22.52 56.04 
Papaya 5 8 0.02 <0.20 <0.05 0.12 6.76 0.12 
Potato 4 12 0.06 0.5 <0.01 0.22 131.44 0.61 
Pumpkin 5 6.6 0.02 0.41 <0.01 0.06 4.40 0.09 
Rice, 
dempetengo 
(parched rice 
flakes) 3 13 0.18 0.97 <0.01 0.08 10.83 0.59 
Rice, imported 5 10 0.21 0.89 <0.01 0.05 4.11 0.84 
Rice, local 6 7.8 0.15 0.95 <0.01 0.04 3.09 0.14 
Saf saf 
(condiment) 2 <5.0 <0.02 <0.20 <0.01 <0.01 0.00 0.00 
Salt, lake 5 5.6 <0.02 <0.20 <0.01 <0.01 0.00 0.00 
Sardines, 
canned 5 48 0.59 13 0.1 0.32 54.38 5.30 
Seafood, crab, 
fresh 3 27 0.22 5.1 0.09 0.07 40.52 247.51 
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Ingredient 
 
N 
 
Folate 
(µg)1 
Methionine  
(g)2 
B12  
(µg)1 
B2  
(mg)2 
B6  
(mg)2 
Choline  
(mg)3 
Betaine 
(mg)3 
Seafood, oyster, 
fresh 3 13 0.33 32 0.03 <0.01 42.81 260.11 
Seafood, 
shrimps, fresh 4 54 0.7 7.4 0.02 0.27 79.85 264.03 
Seafood, 
shrimp, dry 3 9.9 0.71 1.4 <0.01 0.42 117.00 867.08 
Sugar 4 <5.0 <0.02 0.24 <0.01 <0.01 0.00 0.58 
Sweet Potato 5 7.3 0.04 0.93 <0.01 0.05 11.31 14.58 
Tamarind 4 <5.0 0.04 <0.20 <0.01 0.11 7.51 0.46 
Tea 5 <5.0 <0.02 <0.20 <0.02 0.02 34.30 4.44 
Tomato 5 12 <0.02 <0.20 <0.01 0.16 11.37 0.16 
Tomato paste 4 8.8 0.05 0.52 0.04 <0.60 44.82 0.64 
Tomborungo 
(bush fruit) 5 <130 0.05 <0.20 <0.05 0.16 19.61 1.29 
Vegetable oil 3 <5.0 <0.02 <0.20 <0.01 <0.01 0.00 0.00 
Vinegar 4 <5 <0.02 <0.20 <0.01 <0.01 0.00 0.00 
Wheat, flour 5 9.8 0.18 0.49 <0.01 0.04 11.71 81.22 
Wonjo 
(hibiscus 
flower 
infusion) 3 <5 <0.02 <0.20 <0.02 <0.01 68.01 277.16 
(1) Surface Plasmon Resonance Inhibition Assay  
(2) HPLC 
(3) LC/ESI IDMS 
Note: Vitamin B12 assay is mainly designed to measure cyanocobalamin in vitamin B12-rich and 
fortified foods. Since vegetables are not main target matrices for the assay, it is suspected that 
vegetable products can give result measurable concentrations of vitamin B12 although not 
containing any vitamin. This is thought to be a matrix interference effect with the binding protein-
surface interaction which usually occurs in samples which are blank for vitamin B12.  Additionally, 
the extraction procedures may not be adequate for some of the vegetable samples tested and 
therefore, for the dietary intake analysis, foods of vegetal origin have been given value of 0 µg.  
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B. Total choline and choline compounds of common Gambian foods assessed 
(composition per 100g) 
Ingredient N 
Total 
cholinea 
Free 
Choline GPC Pcho  PTC SM  
Atayah (green tea) 3 18.23 30.92 5.82 2.64 38.30 1.34 
Aubergine 5 8.18 5.80 0.54 0.44 1.40 0 
Baobab seeds 5 13.36 3.72 1.71 1.85 6.07 0 
Beans 5 155.80 85.38 10.29 2.03 58.09 0 
Biscuits 5 13.05 5.59 4.83 0 2.64 0 
Bitter Tomato 5 18.03 12.73 1.01 0.36 3.93 0 
Black pepper 4 46.67 19.02 1.58 0 1.98 0 
Bread 5 12.89 6.67 5.09 0 1.12 0 
Butternut squash 5 4.10 1.03 0.07 0.45 2.55 0 
Cabbage 4 14.09 4.22 5.08 0.47 4.32 0 
Cassava 5 6.33 1.42 0.05 1.20 3.66 0 
Chilli pepper, big 7 16.63 14.55 0.86 0.34 0.88 0 
Chilli pepper, dried 4 101.38 89.81 6.30 1.55 3.72 0 
Coffee 5 72.27 76.75 3.34 0 0 0 
Condiments 5 8.57 7.48 0.88 0 0.21 0 
Egg, dry season 5 231.57 0.82 82.59 0.30 69.36 0 
Egg, wet season 5 214.30 1.35 1.23 1.35 210.26 0.11 
Fish, challo, dried 4 50.36 38.39 0.77 2.92 4.49 3.79 
Fish, challo, fresh 6 36.10 5.20 5.56 2.31 20.03 3.00 
Fish, dried 6 43.84 26.08 5.30 3.66 5.06 3.73 
Fish, jeja, 
lambasiso, tutuno 
and kotore, fresh 
5 
38.81 4.58 4.46 1.30 19.24 7.75 
Fish, joto and furo, 
fresh 
6 
39.23 2.58 3.32 2.25 27.19 3.89 
Fish, kujalo, 
kunkolongo and 
salango, fresh 
5 
48.95 5.05 2.39 2.10 34.57 4.30 
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Ingredient N 
Total 
cholinea 
Free 
Choline GPC Pcho  PTC SM  
Fish, moroko, kong, 
kungo and 
chalmoroo, fresh 
5 
43.19 7.37 4.37 2.00 25.20 4.24 
Fish, pie 3 15.51 10.09 2.50 1.43 1.49 0 
Fish, smoked 6 57.27 9.67 5.89 3.15 34.79 3.77 
Fish, tambanjango, 
fresh 
6 
39.30 1.74 7.64 1.28 24.94 3.69 
Garlic 3 22.59 25.61 17.81 0.77 2.47 0 
Groundnut, paste 6 122.79 70.26 2.88 3.10 46.55 0 
Groundnut, roasted 5 99.27 54.07 2.03 4.40 38.76 0 
Groundnuts, 
cooked 
7 
104.19 57.71 3.54 7.23 35.70 0 
Groundnuts, raw, 
dry season 
5 
106.90 96.85 14.20 4.08 3.91 0 
Groundnuts, raw, 
rainy season 
5 
119.05 72.22 26.01 4.55 4.10 0 
Juice powder 3 0.17 0.09 0.08 0 0 0 
Kola nut 4 20.77 13.32 1.47 1.79 3.48 0 
Leaves, baobab, dry 
(naa) 
8 
29.71 27.89 1.39 1.09 1.61 0 
Leaves, cassava, 
fresh 
5 
32.54 12.91 0.94 1.82 16.85 0 
Leaves, jambo 
nduroo, dried 
3 
157.10 154.00 1.06 0.64 1.40 0 
Leaves, jambo 
nduroo, fresh 
4 
28.79 17.74 1.21 0.39 9.44 0 
Leaves, kereng 
kereng, fresh 
4 
25.82 1.90 0.40 0.96 22.54 0 
Leaves, kucha, 
dried 
3 
65.23 53.37 21.31 102.71 6.48 0 
Leaves, kucha, fresh 8 13.81 1.68 5.72 1.39 4.24 0 
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Ingredient N 
Total 
cholinea 
Free 
Choline GPC Pcho  PTC SM  
Leaves, morongo, 
fresh 
6 
36.80 14.85 0.64 1.17 16.42 0 
Leaves, onion, fresh 4 10.65 5.07 0.48 0.88 4.22 0 
Leaves, sweet 
potato, fresh 
5 
20.34 3.17 2.23 2.14 12.79 0 
Locus beans 4 35.41 7.84 2.12 0.29 24.60 0.56 
Macaroni 5 7.16 5.20 1.39 0 0.5 0 
Maize, flour 5 56.07 55.21 0.26 0.50 0.09 0 
Maize, roast 5 29.27 6.97 0.42 7.52 14.35 0 
Maize, steamed 5 21.33 3.10 0.43 6.04 11.75 0 
Mango, bush, dried 3 25.00 22.11 0.92 1.10 0.86 0 
Mango, fresh 5 7.87 7.25 0.47 0 0.15 0 
Margarine 6 2.30 0.09 1.95 0 0.26 0 
Mayonnaise 5 2.91 0 0.96 0 1.95 0 
Meat beef, wet 
season 
5 
44.34 0.97 10.33 0.47 28.25 4.05 
Meat chicken 3 67.41 2.47 2.89 1.12 53.81 7.12 
Meat, beef, dry 
season 
3 
88.36 4.58 19.00 1.22 56.97 6.58 
Meat, goat 3 84.40 4.29 9.30 1.79 57.47 11.53 
Milk, condensed 5 44.80 8.86 25.52 2.10 4.63 3.69 
Milk, fresh, dry 
season 
5 
14.12 8.12 3.08 0 0.98 1.93 
Milk, fresh, wet 
season 
2 
31.47 13.87 11.06 2.79 1.29 2.45 
Milk, powder 4 165.42 27.12 108.54 9.62 12.11 8.02 
Milk, sour 5 19.57 9.08 7.04 0 0.54 2.90 
Millet, dry season 5 9.12 7.98 0.39 0.36 0.39 0 
Millet, flour 5 20.06 17.81 2.14 0 0.10 0 
Millet, porridge 5 10.89 10.32 0.29 0 0.28 0 
Millet, wet season 5 14.22 12.37 1.39 0 0.46 0 
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Ingredient N 
Total 
cholinea 
Free 
Choline GPC Pcho  PTC SM  
Mustard 4 68.65 22.05 41.55 0.23 4.81 0 
Nyet 1 37.67 29.32 0.37 6.33 4.43 0 
Okra 4 11.11 1.48 0.81 0.64 8.18 0 
Okra, powder 3 26.48 21.26 2.90 0.59 1.72 0 
Onion 8 6.40 3.79 0.74 0.39 1.49 0 
Palm oil 4 0.62 0.47 0.15 0 0 0 
Pancake 3 22.52 7.65 13.59 0.24 1.03 0 
Papaya 5 6.76 6.05 0.25 0.32 0.15 0 
Potato 4 131.44 124.31 3.40 0.86 2.87 0 
Pumpkin 5 4.40 1.02 0.14 0.26 2.97 0 
Rice, dempetengo 
(parched rice 
flakes) 
3 
10.83 3.62 4.43 0.62 2.158 0 
Rice, imported 5 4.11 2.17 1.71 0 0.23 0 
Rice, local 6 3.09 0.80 1.09 0 1.20 0 
Saf saf (condiment) 2 0.00 0 0 0 0 0 
Salt, lake 5 0.00 0 0 0 0 0 
Sardines, canned 5 54.38 2.48 5.00 1.20 41.31 4.38 
Seafood, crab, fresh 3 40.52 3.67 12.01 1.10 19.64 4.57 
Seafood, oyster, 
fresh 
3 
42.81 1.26 1.98 1.30 18.18 0.34 
Seafood, shrimp, 
dry 
4 
79.85 17.09 25.10 4.15 50.95 13.81 
Seafood, shrimps, 
fresh 
3 
117.00 4.95 2.69 2.46 60.02 9.73 
Sugar 4 0.00 0 0 0 0 0 
Sweet Potato 5 11.31 4.37 0.56 2.58 3.79 0 
Tamarind 4 7.51 3.07 3.33 0.90 0.21 0 
Tea 5 34.30 42.49 2.60 5.72 26.16 1.04 
Tomato 5 11.37 9.114 0.71 0.60 0.95 0 
Tomato paste 4 44.82 37.61 4.96 1.49 0.76 0 
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Ingredient N 
Total 
cholinea 
Free 
Choline GPC Pcho  PTC SM  
Tomborungo (bush 
fruit) 
5 
19.61 10.33 6.13 0.90 2.24 0 
Vegetable oil 3 0.00 0 0 0 0 0 
Vinegar 4 0.00 0 0 0 0 0 
Wheat, flour 5 11.71 7.45 2.30 0 1.96 0 
Wonjo (hibiscus 
flower infusion) 
3 
68.01 22.48 29.05 7.81 0.16 0 
Method: LC/ESI IDMS 
aCalculated as sum of the 5 choline compounds 
Units: mg 
 
  
 288 
APENDIX XI: Food collection forms 
FORM IG02A –FOOD COLLECTION INFORMATION SHEET 
B) Identification of Food: information to be collected 
 
- Sample code number:  |___|___|___|___|___| 
- Common name of food (+alternative names, scientific name): _____________________ 
_______________________________________________________________________ 
- Part of plant/animal  (which part______________________________);   Entire  
- State of maturity: immature ; ripe  
- Storage conditions when collected: __________________________________________ 
- Labels and ingredients list: ________________________________________________ 
______________________________________________________________________ 
Process and preservation method: canned  smoked  sun-dried   
other  ___________________ 
- Other comments: (e.g. Unusual food- Take picture!) ______________________________ 
_____________________________________________________________________ 
 
C) Record of collection:  
- Date of collection:     |___|___|/|___|___|/|___|___| 
 
- Time of collection:      |___|___|:|___|___| 
- Name of collector: ___________________________________________ 
- Sampling point type: field , garden , rural market , shop , other  
specify:______________  
- Place of origin (village): Jiffarong , Janneh Kunda  Keneba   
Other  specify: _____________ 
 
- Weight of food collected:     |___|___|___|___| (gr) 
- Number of items:  |___|___| 
 
- Other relevant details: ____________________________________________ 
 
- Preparation method for consumption (cooking method, time of cooking, addition of 
water/oil, etc): 
________________________________________________________________________________________________________ 
________________________________________________________________________________________________________ 
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FORM IG02B –LABORATORY FOOD PROCESSING FORM 
- Sample code number:  |___|___|___|___|___| 
- Processing date:  |___|___|/|___|___|/|___|___| 
- Name of person handling sample: _____________________________________________ 
Cooking 
- Part of the food processed (preparation/cleaning): _________________ 
________________________________________________________________________ 
- Cooking      Yes  No (raw)  
- If boiled: Time |___|___|___| 
- Weight before cooking: |___|___|___| (gr)       +    added water  |___|___|___| (gr) 
- Weight after cooking: |___|___|___| (gr) 
Processing 
- Weight of blended ingredient for sample: |___|___|___| (gr)  
- Weight of blended ingredient and container: |___|___|___| (gr) 
- Date/time of freeze-drying start:  |___|___|/|___|___|/|___|___|  |___|___|:|___|___| 
o Weight at 0 h: |___|___|___| (gr) 
o Weight at 12 h: |___|___|___| (gr) 
o Weight at 24 h: |___|___|___| (gr) 
o Weight at 36 h: |___|___|___| (gr) 
o Weight at 48 h: |___|___|___| (gr)    
o Other: Hours |___|___| 
- Date/time of freeze-drying end:  |___|___|/|___|___|/|___|___|  |___|___|:|___|___| 
 
Storage 
o At -40ºC  
o Comments: 
________________________________________________________________________________________________________
________________________________________________________________________________________________________ 
 
Preparation of composite sample (check Excel template for calculation on % and 
reconstitution) 
- Mixing date:  |___|___|/|___|___|/|___|___| 
- Sample code of composite sample: |___|___|___|___|___| 
 
Shipping 
- Date of dispatch for overseas laboratory:  |___|___|/|___|___|/|___|___| 
- Need for water reconstitution on arrival: |___|___|___| (gr) 
- Comments: __________________________________________________________________________________________ 
________________________________________________________________________ 
 APPENDIX XII: Examples of DINO data entry screens 
a) Main menu 
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b) Food composition 
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c) Recipe 
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d) Dietary intake   
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e) Snacks 
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APPENDIX XIII: Menses questionnaire (urine collection after 2nd missed 
menses) 
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